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Abstract 
Introduction: Despite the ongoing developments in cochlear implantation (CI) surgery and 
improvements in hearing preservation, the benefits gained have been overshadowed by the 
fact that a proportion of patients have lost part or all of their residual hearing in the implanted 
ear. The underlying cause of this loss remains unclear and prompts questions regarding the 
biological effects of CI on cochlear structure and function. Animal models are the only means 
of assessing the effects of CI at a cellular and molecular level. The range of naturally occurring 
and genetically-modified mice which mimic human deafness provide excellent opportunities 
for auditory research. To date, there are very few studies of CI in mice. The main aims were 
to develop a reproducible and viable technique of mouse CI and assess the response of the 
mouse cochlea to implantation. 
Methods: CI via the round window was performed in C57BL/6J mice. Two age groups were 
chosen to examine the effects of implantation in the early and later stages of hearing loss, and 
to examine for any implantation-accelerated hearing loss. The contralateral cochlea acted as 
a control. Auditory brainstem response (ABR) audiometry prior to and at time-points following 
CI was undertaken. Following sacrifice, cochleae were harvested and prepared for histological 
examination. 
Results: ABR analysis showed greater threshold shifts in the implanted ear compared to the 
control ear post-implantation, but substantial preservation of hearing, especially at the low 
frequencies. Cone beam computed tomography and light microscopy confirmed correct 
placement of the electrode array within the scala tympani. Histological analysis showed an 
inflammatory response and encapsulation of the implant in tissue with features suggesting the 
presence of fibrosis. 
Conclusion: The results demonstrate that mouse CI via the round window is feasible and 
provides a means for exploring the interface between the biological and technological aspects 
of CI.  
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CHAPTER 1: INTRODUCTION 
 
Worldwide, there are approximately 360 million people who suffer disabling hearing loss, the 
majority being sensorineural in nature. Within the UK around 10 million people are affected by 
hearing loss with around 800,000 suffering with a severe or profound loss. As life expectancy 
is set to rise, the World Health Organisation (WHO) predicts that by 2030 there will be an 
estimated 14.5 million people in the UK with hearing loss, making it one of the top ten disease 
burdens ahead of conditions such as diabetes. Hearing loss is a major public health issue with 
significant personal and social consequences. Difficulties with speech interpretation may result 
in communication problems and delayed language acquisition. Social isolation and exclusion 
may also arise in older patients suffering with hearing loss (Action on Hearing Loss 2012; 
World Health Organization 2012)  
 
Cochlear implants have revolutionised the treatment of profound hearing loss, however, their 
full potential is yet to be realised. At present, cochlear implantation (CI) is limited to selected 
patient groups and the effects of CI on residual cochlear structure and function remains to be 
fully addressed. This thesis is aimed at developing a novel mouse model of CI to aid 
investigation into the effects of implantation. This chapter provides a general description of the 
human auditory system before providing a background on cochlear implants and what is 
known to date regarding their biological effects on the inner ear. The use of animal models in 
CI studies is also discussed together with the advantages of using mice as a model for auditory 
research.  
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1.1 Anatomy and physiology of the human auditory apparatus 
 
1.1.1 The external and middle ear 
The auricle (or pinna) and external auditory canal constitute the external part of the ear and 
act to collect sound and aid transmission to the tympanic membrane. The structure and form 
of the external ear also allows the sound to be enhanced by acting as a resonator (Gates and 
Mills 2005; Wright and Valentine 2008). The middle ear comprises the tympanic cavity, 
Eustachian tube and the system of mastoid air cells. The tympanic cavity containing the 
ossicular chain and intratympanic portion of the facial nerve is housed within the temporal 
bone and is bounded laterally by the tympanic membrane and medially by the osseous 
labyrinth.  
Sound travels via the external auditory canal to the tympanic membrane, a three-layered 
sheet-like structure whose displacement in response to sound allows energy to be transmitted 
to the semi-rigid ossicular chain. This consists of three bones; the malleus, incus and stapes. 
The most laterally placed ossicle, the malleus, is attached in part to the tympanic membrane 
and articulates at its head to the body of the incus. The incus in turn articulates with the head 
of the third and final ossicle, the stapes, via its lenticular process. The stirrup-shaped stapes  
has two crura which extend from the head to connect independently to the footplate, which in 
turn attaches to the oval window, coupling sound (acoustic) energy from the middle ear to the 
inner ear (Wright and Valentine 2008). The anatomy of the ear is demonstrated in Figure 1.1. 
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Figure 1.1 Normal anatomy of the human external, middle and inner ear  
(Reproduced from http://droualb.faculty.mjc.edu/) 
 
1.1.2 The inner ear 
The inner ear consists of the cochlea, vestibule and semicircular canals. It is contained within 
the bony labyrinth or otic capsule which itself is embedded within the petrous portion of the 
temporal bone. The human cochlea has basic characteristics common to all mammals. It is 
essentially a spiral tubular structure lined with membranes which separate it into various fluid-
filled compartments which converge at the vestibule (Furness and Hackney 2008). It is 
generally accepted that the human cochlea has two and three-fourth turns  (Hardy M 1938) 
but studies have shown anatomical variations with up to three turns being present in some 
(Biedron et al., 2009).  
The base of cochlea contains the round and oval windows. The former is membrane bound 
whereas the latter is covered by the footplate of the stapes. It is at the cochlea’s base where 
high frequency sounds are detected, whereas the more apical portion is sensitive to low 
frequency sounds. The stapes overlying the oval window is the point at which the sound waves 
cause pressure changes within the cochlear fluids and allow transmission of sound to the inner 
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ear. Situated more inferior and posterior to the oval window, the round window vibrates in the 
opposite phase to those vibrations entering at the oval window, allowing release of the 
pressure induced secondary to sound stimulation. This dissipates energy within the otherwise 
incompressible internal cochlear fluids, preventing rupture of the delicate membranes 
(Furness and Hackney 2008) (Figure 1.2).  
 
 
 
 
 
 
 
 
 
 
 
 
1.1.2.1 Structure of the cochlea 
The cone shaped modiolus acts as the central bony axis of the cochlea, occupying the initial 
two turns of the cochlea spiral. Projecting from the modiolus, the bilamellar osseous spiral 
Figure 1.2 Human cochlea 
A. Microdissection of human 
cochlea (left) contained within the 
bony labyrinth or otic capsule, which 
appears yellow in the image. (Taken 
from Rask-Andersen 2012) 
B. Diagram of temporal bone cross-
section showing inner ear. The 
membranous and bony canals of 
the cochlea and vestibule are 
shown. The stapes is shown 
overlying the oval window. Situated 
more posterior and inferior, the 
round window is marked by an * 
(Taken and adapted from Forge and 
Wright 2002). 
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lamina also follows the cochlea turns and divides the bony canal into scala vestibuli above and 
the scala tympani below. At its medial border on the upper plate, the endosteum of the spiral 
lamina becomes thickened to form the spiral limbus, which projects into the cochlear duct. The 
area between the vestibular lip (superiorly) and the tympanic lip (inferiorly) of the spiral limbus 
is defined as the inner spiral sulcus. The spiral limbus is covered by interdental cells which 
when followed laterally lie in continuity with the cells lining the inner spiral sulcus and which 
medially (towards the modiolus) are continuous with epithelial cells forming part of Reissner’s 
membrane. Secretions from the interdental cells form the tectorial membrane which projects 
from the vestibular lip to cover the central portion of the organ of Corti (Figure 1.3)  (Krstic 
1991). 
The scala tympani and scala vestibuli, together with the scala media, compose the three main 
fluid-containing compartments within the cochlear duct. The scala vestibuli and the scala 
tympani converge at the helicotrema located at the cochlear apex. The scala media is an 
extension of the membranous labyrinth and is triangular in cross-section, bounded inferiorly 
by the basilar membrane and superiorly by Reissner’s membrane. The latter membrane runs 
from the spiral limbus at the modiolus to the lateral bony cochlea wall and consists of a two-
cell layer separated by a basement membrane. The basilar membrane extends from the 
osseous spiral lamina to the spiral ligament, a thickened area of endosteum on the inner 
aspect of the of the lateral cochlea wall. It is on top of the basilar membrane that the organ of 
Corti is positioned. The spiral ligament makes up part of the lateral cochlear wall together with 
the stria vascularis. Both of these latter structures play an important role in the maintenance 
of cochlear homeostasis (discussed below) (Figure 1.3) (Furness and Hackney 2008; Krstic 
1991). 
The scala media contains endolymph, a potassium (K+)-rich fluid (approximately 140mM) 
which is low in sodium ions and varies in composition to most extracellular fluids. Within the 
cochlea the endolymph has a high positive electrical potential (approximately +80mV) called 
the endocochlear potential. This compartment is isolated both in an electrical and chemical 
manner from both the scala tympani and scala vestibuli which contain perilymph, a fluid high 
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in sodium and low in potassium ions. Maintenance of the endocochlear potential is essential 
to auditory function and relies on the effective separation of the two fluids at the level of the 
junctions between the epithelial cells surrounding the endolymphatic spaces (Forge and 
Wright 2002). 
 
1.1.2.2 The Organ of Corti 
The organ of Corti comprises a mosaic of supporting and sensory cells and is the key sensory 
component of the cochlea. Its surface is covered in part by the two sensory cells of the cochlea; 
the inner and outer hair cells (IHCs and OHCs). In the adult human cochlea, approximately 
3000 IHCs are arranged as a single row and around 9000-10000 OHCs are organised in 3 or 
4 rows along a length of about 35mm (Forge and Wright 2002; Wright 1983). The supporting 
cells are attached to the basilar membrane whereas the hair cells are located in the more 
luminal layer of the epithelium. The tunnel of Corti can be found running between the inner 
and outer hair cell rows and is bounded on its inner and outer aspects by inner and outer pillar 
cell rows respectively (Figure 1.3).  
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Figure 1.3 Histologic sections of human cochlea 
A. Mid-modiolar histologic section showing normal human cochlea. The central spiral of the modiolus is 
seen together with the three fluid-filled compartments of the cochlea: scala vestibuli (SV), scala media 
(SM) and scala tympani (ST). The helicotrema represents the area where the scala tympani and scala 
vestibuli converge. 
B. A higher magnification of the histologic section in B, shows the organ of Corti (OC) positioned upon 
the basilar membrane (BM). Reissner’s membrane can be seen forming the roof of the SM. The spiral 
ganglion is located within the modiolus and contains the cell bodies of bipolar neurons relaying auditory 
information from the organ of Corti to the auditory (cochlear) nerve.  
C. A higher magnification of histologic sections A and B, shows the organ of Corti in more detail. The 
sensory cells: inner hair cell (IHC) and outer hair cells (OHC) can be seen, together with their supporting 
cells including specialised Deiter’s or phalangeal cells (inner and outer, IPh and OPh), inner pillar (IP) 
and outer pillar cells (OP), Hensen’s and Claudius cells. The tunnel of Corti is also shown. The osseous 
spiral lamina and spiral limbus are shown, the latter with its vestibular lip (VL) and tympanic lip (TL) 
delineating the inner spiral sulcus (ISS). The outer spiral sulcus (OSS) is a groove between the spiral 
ligament and the organ of Corti. The interdental cells (IC) of the spiral limbus are also noted with the 
tectorial membrane (TM). The spiral prominence, stria vascularis (StV) and spiral ligament are also 
highlighted. 
(Histologic sections taken and adapted from human temporal bone library at otopathologynetwork.org) 
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1.1.2.3 Hair cells   
Outer hair cells of the organ of Corti are cylindrical in shape with a basally located nucleus. 
The sensory aspect of the OHCs lies at its apical portion, where the stereocilia are located. 
Here the arrangement of the stereocilia gives rise to the ‘W’ or ‘V’-shaped characteristic 
appearance. The IHCs are located closest to the inner sulcus and modiolus, with their apical 
surface covered in stereocilia which project up towards the overlying tectorial membrane and 
endolymph of the scala media. The OHC stereocilia make contact with the overlying tectorial 
membrane, whilst those of the IHCs do not (Furness and Hackney 2008). The IHCs act to 
convey auditory information to the brain by transforming sound-induced motion of the basilar 
membrane into electrical signals which are conveyed via auditory nerve afferents. OHCs in 
contrast, are mechanical effector cells which act as the cochlear amplifier, enhancing the 
auditory stimulus by way of electromechanical feedback. They are responsible for increasing 
the frequency selectivity and amplitude of the basilar membrane vibration to low-level sounds 
(Ashmore and Kolston 1994; Fettiplace and Hackney 2006). The amplification of vibrations by 
OHCs occurs as a result of molecular motors which induce mechanical changes of the OHC 
in response to alterations in membrane potential. This motor protein is known as prestin and 
is found exclusively within the lateral plasma membrane of OHCs (Zheng et al., 2000).  
 
1.1.2.4 Hair bundle 
The sensory hair bundle is made up of stereocilia which increase in height progressively away 
from the modiolus. The kinocilium is a single distinct axonemal cilium which stands behind the 
row of the tallest stereocilia and is present during development of the hair bundle but 
degenerates thereafter as the cochlea matures and is not present in adulthood. The tip of each 
stereocilia is the point at which contact is made with the next. The apical portion of the OHC 
bundle is in contact with the overlying tectorial membrane. In the case of inner hair cells, 
however, contact with the overlying tectorial membrane is not made, rather the stereocilia are 
displaced by friction against the endolymphatic fluid (Robles and Ruggero 2001). Polarity of 
the hair bundle is defined by the position of the kinocilium and the longest row of hair cells. 
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Depolarisation of the hair cells occurs with a deflection of the stereocilia in the direction of the 
kinocilium, opening ion channels and allowing an influx of K+ ions. Movement in the opposite 
direction causes a hyperpolarisation as channels are closed (Forge and Wright 2002) 
 
1.1.2.5 Supporting cells 
The supporting cells of the organ of Corti provide important architectural structure and support 
to the hair cells and epithelium. By intervening between neighbouring hair cells, the supporting 
cells prevent contact between adjacent hair cells. These cells also act to separate the hair 
cells from the basilar membrane by resting on the extracellular matrix that underlies the 
sensory epithelium (Forge and Wright 2002). The IHCs are enclosed completely by the inner 
phalangeal cells on the strial side and border cells on the modiolar side. Junctional complexes 
found at the apex of the cells connect them to the IHCs and to surrounding supporting cells. 
Both types of cells are thought to play a protective role by expressing transporters which 
remove glutamate (the primary neurotransmitter found at the base of hair cells) following its 
release, thereby preventing glutamate-induced nerve cell damage which can occur following 
an auditory insult (Furness and Hackney 2008). At the bases of the OHCs are the specialised 
Deiter’s cells which project their thin phalangeal processes to intervene between the hair cells. 
It is the repetitive triangular configuration of the OHCs and their supporting Deiter’s cells 
beneath the reticular lamina which gives them strong mechanical support. Further support at 
the outer edge of the organ of Corti is provided by both Hensen’s and Claudius’ cells (Figure 
1.3) (Krstic 1991). 
 
1.1.2.6 Ion transporting epithelia of the inner ear and maintenance of the endocochlear 
potential 
As mentioned earlier, effective sensory transduction in the human inner ear is dependent upon 
maintenance of the endocochlear potential and tight regulation of K+ ions. The latter is partly 
achieved through coupling and direct communication between all supporting cells via large 
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numbers of gap junctions. These function to remove intercellular K+ ions from within the 
sensory epithelium as they pass from hair cells, thereby maintaining a low K+ ion concentration 
around the base of the hair cell to create an environment conducive for stimulation and 
transduction (Forge and Wright 2002). Although this extensive communication exists between 
the supporting cells of the organ of Corti, no gap junctions have been identified between 
supporting cells and hair cells, providing functional isolation of the former (Forge et al., 2013; 
Jagger and Forge 2006; Santos-Sacchi and Dallos 1983; Taylor et al., 2012). Gap junctions 
play a vital role in fluid homeostasis and intracellular signalling within the inner ear (Kikuchi et 
al., 2000b). Two gap junction networks work together to mediate the circulation of K+ between 
the perilymph and endolymph. The ‘epithelial gap junction network’ is composed of epithelial 
cells from the basilar membrane, supporting cells and outer sulcus cells. The ‘connective 
tissue gap junction network’ is formed by the intermediate and basal cells of the stria vascularis 
and the fibrocytes of the spiral ligament (Kikuchi et al., 2000a). The latter allows direct cell-to-
cell communication between the basal and intermediate cells and also with spiral ligament 
fibrocytes. The interaction between cells in each network via the numerous gap junctions mean 
that the recycling of K+ ions between the endolymph, hair cells, perilymph and spiral ligament 
can occur to effectively maintain the endocochlear potential (Forge and Wright 2002). 
 
Stria vascularis 
As the key secretory epithelia, the stria vascularis is a vital component within the cochlea 
responsible for the production and maintenance of the K+-rich endolymph. It contains a 
complex network of capillaries and drains via venules found on the scala tympani side. 
Compartmentalisation of the stria vascularis exists with three distinct cell layers: basal, 
intermediate and marginal cells (Figure 1.4). Separation from Reissner’s membrane and the 
spiral prominence occurs via the placement of spindle-shaped border cells (Ciuman 2009).  
The basal cells are elongated and placed in close apposition with gap junctions providing 
communication between adjacent cells. They act to separate the stria from the underlying 
connective tissue forming a border along the spiral ligament (Cable and Steel 1991). 
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Intermediate cells are derived from the neural crest and contain melanin pigment. Studies in 
mice have shown that these cells are not only essential for normal strial development, but that 
they are also vital in the production of the endocochlear potential (Steel et al., 1987). 
The marginal cells are also actively involved in K+ transport. Infoldings occurring at the 
basolateral aspect of the cells increase surface area for ion exchange and this together with 
the presence of condensed mitochondria and high levels of Na+/K+-ATPase, mean the cells 
are specially adapted for active transport of K+. Although the marginal cells are in contact with 
the other cells in the stria through their processes, they are a functionally distinct unit lacking 
gap junctions both between each other and also between themselves and the intermediate 
and basal cells. Tight junctions do however exist between marginal cells and the line of cells 
providing a barrier against the endolymph on the apical side of the stria vascularis (Ciuman 
2009; Forge and Wright 2002).  
 
Spiral ligament 
Cells of the spiral ligament are also thought to be important in the maintenance of cochlear 
homeostasis. Of the five different types of fibrocytes present within the spiral ligament, types 
II, IV and V have a role in drawing K+ from the perilymph. This acts to generate an intracellular 
diffusion gradient to promote the movement of K+ ions through gap junctions to strial basal 
cells and other fibrocytes. Type II fibrocytes are also active in pumping K+ between the break 
that exists between the epithelial and connective tissue gap junction networks, thereby 
directing the flow of ions (Spicer and Schulte 1996). 
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1.1.2.7 Cochlear tonotopicity 
The basilar membrane is coupled to the overlying tectorial membrane via the hair cell 
stereocilia. As a result, oscillations of the basilar membrane give rise to movement of the hair 
bundles. Variations in compliance and stiffness along the basilar membrane mean that this 
movement is non-uniform; at the apex the membrane is wider and more compliant whereas 
towards the basal end, it is narrower and stiffer (Rask-Andersen et al., 2012; Robles and 
Ruggero 2001). In assessing the vibrational response of the basilar membrane to sound, von 
Békésy described the propagation of the wave travelling along the basilar membrane, 
increasing in amplitude and reaching a maximum before decaying. He related maximal 
displacement of the basilar membrane to a function of stimulus frequency. He described low 
frequency waves peaking at the cochlear apex and high-frequency stimuli causing maximal 
displacement of the basilar membrane at the basal end of the cochlea (von Bekesy 1956). 
This results in hair cells at the apical end of the cochlea being stimulated by low-frequency 
sounds and those in the basal cochlea being stimulated by higher frequencies, giving rise to 
a spatial or tonotopic representation of sound frequency along the length of the cochlea. This 
Figure 1.4 Stria vascularis  
The basal cells (BC), intermediate 
cells (IC) and marginal cells (MC) 
cells and capillaries (C) are clearly 
seen. Adjacent fibroblasts of the 
spiral lamina are also labelled.  
 
(Taken from Human Microscopic 
Anatomy, R.V. Krstic) 
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concept of tonotopicity is maintained at every level within the auditory pathway all the way up 
to and including the auditory cortex (Figure 1.5)  (Mann and Kelley 2011). 
 
 
 
 
 
 
 
Figure 1.5 Pathway of sound conduction together with a tonotopic frequency map of the cochlea 
(inset in box). Vibrations of the tympanic membrane (t) in response to sound waves are transmitted by 
the ossicular chain (malleus (m), incus (i) and stapes (s) to create pressure waves within the cochlear 
fluids. These waves stimulate movement of the basilar membrane and stereocilia of the hair cells, where 
mechanical stimuli are converted to electrochemical stimuli. The cochlea is shown uncoiled in the main 
image and coiled in the inset image. Both are labelled with sound frequencies from 0.1 to 20kHz 
according the region of the cochlea that frequency stimulates. (Image taken from Fettiplace and Hackney, 
2006). 
 
1.1.2.8 Innervation of the organ of Corti 
Innervation of IHCs occurs exclusively by afferent nerves. These neurons contribute to more 
than 90% of the neurons present within the spiral lamina and reflect the major role played by 
the IHCs in transmitting auditory information to the brain. The remaining 5-10% of afferent 
innervation arises from the OHCs. Conversely, efferent innervation to the organ of Corti mainly 
consists of medial olivocochlear efferents connecting with bases of OHCs, innervating both 
the ipsilateral and contralateral cochlea. Lateral olivocochlear efferents arising in the lateral 
superior olive, terminate on the peripheral processes of Type I SGCs below the IHCs of the 
ipsilateral cochlea. These arrangements reflect the primary roles of the hair cells: the IHCs as 
receptors and more of a modulatory role for the OHCs (Forge and Wright 2002; Raphael and 
Altschuler 2003).  
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Spiral ganglion cells (SGCs) are a key component of the neuronal pathway. The extensive 
afferent fibres arising from these cells combine to form the auditory nerve which in turn, 
transfers auditory data to the cochlear nucleus within the brainstem. The cell bodies of the 
SGCs are located within the modiolus and correspond to the course of the organ of Corti. Two 
types of SGC neurons exist; Type I which are large bipolar neurons which make up the majority 
(90-95%) and innervate the IHCs, and Type II, smaller and pseudounipolar neurons which 
innervate the OHCs (Raphael and Altschuler 2003)  
As movement of the IHC stereocilia is activated, ion channels are opened allowing influx of K+ 
and calcium ions. The resulting transduction current opens voltage-gated calcium channels in 
the basal and lateral wall of the IHC, which in turn drive calcium activated K+ channels to open. 
These steps give rise to the release of the neurotransmitter glutamate at the base of the hair 
cell. Ribbon synapses exist between IHCs and the peripheral processes of Type I neurons. 
Presynaptic vesicles containing glutamate cover the ribbon within the active zone and ensure 
a continuous supply of vesicles are readily available for exocytosis at the plasma membrane 
(Trussell 2002). Each ribbon is capable of multivesicular release which is thought to enable 
sustained transmission in the presence of an ongoing sound stimulus (Glowatzki and Fuchs 
2002). Whilst Type I neurons have a single peripheral process which makes contact with only 
one IHC, IHCs receive connections from multiple peripheral processes. As the 
neurotransmitter released from the hair cell makes contact with postsynaptic afferent boutons 
of the Type I neurons, an action potential is generated and transmitted to the brain via the 
auditory nerve (Raphael and Altschuler 2003; Trussell 2002).  
Type II neurones innervate the OHCs and represent 5-10% of the population. OHCs differ 
from IHCs in that there are a lack of synaptic ribbons at the presynaptic terminal and far fewer 
neurotransmitter-containing vesicles present. When stimulated, OHCs do release 
neurotransmitter in response to transduction currents at the basal ends of the cells, however, 
there is a relatively poor synaptic transfer compared to IHCs. There is limited data on the role 
of Type II neurons compared to Type I neurons, however, studies have shown that they are 
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likely to operate as cochlear afferents and may act to provide integrated feedback from the 
cochlear amplifier (Jagger and Housely 2003; Weisz et al., 2009). 
The central nerve processes from the SGCs enter the mid-modiolus at the cochlear apex and 
spiral down with the successive addition of more processes to the nerve bundle until it grows 
to its maximum diameter and exits at the internal acoustic meatus. Within the auditory nerve, 
the central portion carries low frequency fibres and the periphery contains fibres conveying 
high frequency information. This tonotopicity is maintained throughout the rest of the 
ascending auditory pathway up to the auditory cortex and includes the cochlear nuclear 
complex, superior olivary complex, inferior colliculus and medial geniculate nucleus (Saenz 
and Langers 2014).  
 
1.2 Classification of hearing loss 
Hearing loss can be classified by type (conductive, sensorineural,mixed or non-organic), 
severity, onset (pre- or postlingual) and cause (congenital or acquired) (Kochhar et al., 2007). 
Conductive hearing loss typically arises due to pathology affecting the external ear and or the 
middle ear. Examples of the former include wax occlusion, canal stenosis and atresias. In 
terms of the latter, middle ear disease giving rise to conductive hearing deficits can be 
temporary and fluctuating e.g. otitis media with effusion, or progressive e.g. otosclerosis. 
Audiological consequences are represented by the presence of an air-bone-gap and varying 
degrees of loss which can be amenable to surgical intervention often with promising results. 
Sensorineural hearing loss (SNHL) results from abnormalities of the cochlea, cochlear nerve 
or auditory pathway. Conditions may be hereditary or acquired and give rise to varying degrees 
of hearing deficits. A combination of both conductive and SNHL components give rise to a 
mixed type of loss. Problems occurring at the higher levels such as the vestibulocochlear 
nerve, brainstem and cerebral cortex can lead to central auditory dysfunction (Kochhar et al., 
2007; Wright and Valentine 2008).  
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There are various classifications of hearing loss based on severity, with formal quantitative 
definitions grading hearing impairment on audiological criteria, with slight variations between 
organizations. The WHO classifies hearing loss into five categories (Table 1) (World Health 
Organization 2013). Disabling hearing impairment is classed as grade 2 or more with unaided 
hearing threshold levels for the better ear of 41 dB or more. The hearing threshold is defined 
as the lowest level sound that can be heard more than 50% of the time. A limitation of the 
WHO classification, however, is that it is based on the better hearing ear.  Definitions of hearing 
impairment according to the British Society of Audiology (BSA) (British Society of Audiology 
1988) are shown in Table 2 and are based on the average pure tone thresholds at 0.25, 0.5, 
1, 2 and 4 kHz. 
Table 1.1 WHO grades of hearing impairment (World Health Organization 2013) 
Grade of impairment Corresponding 
audiometric ISO value 
Performance Recommendations 
0 - No impairment 25 dB or better 
(better ear) 
No or very slight hearing 
problems. Able to hear 
whispers. 
  
1 - Slight impairment 26-40 dB 
(better ear) 
Able to hear and repeat 
words spoken in normal 
voice at 1 metre. 
Counselling. Hearing 
aids may be needed. 
2 - Moderate 
impairment 
41-60 dB 
(better ear) 
Able to hear and repeat 
words spoken in raised 
voice at 1 metre. 
Hearing aids usually 
recommended. 
3 - Severe impairment 61-80 dB 
(better ear) 
Able to hear some 
words when shouted 
into better ear. 
Hearing aids needed. If 
no hearing aids 
available, lip-reading 
and signing should be 
taught. 
 
4 - Profound 
impairment including 
deafness 
81 dB or greater 
(better ear) 
Unable to hear and 
understand even a 
shouted voice. 
Hearing aids may help 
understanding words. 
Additional rehabilitation 
needed. Lip-reading and 
sometimes signing 
essential. 
The audiometric ISO values are averages of values at 500, 1000, 2000, 4000 Hz. 
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Table 1.2 British Society of Audiology definitions of hearing loss  (British Society of Audiology 
1988) 
 
Descriptor of hearing loss Hearing level 
 
Mild 20 - 40 dB 
 
Moderate 41 - 70 dB 
 
Severe 71 - 95 dB 
 
Profound Greater than 95 dB 
 
 
1.3 Aetiology of hearing loss 
There are a variety of genetic and environmental causes leading to hearing impairment. 
Acquired hearing loss can be caused by a range of environmental factors including ageing, 
ototoxic drugs, acoustic trauma and infections (Dror and Avraham 2009; Gibbin 2008; Kochhar 
et al., 2007). Prenatally, viral infections due the ‘TORCH’ organisms (toxoplasmosis, other 
infections, rubella, cytomegalovirus and herpes) together with drug exposure in utero and 
erythroblastosis fetalis can give rise to acquired SNHL. Postnatally, bacterial meningitis due 
to Neisseria meningitides is the most common cause of acquired SNHL in childhood. Other 
infectious causes include Streptococcus pneumoniae, Haemophilus influenzae and 
cytomegalovirus (Gibbin 2008; Kochhar et al., 2007). Hearing loss attributed to genetic factors 
is caused by mutations in various genes or regulatory elements which form part of the 
development of the structure and function of the ear. The interplay between environmental 
and genetic factors is also observed as triggers in the former can induce or contribute to 
hearing loss in an individual with an underlying genetic-susceptibility (Dror and Avraham 
2009). Examples include PCDH15 and MYH14 as potential susceptibility genes in noise-
induced hearing loss (Konings et al., 2009) and a mitochondrial mutation in the 12S ribosomal 
RNA gene predisposing to aminoglycoside ototoxicity (Fischel-Ghodsian 2005). 
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1.3.1 Genetic causes 
The inheritance mode of mutations leading to genetic hearing loss can be autosomal dominant 
(DFNA), autosomal recessive (DFNB), mitochondrial or X-linked (DFN). Characteristically 
prelingual, autosomal recessive conditions account for between 77-93% of all cases of genetic 
hearing loss. Conversely, autosomal dominant causes account for 10-20%, with mitochondrial 
and X-linked disorders making up the remainder of cases (Duman and Tekin 2012). Inherited 
hearing impairment can be categorised as syndromic hearing loss (SHL) which is associated 
with other clinical features as well as hearing loss and non-syndromic hearing loss (NSHL), an 
inherited SNHL in the absence of additional clinical features.  
A systematic review of the aetiology of bilateral SNHL in children revealed NSHL to account 
for 29.2% of cases, with a much smaller percentage 3.2% attributed to SHL (Morzaria et al., 
2004). Although the majority of genetic hearing loss is sensorineural in nature, there are a few 
cases which lead to CHL (Dror and Avraham 2009). For example, mutations in the POU3F4 
gene, located on the X chromosome, causes DFN3 deafness which is characterised by stapes 
fixation and a middle ear conductive loss. Other inherited CHLs include Treacher Collins 
syndrome, Goldenhar syndrome and Osteogenesis imperfecta. (U.S.National Library of 
Medicine 2006).  
A variety of genes for SHL have been discovered since the identification of the first gene, 
USH2A (for Usher syndrome) which was mapped in 1990. These include those for Stickler 
syndrome, Alport syndrome, Treacher-Collins syndrome, Waardenburg syndrome and 
Branchio-Oto-Renal syndrome (see table 3) (Dror and Avraham 2009; Hereditary Hearing 
Loss Homepage 2013; Kochhar et al., 2007). With regards to NSHL, the first recessive locus 
to be mapped in 1994 was the DFNB1 which was later found to be associated with the GJB2 
or connexin 26 (CX26) gene (Dror and Avraham 2009). Mutations in the genes that encode 
connexins are the most common cause of NSHL loss, with up to 50% of reported cases due 
to mutations on CX26, the predominant connexin of the cochlea. Connexin 30 (CX30) is 
another major cause and is encoded by the gene GJB6. Connexins form part of intracellular 
gap junction channels and therefore play a vital role in cell-cell communication and electrolyte 
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transportation (Dror and Avraham 2009; Vivero et al., 2010). Associations of other mutations 
in CX26 or CX30 with various skin conditions in conjunction with hearing loss have also been 
noted, including keratitis-ichthyosis-deafness syndrome, Vohwinkel syndrome, palmoplantar 
keratoderma and Bart-Pumphrey syndrome (Xu and Nicholson 2013). Other autosomal 
recessive and autosomal dominant genes associated with NSHL are shown in Table 1.4 
(Bitner-Glindzicz 2008). 
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Table 1.3 Genes associated with SHL  (Hereditary Hearing Loss Homepage 2013; Kochhar et al., 
2007) 
Syndrome Chromosomal locus Gene symbol 
 
Autosomal dominant 
 
Branchio-oto-renal (BOR) 
BOR1  
BOR2  
BOS3  
 
Waardenburg 
WS1  
WS2  
WS3 (Klein-Waardenburg syndrome) 
WS4 (Shah-Waardenburg or Waardenburg-
Hirschsprung) 
 
 
 
Stickler 
STL1  
STL2  
STL3  
STL4  
 
Neurofibromatosis 
NF2  
 
Treacher-Collins 
TCOF1 
 
 
 
 
8q13.3  
1q31  
14q  
 
 
2q35 
3p14.1-p12.3  
2q35 
13q22  
20q13.2-q13.3  
22q13  
 
 
12q13.11-13.2  
6p1.3  
1p21  
6q13 
 
 
22q12  
 
 
5q32-q33.1 
 
 
 
 
EYA1 
Unknown 
SIX1 
 
 
MITF 
SNAI2 
PAX3 
EDNRB 
EDN3 
SOX10 
 
 
COL2A1 
COL11A2 
COL11A 
COL9A1 
 
 
NF2  
 
 
TCOF1 
Autosomal recessive 
 
Pendred  
 
Usher 
USH1A  
USHIB  
USH1C  
USH1D  
USH1E  
USH1F  
USH1G  
USH2A  
USH2B  
USH2C  
USH3  
 
Jervell and Lange-Nielsen 
JLNS1  
JLNS2  
 
 
 
7q21-34  
 
 
14q32  
11q13.5  
11p15.1  
10q22.1  
21q21  
10Q21-22  
17Q24-25  
1q41 
3p23-24.2  
5q14.3-q21.3  
3q21-q25  
 
 
11p15.5  
21q22.1-q22.2  
 
 
SLC26A4/PDS 
 
 
Unknown 
MYO7A 
USH1C 
CDH23 
Unknown 
PCDH15 
SANS 
USH2A 
Unknown 
VLGR1 
USH3A 
 
 
KCNQ1 
KCNE1 
X-linked 
 
Alport  
 
 
 
Xq22  
2q36-2q37 2q36-2q37  
 
 
COL4A5 
COL4A3 
COL4A4 
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Table 1.4 Genes associated with NSHL. Autosomal recessive (below left) and autosomal dominant 
(below right) genes associated with NSHL (Taken from Bitner-Glindzicz 2008). 
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1.3.2 Age-related hearing loss 
Presbycusis can be defined as hearing loss due to the ageing process. Age-related hearing 
loss (ARHL) is a term used to encompass the cumulative effects of insults over a lifetime which 
may give rise to hearing impairment, including the effects of noise, genetic susceptibility, 
ototoxic agents, ageing and other systemic pathological processes. Although some authors 
choose to differentiate between the terms, presbycusis and ARHL are often used 
synonymously; this is especially because it is difficult to segregate ageing effects from the 
many other likely variables involved. ARHL is the main cause of acquired hearing loss 
worldwide and the most common sensory disability in the elderly. Cognitive, behavioural and 
emotional problems are recognised adverse effects associated with this type of untreated 
hearing loss, which may lead to depression, loss of self-esteem and social isolation (Gates 
and Mills 2005; Sprinzl and Riechelmann 2010).    
For some elderly patients acceptance of the impairment as an inevitable consequence of the 
ageing process, together with reluctance, embarrassment and concerns regarding cost, 
means that they do not seek help. Conversely, other individuals experience denial in 
recognition and acceptance, attributing the difficulty to mumbling speakers (Gates and Mills 
2005). The causes of ARHL can be classified according to anatomical and physiological 
alterations within the ear. With regards to the outer ear, changes including excess cerumen 
production and poor epithelial migration, often giving rise to wax impaction may have an effect 
on increasing the air-bone gap. However, these effects are minimal as are those associated 
with the ageing middle ear which include tympanic membrane alterations (thinning, stiffening 
and loss of vascularity) and arthritic changes within the ossicular joints.  
The cochlea, however, is significantly affected by the ageing process (Chisolm et al., 2003; 
Gates and Mills 2005). Schuknecht originally described four categories of presbycusis based 
on histopathologic findings which were correlated with audiometric results. Sensory 
presbycusis was so-called due to primary hair cell loss within the organ of Corti. This was 
associated with the classic audiometric findings of high-frequency SNHL. The second type 
was neural presbycusis which occurred as a result of spiral ganglion neuron loss. Pure-tone 
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thresholds were found to be stable on testing, however, there was a progressive loss of word 
discrimination. Metabolic presbycusis presented following atrophy of the stria vascularis, a key 
component in maintaining the endocochlear potential. Pure tone audiometry showed a flat or 
descending result, however, word discrimination was maintained. The fourth and final type 
was described as cochlear conductive presbycusis, in the absence of a histological correlate, 
this was associated with a downward-sloping audiogram, with loss mainly in the higher 
frequencies (Schuknecht 1955; Schuknecht 1964). As research has progressed it has become 
clear that the underlying pathological processes occurring in the inner ear secondary to ageing 
cannot be simplified to the concept of these four predominant pathologic types. Rather it has 
emerged that ARHL occurs as a result of the complex interplay between risk factors (ageing, 
environment, co-morbidity and genetic predisposition) and intricate mechanistic pathways 
(Figure 1.6).  The inner and outer hair cells as well as the SGCs, stria vascularis and spiral 
ligament represent potential sites for age-related damage. As it is highly metabolically active, 
the stria vascularis has been noted to be particularly sensitive to insults such as oxidative 
stress secondary to noise exposure, cell loss due to ageing and genetic aberrations. These 
factors together with microvascular disease, can compromise function and lead to hearing loss 
(Ohlemiller 2009). In a similar manner, multifactorial injury to the hair cells and cochlear nerve 
may be observed. Over time, the accumulation of damage from noise, oxidative insults, 
ototoxic drugs and ageing together with poor mechanisms of repair mean that hair cells are 
particularly vulnerable (Yamasoba et al., 2013). 
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Figure 1.6 Conceptual model of the development of ARHL  
(Adapted from Yamasoba et al., 2013) 
 
 
 
 
 
 
 
 
 
 
  
39 
 
1.4 Treatment of hearing loss: Cochlear implants 
The treatment of hearing loss is dependent on the underlying cause, type and severity of the 
hearing impairment. Management can range from various types of amplification to more 
sophisticated middle ear, cochlear and brainstem implants. In patients with profound SNHL, 
cochlear implants are the most appropriate intervention strategy.   
Cochlear implants are the most successful sensory prosthetic device developed to date, as 
shown by their capacity to restore some hearing to those with profound SNHL. With numbers 
continuing to rise, it is estimated that approximately 324,200 individuals have been implanted 
worldwide (National Institute on Deafness and Other Communication Disorders 2016). As 
discussed, normal cochlea function entails the conversion of acoustic energy via the hair cells 
of the Organ of Corti to electrical impulses which subsequently activate the neurones and 
SGCs of the auditory nerve. Information is then passed via the brainstem and auditory portion 
of the midbrain to the auditory cortex. Although SNHL may arise due to disorders at any point 
within this pathway, the majority are accounted for by damage to the sensory hair cells (Cosetti 
and Waltzman 2011). The fragility of these sensory components makes them particularly 
prone to a wide variety of insults including infections, ageing, drugs, noise and genetic defects. 
OHC losses cause degradation in frequency resolution and elevation of hearing thresholds, 
whereas destruction of the IHCs leads to a more profound hearing loss (Wilson and Dorman 
2008b).  
The function of the cochlear implant is, therefore, to bridge the gap left as a consequence of 
the missing hair cells. Consisting of a linear array of platinum electrodes, the prosthesis is 
inserted into the cochlea via the round window or through a cochleostomy, an opening into the 
cochlea generally sited anterior and inferior to the round window. The site of insertion is usually 
sealed with muscle tissue to prevent perilymph leakage. The electrode array is connected to 
a transducer mounted externally converting sounds into electrical signals. These signals act 
to stimulate remaining cochlear neural elements (spiral ganglion neurons) and provide the 
implant recipient with a useful representation of environmental sounds that assist the 
understanding of speech (Wilson and Dorman 2009). 
  
40 
 
1.4.1 Design and function of the cochlear implant 
 
1.4.1.1 Components of cochlear implant systems 
The key components within the cochlear implant system are illustrated below (Figure 1.7) with 
details regarding functionality given in Table 1.5. The raw signal detected by the external 
components comprising of the microphone and speech processor, is modified and refined prior 
to delivery to the implanted array. Various speech processing strategies are employed by the 
different implant manufacturers with the aim of converting the raw signal into one which 
highlights and retains features needed for speech recognition. The concept that speech 
consists of a variety of bands or formants of spectral energy forms the basis of many of the 
earlier speech processing strategies used in CI. These act to analyse the signal and identify 
the major spectral peaks in each frame before transmitting the information to the internal coil 
via inductive coupling through the skin.  
Current devices use one or a combination of processing strategies which in broad terms aim 
to mimic the organ of Corti’s tonotopic organisation. Information regarding consonants is 
conveyed across both low and high frequencies, whereas mainly lower frequencies 
correspond to vowels which are involved in the intonation, rhythm and the stress of speech. 
However, relaying an acoustic signal’s temporal fine structure is often limited and therefore 
impacts on the CI users’ perception of speech in noise (Fu et al., 1998; Schafer and Thibodeau 
2004; Wolfe et al., 2009), perception of tonal language (Han et al., 2007; Xu et al., 2004) and 
their appreciation of music (Alexander et al., 2011; Gfeller et al., 1998).  
In order for effective function of the implant, the individual components should work together 
as one system. A weakness within one component can cause a reduction in performance of 
the system as a whole. The auditory pathways within the brainstem and auditory cortex which 
act to convey the electrical information are also key components of the system. Variations in 
functional reliability and capabilities of this biological system can, therefore, explain the 
diversity of outcomes exhibited between implanted patients (Wilson and Dorman 2008a). 
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Table 1.5 Components of cochlear implant 
Component 
 
Function 
Microphone Environmental sound sensor 
Speech processor Transforms output from microphone into a set of 
stimuli for implanted electrode array 
Transcutaneous link Transmission of power and stimulus information 
across the skin 
External transmitter coil Produces radiofrequency signal 
Receiver/stimulator 1) decodes information received from the 
external transmitter 
2) uses the decoded information to generate 
stimuli 
Multi-wire cable Connects the outputs from the 
receiver/stimulator to the individual electrodes 
Electrode array Inserted into the scala tympani of the cochlea to 
provide electrical stimulation to neural 
components 
 
Figure 1.7 Components of a 
cochlear implant system 
(A) Schematic of implant system 
in place 
1. Microphone 
2. Coil 
3. Intracochlear electrode array 
(B) Individual components of 
system 
(Images from Cochlear® Ltd at 
www.cochlear.com) 
 
 
 
A 
B 
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1.4.1.2 Electrical stimulation of the auditory nerve 
Both the afferent and efferent pathways between the peripheral and central auditory systems 
become disconnected as a result of the lack of hair cells in the deafened cochlea. In the 
absence of normal stimulation, without the presence of both sensory and supporting cells, 
peripheral cochlear nerve fibres which extend from the organ of Corti to cell bodies within the 
spiral ganglion, undergo retrograde degeneration. Whilst the underlying mechanism for this is 
controversial the overall result is the moderate to complete loss of peripheral processes within 
the cochlea (Shepherd and Javel 1997). The ultimate effect on SGCs, however, is variable as 
temporal bone studies have shown that they can often survive these insults and remain in 
large numbers (Hinojosa and Marion 1983). Survival of these neuronal cell bodies is important 
in CI as they are thought to be the presumed site of excitation, although should more peripheral 
processes be present, stimulation at these sites may also occur. The majority of CI systems 
in use at present require insertion into the scala tympani of the cochlea, with access gained 
either via the round window or a cochleostomy. Electrical currents pass along the array to 
electrodes lying within the scala tympani to produce stimulation of the remaining neural 
portions. The anatomical arrangement of the scala tympani lumen, which narrows from base 
to apex, together with the natural spiral curvature of the cochlea mean that insertion depths 
further than 30mm is precluded. The presence of partial cochlear ossification may also cause 
obstruction and limit insertion depth. Typical insertion depths vary from 18-26mm (Wilson and 
Dorman 2008a). 
Cochlear implants are multichannel devices which are designed to allow stimulation of isolated 
neuronal subpopulations by each electrode contact when placed within the cochlea. The 
theory is that specific regional stimulation generates a different sound percept as the spatial 
arrangement of electrodes utilises the tonotopic arrangement of the cochlea. Low frequency 
tones are generated towards the electrodes placed more apically, whereas higher tones are 
generated by electrodes within the basal portion. Temporal coding of the auditory signal occurs 
based on the electrical stimulation of contacts over time. The number of nerve cells stimulated 
as a result of the current intensity stimulating a single contact determines loudness perception 
(Lenarz et al., 2013; O'Leary et al., 2009).  
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Current implant systems utilise a monopolar arrangement in which stimuli are presented to 
single electrodes within the array with reference to an electrode positioned in a more distant 
location, most commonly beneath the temporalis muscle or in some cases adjacent to the 
receiver/stimulator case. This wide spacing between the active and receiver electrode means 
that the current is spread over a wider neuronal range. A greater number of neurons are 
stimulated as a result and in turn this means that monopolar systems can achieve higher levels 
of loudness using comparatively lower levels of current and therefore, less battery power. The 
alternative is a bipolar system in which the electrodes are placed more closely as pairs with 
stimuli passing between them, hence stimulating a much more focused population of neurons. 
The monopolar system also has the advantage that differences in thresholds between 
electrodes within the array are much lower compared to the bipolar setup which in turn 
corresponds to increased ease and simplicity of speech processor fitting in patients (Wilson 
and Dorman 2008b; Wilson and Dorman 2009).  
One challenge within the system is the non-specific stimulation of neurons adjacent to the 
target neuronal population which occurs as a result of current dispersal not only between 
electrodes, but also via the perilymph in a longitudinal manner along the cochlea. This means 
that although there can be between 12 and 22 electrode contacts within an implant, only 
around 8 distinct perceptual channels are available and functioning (Dorman et al., 1998; 
Friesen et al., 2001). This number is adequate for speech comprehension in quiet but not in 
the presence of background noise, where it is thought that up to 20 perceptual channels may 
be needed to hear well (Dorman et al., 1998). For users to appreciate music more than 30 
channels which can also function on a specific spectral and temporal scale are required (Kong 
et al., 2004; Xu and Pfingst 2003). There are a variety of factors that can influence an implant’s 
ability to stimulate a more discrete neuronal population. One is the proximity of the electrode 
to the target neurons. When the distance between the electrode and the nerve is increased, 
the current required to activate the target is increased which in turn leads to the greater 
perilymphatic spread and decay of the electrical signal. This can be overcome in part by 
increasing the space between electrodes, however, this also increases the distance over 
which the current will need to be transmitted, requiring more power. By bringing the neuronal 
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targets into closer apposition with the electrode, a smaller current can be used with less spread 
and reduced power requirements (Snyder et al., 2008; Wilson and Dorman 2008a; Wilson and 
Dorman 2009). One way in which this is achieved is through the use of perimodiolar 
electrodes. On insertion these implants curve to lay in closer apposition to the SGCs within 
the modiolus with electrodes positioned on the medial aspect of the electrode array. Although 
these implants have been shown to maintain tonotopicity, reduce thresholds, improve dynamic 
range and the specificity of neural excitation, these changes have not consistently translated 
to improvements in speech recognition or music appreciation (Shibata et al., 2011). Another 
important factor which can influence spatial specificity of the electrodes is the state of the 
implanted cochlea in terms of the presence of fibrosis, ossification and nerve survival. 
Improving spatial resolution at the electrode-neural interface may be approached in a variety 
of ways ranging from advancements in electrode design to improving the state of the implanted 
cochlear through soft-surgical techniques to studies exploring neuronal fibre regeneration. 
Such areas remain the focus of much ongoing research in the field and are necessary for gains 
in perceptual performance to occur. 
 
1.4.2 Challenges in CI 
 
1.4.2.1 Expansion of candidacy 
Traditionally, candidates for cochlear implants have fallen into two main groups: infants and 
young children with congenital bilateral profound hearing loss; and postlingually deafened 
children and adults. The well-documented success in these groups has raised the profile of CI 
in the last 20 years. However, although the overall gains in these groups have been significant, 
there is still scope for improvement with regards to enhancing their understanding of speech 
in noise and appreciation of music. In order to address this and broaden the potential of CI, 
there have been continuing changes and improvements in technology and surgical technique. 
Such advances have also led to an expansion of candidacy to include groups who previously 
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would not have been considered such as children under the age of one, prelingually deafened 
adolescents and adults, patients with auditory neuropathy spectrum disorder, multiple 
disabilities or those with abnormal cochlear pathology such as deficient cochlear nerves 
(Cosetti and Waltzman 2011). Both children and adults have also reaped the benefits of 
bilateral CI which has shown positive results with regards to speech performance and sound 
localization (Bond et al., 2009). It has also led to patients with ARHL (Eshraghi et al., 2009; 
Lundin et al., 2013; Migirov et al., 2010; Noble et al., 2009; Rafferty et al., 2013; Sprinzl and 
Riechelmann 2010) and others with low-frequency residual hearing being implanted (Balkany 
et al., 2006; Boggess et al., 1989; Clark et al., 1995a; Gantz and Turner 2003; Hodges et al., 
1997; James et al., 2005; Kiefer et al., 2004; Shiomi et al., 1999; Skarzynski et al., 2002) 
 
1.4.2.2 CI in the elderly 
Despite the increasing prevalence of ARHL with the expanding ageing population, CI in older 
patients has been met with hesitation. This is due to concerns regarding fitness for surgery, 
age-related degenerative changes in the auditory system and rehabilitative potential post-CI. 
However, research now suggests that age should not be used as the sole reason for rejecting 
an older patient for CI. The perception that advanced age is the key risk factor for general 
anaesthesia is outdated and several studies have shown that in fact it is well-tolerated and 
without significant morbidity and mortality (Alice et al., 2013; Coelho et al., 2009; Lundin et al., 
2013). However, this is with the caveat that a thorough pre-operative evaluation is performed 
with relevant co-morbidities used as a predictor of perioperative complications rather than age 
alone (Carlson et al., 2010; Coelho et al., 2009). An intact auditory pathway, from functioning 
SGCs to cortex, is also required for successful CI and has been a further concern regarding 
CI in the elderly. A decline in general cognitive function and neural plasticity together with 
degenerative changes in the auditory system, both centrally and peripherally, means that there 
are multiple points at which the pathway may be adversely influenced by ageing, therefore 
affecting outcomes following CI (Cosetti and Waltzman 2011). Despite this a number of studies 
have shown improvements in speech perception after CI, with additional benefits in terms of 
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self-confidence and improved quality of life (Alice et al., 2013; Carlson et al., 2010; Eshraghi 
et al., 2009; Lundin et al., 2013; Migirov et al., 2010; Rafferty et al., 2013) 
 
1.4.2.3 CI in patients with residual hearing 
With regards to those patients with low-frequency residual hearing, implantation has involved 
use of electroacoustic stimulation (EAS) which comprises an electrode array for electrical 
stimulation of the higher frequencies, with conventional amplification to stimulate the low-
frequencies. Many of the early studies into the use of EAS showed promising results following 
implantation including improvements in the patient’s understanding of speech in noise and 
appreciation of music (Fraysse et al., 2006; Gantz et al., 2005; Gantz and Turner 2004; Gfeller 
et al., 2006; James et al., 2006; Lenarz et al., 2006). In many of these studies, however, 
hearing preservation outcomes varied as did the duration of follow-up.  
A systematic review of EAS undertaken by Talbot and Hartley in 2008 included 253 EAS 
candidates from 23 trials where shorter electrodes were used. The results demonstrated some 
preservation of hearing in 87% of patients, with improvements in pitch perception. However, 
24% of patients had a significant increase in their acoustic hearing loss and 13% lost all 
remaining residual acoustic hearing. The authors concluded that although the use of EAS 
shows great potential, the loss of residual hearing cannot be ignored, with ongoing larger 
clinical trials recommended (Talbot and Hartley 2008). Since the review, several authors have 
taken EAS forward with modifications in electrode design and surgical technique as discussed 
below. 
A multicentre trial conducted in 2009 by Gantz and colleagues included 87 patients who were 
implanted with the 10mm Iowa/Nucleus Hybrid Implant (Hybid S, Cochlear™) consisting of 6 
electrodes at its distal end. In an attempt to be minimally invasive and allow the best chance 
of preserving residual hearing, the electrode design was shorter (10mm), with a reduced 
diameter and was designed to sit within the scala tympani of the descending basal turn only, 
having been introduced via a cochleostomy. Initial results at one month post-CI showed that 
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residual low-frequency hearing was maintained in 98% of subjects and that some degree of 
hearing preservation was maintained between 3 and 24 months post-implantation in 91% of 
subjects. The majority of these patients found the use of EAS improved speech understanding 
compared to preoperatively when using bilateral hearing aids alone. However, 2 patients 
experienced complete hearing loss within the first month following implantation and a further 
6 subjects in the subsequent follow-up period of 3 to 36 months. Overall, 91% of patients 
maintained some degree of hearing preservation. However, of those patients, 30% 
experienced threshold changes of more than 30dB (Gantz et al., 2009).  
The Hybrid-L electrode (Cochlear™) is another shorter electrode (16mm) designed to be less 
traumatic but with a full complement of 22 electrodes, made to occupy 270° of the basal turn. 
In the case of the Hybrid S, if complete loss of residual hearing occurs, the patient may find 
the 6 active electrodes too few to gain appreciable hearing improvements and would therefore 
need to undergo removal and re-implantation with a longer electrode. With its 22 electrodes, 
the Hybrid-L has the advantage that should residual hearing be lost; the electrode can be used 
in the traditional manner without the need for replacement. Lenarz et al. (2009) reported 
preliminary findings of the Hybrid-L in a group of 32 patients, 24 of whom had substantial 
residual hearing at implantation. Use of EAS showed significant improvements in auditory 
performance in the implanted ear when compared to preoperative levels when using acoustic 
stimulation only. Their results showed that there were no cases of complete hearing loss and 
that residual hearing was preserved within 30dB and 15 dB in 96% and 68% of patients 
respectively. For the 16 patients for whom data at 12 months was available, 94% had 
maintained residual hearing within 30dB of the initial thresholds and 69% within 15dB (Lenarz 
et al., 2009). Other studies of EAS have also shown positive results in terms of hearing 
preservation, speech understanding and spatial awareness (Lorens et al., 2008; Skarzynski 
and Lorens 2010).  
Despite the ongoing developments and improvements in EAS, the benefits gained have been 
overshadowed by the fact that a proportion of patients have lost a substantial part or all of their 
residual hearing in the implanted ear. This is significant since one of the major preconditions 
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of the device is hearing preservation. Although residual hearing appears to be preserved 
initially in many patients, progression of hearing loss can then occur at a faster rate than would 
be anticipated due to the natural process of their disease. The underlying cause of this loss 
remains unclear and prompts questions regarding the biological effects of CI on cochlear 
structure and function (Mowry et al., 2012; Santa Maria et al., 2013). Possible reasons for the 
loss have been proposed such as an immune reaction in response to the electrode and the 
impact of the combination of both acoustic and electrical stimulation at the hair cell causing 
loss of the afferent spiral ganglion neuron synapse (Mowry et al., 2012). In the early days of 
EAS it was anticipated that animal models would form the crucial basis for investigating many 
key questions such as the effects of electrical stimulation on the still functioning cochlea and 
preservation of hearing. However, as the initial clinical trials revealed such positive outcomes, 
the result has been for the basic science and clinical studies to progress alongside each other 
rather than in series (von Ilberg et al., 2011). The true long-term effects of EAS are yet to be 
ascertained. These concerns need to be addressed before EAS can be further extended in a 
wide-reaching manner to individuals with greater residual acoustic hearing such as children 
and elderly patients with ARHL. 
 
1.4.2.4 Biological effects of CI 
Intracochlear damage as a result of CI can be immediate or delayed. Immediate damage can 
occur at the site of insertion, along the electrodes trajectory and secondary to the disruption 
of the cochlear fluids. Delayed damage involves the host response to CI and the loss of 
function of intracochlear structures (Li et al., 2007). The extent of the traumatic damage and 
consequent potential death of remaining hair cells and neurons that is caused by the implant 
procedure is important due to the growing interest of CI in patients with residual hearing. Like 
many biomedically-active implantable devices, cochlear implants have the potential to provoke 
an acute inflammatory reaction initially. This then progresses to the chronic phase in response 
to the sustained presence of the electrode, ultimately resulting in the formation of a fibrous 
capsule around the implant (Richard et al., 2012). While a fibrotic reaction is most likely helpful 
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with respect to tissue repair at the site of insertion itself, increasing evidence suggests 
encapsulation of the implant significantly reduces electrical signal transmission between 
implantable devices and their target neurons. This may reduce the utility of the device by 
increasing power consumption, and increasing the spread of the electrical field generated by 
electrode stimulation (Fayad et al., 2009). The consequent reduction in the efficacy of signal 
coding, increases implant size, reduces battery life and in many patients the devices need to 
be replaced. It is not known whether the fibrotic reaction results from the surgical trauma at 
the site of the cochleostomy, from the muscle tissue used in sealing the incision, or from 
immune responses to the implanted foreign body within the cochlea, or a combination of any 
or all these factors.  
 
1.4.2.5 Temporal bone studies of CI trauma 
Evaluation of cochlear trauma and the effects of electrode insertion has generated ongoing 
interest from researchers. One of the first published studies documented mechanical damage 
from electrode insertion largely within the region of the spiral ligament (Shepherd et al., 1985). 
Since then there have been numerous studies. Investigation of the biological effects of CI in 
humans has mainly been restricted to cadaveric studies of temporal bones which have 
provided useful information (Cervera-Paz and Linthicum, Jr. 2005; Fayad et al., 2009; Kawano 
et al., 1998; Linthicum, Jr. et al., 1991; Marsh et al., 1992; Nadol, Jr. 1997; Nadol, Jr. et al., 
2001; Somdas et al., 2007). Nadol et al. (2001) analysed the cochleae from 8 patients who 
had undergone CI with multichannel devices via cochleostomy. Duration of CI ranged from 1 
to 8 years with patients aged between 54 to 84 years. Insertion-related trauma to the soft 
tissue of the lateral wall, predominantly of the ascending basal turn, was universal. Coinciding 
within the region of this trauma, neo-osteogenesis was also noted in 6 of the patients for whom 
there was no evidence of labyrinthitis ossificans pre-implantation. In 4 of the patients, the 
contralateral non-implanted temporal bone was available for comparison when assessing 
SGC numbers. The majority revealed no significant difference in terms of the SGC count. A 
negative correlation between SGC numbers and performance assessed during life using 
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single-syllable word recognition was also noted (Nadol, Jr. et al., 2001). These findings have 
been echoed by other authors (Fayad and Linthicum, Jr. 2006; Nadol, Jr. et al., 1994; Somdas 
et al., 2007). More recently, Seyyedi and Nadol (2014) analysed 28 temporal bones for an 
inflammatory response in patients implanted with multichannel devices. Their results revealed 
the presence of foreign body giant cell infiltration together with a granulomatous reaction in 27 
of the 28 temporal bones. Significantly greater numbers of giant cells and lymphocytes were 
noted at the site of cochleostomy in comparison to the middle and tip portions of the electrode 
(Seyyedi and Nadol, Jr. 2014). All of the aforementioned studies were from temporal bones of 
patients who had undergone CI during life, however, cadaveric implants, where implants are 
performed on temporal bones after death, have also been used by researchers to provide 
valuable data on implantation trauma (Gstoettner et al., 1997; Shepherd et al., 1985; Welling 
et al., 1993).   
 
1.4.2.6 CI trauma at a cellular and molecular level 
Even in the absence of any macroscopic trauma, tissue trauma at a molecular level may still 
occur leading to hair cell damage and death (Eshraghi and Van De Water 2006).  These 
mechanisms may be initiated via inflammatory and oxidative reactions. The presence of 
cytokines such as tumour necrosis factor alpha (TNF-α) is well-documented following injury in 
the cochlea and can initiate both intrinsic and extrinsic apoptotic programmed cell death 
pathways leading to hair cell death. The presence of reactive oxygen species following trauma 
can also activate apoptosis. The sustained presence of inflammation is associated with growth 
factors such as transforming growth factor-β1 (TGF- β1) which contribute to fibrous scar 
deposition through a fibroproliferative response (Bas et al., 2012a).  
 
1.4.2.7 Surgical approach: round window vs cochleostomy 
In order to ameliorate the effects of electrode insertion and minimise trauma, one focus has 
been to modify and optimise surgical techniques. Array insertion can be performed via the 
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round window or via a cochleostomy to access the scala tympani of the basal turn. Most 
surgeons have their own preference regarding their approach and as yet there is no consensus 
as to which is superior (Mangus et al., 2012). The round window provides direct access to the 
scala tympani and would appear to be the obvious choice, with several temporal bone studies 
demonstrating the potential for minimising collateral damage (Adunka et al., 2004; Briggs et 
al., 2006; Richard et al., 2012; Roland et al., 2007). Other advantages include avoiding noise 
exposure from the 130dB generated from drilling the cochleostomy  (Pau et al., 2007) and a 
reduction in post-operative vertigo (Todt et al., 2008). However, negotiating the hook region 
on entering the round window is technically challenging, with the possibility of causing 
inadvertent damage to important structures which run in an anterior direction from the posterior 
round window margin such as the spiral ligament, basilar membrane, osseous spiral lamina 
and scala media. The alternative approach of the cochleostomy involves drilling a hole into 
the promontory to gain access to the scala tympani. Placement is usually anterior and superior  
to the round window membrane. This approach has the advantage that the hook region of the 
basal turn does not have to be negotiated (Mangus et al., 2012). Another method known as 
the extended round window approach, positions the cochleostomy at the anterior aspect of 
the round window. A recent meta-analysis of hearing preservation surgery for CI included 24 
studies and revealed superior results with the cochleostomy approach compared to round 
window insertions. The former, however, included true cochleostomy approaches as well as 
extended round window insertions as the authors were unable to distinguish between the two 
when undertaking their analysis (Santa Maria et al., 2014). 
 
1.4.2.8 Soft surgery in CI 
Overall, it appears that rather than the approach itself, whether it be via the round window or 
via cochleostomy, the way in which the cochlea is opened, using a controlled and meticulous 
manner is the more relevant and vital factor in minimising trauma and preserving hearing. 
Aside from direct mechanical trauma, several other factors in CI are a potential source of injury 
and have the ability to compromise residual hearing. These include the displacement of blood 
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and bone particles into the perilymph during surgery, use of the drill giving rise to acoustic and 
vibratory trauma and the disruption of cochlear homeostasis and the endocochlear potential 
(Bas et al., 2012a). The concept of ‘soft surgery’ was first introduced in 1993 by Lehnhardt 
and has remained an important part of CI surgical methodology, especially with the increasing 
emphasis on hearing preservation (Lehnhardt 1993). The main aim of soft surgery is to avoid 
mechanical trauma to the cochlea and to minimise the initiation of factors that may promote 
adverse reactions such as the formation of fibrosis and neo-osteogenesis. The key factors, 
outlined in a review by Friedland et al. (2009) include the prevention of blood and bone dust 
entering the perilymph, as well as care in avoiding contact of the drill with the ossicular chain 
and cochlear endosteum. The use of hyaluronate, both as a protective agent and as a lubricant 
is also supported, as is the avoidance of suction of the perilymph and the use of systemic 
steroids (Friedland and Runge-Samuelson 2009; Laszig et al., 2002). Attention must also be 
paid to insertion depth and any resistance felt when introducing the electrode array as this 
may indicate that the tip is abutting the basilar membrane, lateral wall or osseous spiral lamina. 
Continued force could in turn lead to damage and potential misplacement of the electrode 
outside of the scala tympani (Carlson et al., 2012; Friedland and Runge-Samuelson 2009).  
 
1.4.2.9 CI and therapeutics 
Cochlear implants allow access to the inner ear and therefore the possibility of combining 
hearing rehabilitation with pharmacotherapy.  Another area of key interest, therefore, is the 
use of drugs and therapeutics to reduce the adverse effects of inflammation and fibrosis and 
to also slow and potentially reverse the loss of neural components. Steroids have wide-ranging 
activity including anti-oxidative and inflammatory effects and have already been shown to be 
valuable in helping to preserve hearing in implantation-related trauma models by a number of 
groups (Eshraghi et al., 2007; James et al., 2008; Vivero et al., 2008). An apoptotic-inhibitor 
AM111 (D-JNK-1 inhibitor) has also been investigated in relation to implantation trauma by 
Eshraghi and Van de Water (2006) who demonstrated that treatment with D-JNKI-1 could 
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prevent the progression of hearing loss following electrode insertion trauma (Eshraghi and 
Van De Water 2006).  
Trophic support for the spiral ganglion cells is provided by a variety of factors including brain-
derived neurotrophic factor (BDNF) and neurotrophin 3 (NT-3), together with their receptors, 
tyrosine kinase B and tyrosine kinase C. Most hair cells have been found to express both 
neurotrophins, with the majority of neurons also expressing both receptors. Several studies 
investigating the role of the exogenous application of neurotrophins, BDNF or NT-3 in the 
deafened ear have found significant improvements spiral ganglion neuron survival (Altschuler 
et al., 1999; Nakaizumi et al., 2004; Staecker et al., 1998). In addition, the role of these factors 
in neuritogenesis also shows huge potential with in vivo studies demonstrating growth of 
peripheral neuronal fibres following aminoglycoside deafening and neurotrophin 
administration via the perilymph (Altschuler et al., 1999; Miller et al., 2007; Wise et al., 2005). 
Although regrowth has been disordered, more recent studies using viral vectors have shown 
directional growth patterns towards the basement membrane which will prove more useful in 
terms of CI where they will lie in closer apposition to the electrode array (Shibata et al., 2010; 
Wise et al., 2011). The combined effects of neurotrophic factors together with electrical 
stimulation have also been described with reductions in hearing thresholds and significantly 
greater spiral ganglion neuron rescue compared to the use of neurotrophins alone (Kanzaki et 
al., 2002; Shepherd et al., 2005).  
Overall, the act of opening the cochlea and inserting a foreign body can provoke a biological 
response. Although this may be inevitable, the response can be modified through changes in 
surgical technique and through alterations in electrode design. It may also require further 
clarification into which of the intracochlear responses, provoked by implantation, has the most 
detrimental effect on residual hearing. This would subsequently help focus efforts towards 
other interventions in the form of therapeutics and allow the long-awaited gains in hearing 
preservation CI surgery to be made.  
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1.5 Role of animal models in CI 
Aside from the assessment of human temporal bones, high resolution computed tomography 
(Aschendorff 2011; Kong et al., 2012; Tamir et al., 2012) and analysis of tissue on explanted 
electrode arrays (Clark et al., 2014; Fishpool et al., 2012) are the only other means of 
evaluating the effects of CI in humans. This inability to explore the biological effects of CI in 
patients has therefore led to the development of various animal models which play a key role 
in CI research to date. Animal models are the only means of assessing the effects of CI at a 
cellular and molecular level. Some of the first implants performed were in cats (Brennan and 
Clark 1985; Shepherd et al., 1983). Since then, several authors have taken advantage of this 
model. Chow et al. (1995) examined intracochlear ossification in relation to CI and found a 
significant correlation between the extent of new bone formation and an elevation in hearing 
thresholds (Chow et al., 1995). Kretzmer et al. (2004) used deaf white cats as a model of early-
onset deafness to study their feasibility for investigating the neuronal aspects of CI (Kretzmer 
et al., 2004). More recently, Irving et al. (2014) devised a partial hearing model using kittens 
and adult cats to assess EAS (Irving et al., 2014b). Aside from cats, guinea pigs have been 
the other major animal model for CI. Early studies assessed electrical activity and 
morphological changes as a result of implantation (Duckert and Miller 1982; Duckert and Miller 
1986; Hildesheimer et al., 1979; Spelman et al., 1980). More recently authors have continued 
to use guinea pigs as a means to assess delivery of therapeutics to the inner ear via pumps 
and gene therapy, quantify soft tissue responses, and assess nerve survival patterns in 
relation to CI (Addams-Williams et al., 2011; Atkinson et al., 2012; Nguyen et al., 2009; Pfingst 
et al., 2011). Other animal models for CI have included primates (Parkins 1989; Pfingst et al., 
1979; Pfingst et al., 1995; Shepherd et al., 1995), sheep  (Schnabl et al., 2012) and the 
chinchilla (Saunders et al., 1994). A key component in the selection of the previously 
mentioned animal models for CI has been the size and accessibility to the cochlea. In many 
cases, a full size human electrode array could also be used rather than the additional need to 
manufacture a bespoke array. Other factors such as well-established anaesthetic protocols 
and post-operative care will also have played a part in their selection.  
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In comparison to these models, the use of rodents such as rats, gerbils and mice is considered 
more challenging. This is due to the relatively small size of the cochlea as well as the presence 
of the stapedial artery running through the middle ear cavity, impeding access to the scala 
tympani for implantation. Another issue is the difficulty in developing a multichannel electrode 
array small enough for the rodent cochlea. Despite this, a number of authors have overcome 
such difficulties in both the rat  (Hsu et al., 2001; Lu et al., 2005a; Nagase et al., 2000; Vischer 
et al., 1997) and the gerbil (Adunka et al., 2010; Ahmad et al., 2012; Campbell et al., 2010a; 
Campbell et al., 2010b; DeMason et al., 2012; Hessel et al., 1997). 
 
1.5.1 Mice as a model for auditory research 
The mouse is considered an invaluable model for investigating the genetic basis of human 
disease and is already widely used to explore a variety of conditions including cancer and 
diabetes. Advantages of mice over other animal models include their short life span, the fact 
that they can be handled in a controlled environment, their limited genetic heterogeneity and 
the ease with which they can be manipulated experimentally. In addition to this is the low cost 
in housing and maintaining mice, which can have significant economic benefits for 
researchers. Another key advantage is the availability of isogenic mice which allow more 
controlled studies within these groups and enable comparisons between groups. Next to the 
human, the mouse genome is the most well-characterised of all mammals. As such, over the 
last 50 years, mice have become an established model for auditory research and hold several 
advantages over other animal models.  
The major similarities in anatomical structure of the auditory systems have resulted in mouse 
studies providing important insights into human ear function and ontogenesis. The 
histopathological evaluation of human auditory tissue can only be performed following death 
when numerous other factors can have an effect on investigative outcomes.  Mice are 
therefore extremely useful for such assessment as analysis can be undertaken in a more 
controlled manner (Ahituv and Avraham 2002; Avraham 2003; Kikkawa et al., 2012). The 
human hearing range is between 20Hz to 20kHz whereas mouse hearing goes into the much 
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higher ultrasonic frequencies, with a range of between 1 and 100kHz (Reynolds et al., 2010). 
Although this means that the overlap is only around three octaves (2.5 – 20 kHz), evoked 
potentials on auditory testing in the mouse are very similar to those of humans. Use of auditory 
brainstem response (ABR) audiometry testing in the mouse is also minimally-invasive, low 
cost and simple to perform and provides a consistent means of assessing the peripheral 
auditory neural pathway (Scimemi et al., 2014).  
Mice share a high degree of genetic homology with humans, with many of the auditory mouse 
genes displaying strong geno- and phenotypic similarities to their human counterparts 
(Kikkawa et al., 2012). The diverse range of naturally occurring and genetically-modified 
mouse strains which mimic human deafness have allowed significant progress in the field of 
hearing research to be made. Mutant strains exist through the presence of spontaneous 
mutations or via mutations induced using radiation or chemicals. In the case of the latter, 
examples include the use of N-ethyl-N-nitrosourea (ENU) to create novel models of hearing 
impairment such the Junbo mouse model of otitis media (Parkinson et al., 2006). Gene-
targeted knockouts are a more recent method of producing mutant strains. A key example is 
the specific removal of Cx26. The embryonic lethality of Cx26 knockouts had previously limited 
in vivo attempts to investigate the role of Cx26 in NSHL. However, with targeted ablation, the 
authors were able to overcome such problems, providing insight into the importance of Cx26 
in the development of the organ of Corti and cochlear function (Cohen-Salmon et al., 2002).  
Inbred mouse strains have been used extensively to investigate age-related and noise-
induced hearing loss. Mouse models have helped to identify around 20 ARHL (ahl) loci for 
which 4 of the underlying genes have been isolated. The proteins encoded by three of the 
genes (Cdh23, Gipc3 and Fscn2) are vital for hair cell stereocilia structure. In particular, 
cadherin 23 is an important component of tip links, filamentous links which act as gates to 
transduction channels at the tip of the stereocilia of immature hair bundles (Michel et al., 2005). 
Several inbred strains possess the Cdh23ahl allele including the C57BL/6J mouse which is 
homozygous for this defect. This strain in particular shows progressive loss of hair cells 
together with other changes such as spiral ligament, stria vascularis and afferent neuron 
  
57 
 
degeneration (Ohlemiller 2006). Elevated hearing thresholds in these mice are seen as early 
as 3 months of age and correlate with the progressive loss of both OHCs and IHCs, from the 
basal to apical cochlea, in an age-related fashion. OHC loss in the basal region occurs first, 
followed by basal IHC loss between 3-7 months with subsequent SGC loss and neuronal 
degeneration (Hequembourg and Liberman 2001). In contrast to the early-onset HL seen in 
the C57BL/6J mouse, another commonly used strain, the CBA mouse, exhibits a much later 
pattern of progressive HL at around 22-25 months of age. Hearing loss in these mice is not 
linked to the Cdh23ahl allele. Instead, the presence of an ahl-allele causes a gradual 
deterioration in the high-frequencies as they age, similar to humans (Park et al., 2010).   
 
1.5.2 Mice as a model for CI 
Despite their suitability for auditory research, there are disadvantages to the use of mice and 
some of these may represent possible reasons as to why its use as a model for CI has been 
precluded thus far. The small auditory bulla and cochlea of the mouse makes access difficult. 
The mouse cochlea is around a third of the size of the guinea pig, with an average size of 
2.8mm x 3.5mm (Jero et al., 2001). Electrode implantation is therefore technically challenging 
and this in combination with the lack of availability of an implant of sufficiently small size has 
meant that there are very few published studies of CI in mice to date.  
Authors have, however, accessed the murine cochlea for other reasons. Jero et al.(2001) first 
described the paramedial (ventral) approach to access the mouse cochlea in order to deliver 
a gene therapy vector (Jero et al., 2001). This approach has also been used by other research 
groups (Chen et al., 2006; Jero et al., 2001). Do et al. (2004) used a postauricular approach 
in the CBA/Ca mouse to investigate acute hydraulic trauma in the cochlea. The authors did 
this by means of an alteration in perilymph volume, generated by a bolus injection into the 
basal turn via the round window (Do et al., 2004). Other authors have also used the postaural 
approach to gain access to the auditory bulla to enable cochleostomy and cell injection 
(Bogaerts et al., 2008) as well as for the inoculation of adenovirus vectors for gene therapy 
(Kawamoto et al., 2001; Praetorius et al., 2003). More recently, Akil et al. (2012) adopted both 
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the ventral and postauricular techniques to perform gene therapy via a round window and 
cochleostomy approach (Akil et al., 2012).  
Devising a reproducible and viable model of mouse CI is the next logical step and would enable 
the many positive aspects, which are already being exploited in other areas of auditory 
research, to be harnessed in CI studies. Developing a mouse model of CI would provide a 
means for further exploring the interface between the biological and technological aspects of 
CI. With growing interest in drug delivery and neural engineering to enhance the efficacy of 
CI, many are looking towards the use of improved animal models. The establishment of a 
mouse model will also be advantageous in this area as it will allow further exploration of the 
regulation of neurotrophins and the development of mechanisms for delivering therapies to 
the cochlea. 
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1.6 AIMS 
 
The aims of this study are to: 
1. Develop a reproducible and viable surgical technique for mouse CI. 
 
2. To assess functional outcomes following mouse CI in the absence of electrical 
stimulation. 
 
3. To assess the histopathological effects of mouse CI, in the absence of electrical 
stimulation. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 Drugs and nutritional support 
The various drugs and nutritional support used are given below in Table 2.1.  
Table 2.1 Drugs and nutritional support 
Drug/Product Trade name Concentration Supplier 
Ketamine Narketan®-10 10mg/ml Vétoquinol UK Limited 
(Buckingham, UK) 
Medetomidine 
 
Domitor® 0.1mg/ml Orion Corporation (Espoo, 
Finland) 
Atipamazole 
 
Antisedan® 5mg/ml Orion Corporation (Espoo, 
Finland) 
Buprenorphine 
 
Vetergesic® 0.3mg/ml Reckitt Benckiser Healthcare 
UK Ltd (Kingston upon Thames, 
UK) 
Carbomer 
(Liquid tears) 
 
Viscotears® 2mg/g Novartis AG (Basel, 
Switzerland) 
Nutrient fortified 
water gel 
DietGel® 
Recovery 
 
n/a Clear H2O (Portland, Maine, 
USA) 
 
2.1.2 Surgical equipment 
The surgical equipment used is given below in Table 2.2. 
Table 2.2 Surgical equipment 
Equipment Supplier 
All surgical instruments including dissecting 
forceps, scissors, blades, small animal 
magnetic fixator retraction system and small 
vessel cauteriser kit. 
Fine Science Tools (Interfocus Ltd, Linton, 
UK) 
Specialised animal recovery chamber Harvard Apparatus Ltd (Kent, UK) 
Skeeter drill with 0.5mm burr Medtronic Ltd (Hertfordshire, UK) 
Surgical drapes, disposable gowns, surgical 
skin preparation fluid and masks 
3M Healthcare (Bracknell, UK) 
 
Sterile surgical gloves 
 
Premier Healthcare & Hygiene Ltd (Tyne 
and Wear, UK) 
Fluorocarbon thread (‘dummy’ implant, 
0.185mm tip diameter) 
Grand Max Soft-Plus, Kureha Corporation 
(Tokyo, Japan) 
Electrode array (0.21mm tip diameter) Cochlear™Ltd 
5-0 monocryl suture Ethicon (Livingston, Scotland, UK) 
Histoacryl® tissue adhesive TissueSeal LLC (Ann Arbor, MI, USA 
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2.1.3 Laboratory equipment 
All reagents and materials used in tissue preparation and for immunofluorescence were 
purchased from Sigma-Aldrich (Dorset, UK) unless otherwise stated.  
 
 
2.2 METHODS 
2.2.1 Animal Surgery 
 
2.2.1.1 Choice of mouse strain 
C57BL/6J mice aged 3 and 6 months were used. This strain exhibits an early-onset hearing 
impairment which begins in young adulthood around 3-4 months of age. This pre-disposition 
is related to a defect in the Cdh23ahl allele of the cadherin 23 gene, a vital component of 
stereocilia of hair cells (Ohlemiller 2006). Hearing loss occurs spontaneously without the need 
for ototoxins or noise, typically starting with the high frequencies at the basal cochlear portion 
and progressing to involve the lower frequencies over a time period of 12-15 months. In the 
latter stages, hearing loss is profound with corresponding sensorineural changes observed on 
cochlear histopathology (Henry and Chole 1980; Mikaelian et al., 1974; Ohlemiller 2006; 
Willott 1990). As a result of this progressive high to low frequency hearing loss, C57BL/6J 
mice are an established model to study age-related hearing loss (Ohlemiller 2006; Prosen et 
al., 2003; Shnerson and Pujol 1981; Spongr et al., 1997; Willott 1990).  
For the purposes of the current study, mice aged 3 months and 6 months were used. Three 
month old mice typically have near normal hearing thresholds or may start to show signs of 
hearing loss affecting higher frequencies only. At 6 months, this high frequency sensorineural 
hearing loss is established and may progress to include mid-frequencies. Use of the older 
mice is important as it allows assessment of implantation on residual hearing and enables 
investigation to see whether or not the act of implantation accelerates hearing loss by 
comparing results with the younger age group. 
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C57BL/6J mice were obtained from our own breeding colony and were housed in suitable 
conditions with free access to food and water. All work was performed in accordance with 
regulated, licensed procedures of the British Home Office Project Code (1276). Work was 
approved by the Animal Ethics Committee of UCL.  
 
2.2.1.2 Pre-, intra- and postoperative procedures 
As the main aim of the project was to develop a viable and reproducible mouse model of 
cochlear implantation, much of the detail regarding the choice of anaesthetic, operative 
planning and procedure are discussed in the subsequent results chapter. A brief outline of the 
pre-, intra- and postoperative care undertaken is discussed below. The choice of surgical 
technique was influenced by a desire to maximise the information yielded from experiments 
whilst minimising the number of animals operated upon and of the invasiveness of the surgery 
in line with Home Office regulations. 
A designated operating facility was set up and surgery performed under sterile conditions. 
C57BL/6J mice were weighed and anaesthetised using intraperitoneal ketamine (Narketan®-
10, Vétoquinol UK Limited, 0.01ml/g of 10mg/ml) and medetomidine (Domitor®, Orion 
Corporation, Finland, 0.005ml/g of 0.1mg/ml). Half dose of buprenorphine (Vetergesic®, 
Reckitt Benckiser Healthcare (UK) Limited, 0.1mg/kg of 0.03mg/ml) was also given at 
induction and anaesthesia confirmed by the absence of pedal reflexes. Body temperature was 
maintained at 37˚C using a heated mat and monitored using a rectal thermometer. Following 
induction of anaesthesia, fur in the left post-aural region was shaved to expose the skin. This 
area was subsequently prepared using topical chlorhexidine and the animal placed on a 
heated mat in a semi-prone position. Surgical drapes were used to maintain a sterile operating 
field. Care was taken to ensure that the depth of anaesthesia could be monitored and if 
required, supplemental anaesthetic was given for maintenance purposes. Eyes were coated 
with a lubricating eye gel to protect the corneas from abrasions. 
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Following a post-auricular incision, the round window was accessed and implantation 
performed. Two types of implant were used. One was an inert fluorocarbon thread (‘dummy’ 
implant; 0.185mm tip diameter, Grand Max Soft-Plus, Kureha Corporation, Japan) (n=21). The 
other was a specialised electrode array (n=16) comprising parylene coated platinum/iridium 
wire with 4 electrodes, measuring 0.21mm in diameter at the tip (supplied by Cochlear Ltd). In 
all instances, the contralateral right cochlea acted as a control. Intraoperatively, great care 
was taken to maintain body temperature and prevent hypothermia using a heated mat and 
adequate draping of the animal. Temperature monitoring was performed using a rectal 
thermometer.  
In the immediate post-operative period, the mouse was placed within an animal recovery 
chamber (Harvard Apparatus Ltd, Kent, UK) to maintain body temperature at 37˚C. The 
remaining dose of buprenorphine was administered together with subcutaneous warmed 
saline according to body weight and the reversal drug atipamazole (Antisedan®, Orion 
Corporation, Finland, 0.002ml/g of 0.5mg/ml subcutaneously). Supplemental oxygen was also 
given to support recovery via an adapted face mask.  
Once the mouse had regained normal activity it was transferred to a cage and housed singly, 
with free access to water, wet mash and DietGel® Recovery (Clear H2O, Portland, ME). Mice 
were monitored for any signs of pain or distress and further analgesia was administered as 
required. Weighing and general examination of the surgical site for signs of haematoma, 
infection and wound dehiscence were undertaken on a daily basis for the first week and weekly 
thereafter. The animal’s general appearance and behaviour was also noted, as was the 
presence of any signs to suggest vestibular dysfunction including circling, head-bobbing, 
head-tilting and abnormal reaching responses. Mice were sacrificed and tissue harvested at 
48 hours, 1 week, 4 weeks and 12 weeks after implantation.  
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2.2.2 Auditory brainstem response audiometry (ABR) 
ABRs were recorded in all animals preoperatively and at appropriate time points following 
implantation. General anaesthesia was induced and maintained using intraperitoneal 
ketamine (0.01ml/g of 10mg/ml) and medetomidine (0.003ml/g of 0.1mg/ml). Body 
temperature was maintained at 37˚C using a heated mat and checked using a rectal 
thermometer. Examination of the external auditory canal under the microscope was 
undertaken to check for occluding wax. If present this was carefully removed with a wax hook. 
Needle electrodes were placed subdermally at the hind leg (ground), vertex (active) and lateral 
to the cheek (reference) of the ear being tested. Testing was carried out in a soundproof booth 
and acoustic stimuli were delivered via a directional speaker into the external auditory canal 
(EAC) of the tested ear (See section 2.2.2.1 for justification of set-up used). Click-evoked 
responses were first acquired followed by those to tone pip stimuli at frequencies of 8, 12, 24, 
32 and 40 kHz. Clicks and tones were delivered at 10dB intervals using the Tucker Davis 
Technologies System III (Tucker-Davis Technologies, Alachua, Florida, USA). Calibration of 
the equipment was performed regularly by Dr Ruth Taylor. 
Thresholds were determined by visual inspection to identify the lowest sound pressure level 
at which clear waveforms were apparent. In cases where there was no ABR waveform, at the 
highest stimulus level, a threshold of 90dB was noted. For those mice in which the implant 
was retained for 4 weeks or more, ABR’s were also performed at 2 and 4 weeks and at further 
time points of 8 and 12 weeks postoperatively in mice kept for up to 12 weeks. Comparisons 
between the implanted and control ears were made across the various time points and 
statistical analysis was performed using a paired samples T-Test (IBM SPSS Statistics 21.0) 
with a value of P<0.05 used to define significance.  
 
2.2.2.1 Justification of ABR technique 
When performing the ABR testing for individual ears, a directional sound delivery method was 
used into the EAC of the tested ear. The opposite, untested ear was not routinely occluded 
(Figure 2.1A). In order to ascertain the effects of occlusion and whether it is necessary ABR 
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testing was undertaken in the same mouse with and without the use of occlusion. Occlusion 
of the ear canal was performed using an expandable foam ear plug which filled the canal. The 
test was performed in the absence of any occlusion, occlusion of the opposite (untested ear), 
occlusion of the test ear (in order to check the contribution, if any, of the non-tested ear) and 
with both ears occluded (Figure 2.1B-E). From the results it can be seen that occlusion 
contributed little to the overall ABR outcomes (Figure 2.1 and Figure 2.2). The results with and 
without occlusion of the non-test ear were identical suggesting that use of the occlusive foam 
plug did not make any difference. Where the test ear was occluded, small changes were noted 
in thresholds (≤10dB). Figure 2.3 shows the mean thresholds of 3 mice tested under occluded 
and non-occluded conditions. As shown, there was found to be very little difference between 
the two test conditions suggesting that occlusion would not have significantly altered outcomes 
of functional testing.  
 
2.2.3 Cone beam computed tomography 
Cone beam CT (CBCT) is an upcoming imaging modality which has several advantages over 
other imaging techniques, including higher resolution images, faster image acquisition and a 
reduction in metal artefact. There is growing interest in its use to assess CI patients pre- and 
post-operatively, in particular with regards to the latter to assess scalar electrode position 
(Saeed et al., 2013; Saeed et al., 2014). In view of this, it was deemed an appropriate method 
to assess electrode placement in the mouse post-CI.  
Following implantation with the electrode array and post-sacrifice, CBCT was performed to 
assess electrode placement using a 3D Accuitomo F170 scanner (J. Morita Mfg. Corp, USA - 
access courtesy of Cavendish Imaging, London, UK). The mouse was positioned for optimal 
imaging of the auditory bulla with the implanted electrode array in place. Parameters used for 
scanning included a tube voltage of 97kV and a tube current of 5-7 mA. The total scanner 
rotation time was 17.5 seconds with a cylindrical acquisition volume of 6 x 6cm (diameter x 
height). A 3D volumetric dataset was obtained with an isometric voxel size of 250µm and 
reconstructed images were examined using OneVolumeViewerTM and Amira® software.  
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Figure 2.1 ABR set-up and occlusion experiment 
Standard ABR set up (A) and results following occlusion experiment (B-E). NB: electrodes are shown on 
right side for example of right ear testing. Electrodes were moved accordingly to the opposite side for left 
sided testing. 
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Figure 2.2 Results of occlusion experiment 
Results from non-occluded and occluded ears revealed very similar thresholds on ABR testing. 
 
 
 
 
 
Figure 2.3 Mean ABR thresholds with and without occlusion 
Mean thresholds in 3 mice who underwent ABR with and without occlusion. 
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2.2.4 Sacrifice and harvesting of cochleae 
Mice were sacrificed following the final postoperative ABR either by cervical dislocation alone 
or by CO2 inhalation followed by cervical dislocation in accordance with Schedule 1 of the 
United Kingdom Animals (Scientific Procedures) Act of 1986. Following decapitation, the 
overlying skin was cut and the bony skull exposed and opened along the sagittal suture line 
to access the brain tissue. Closed forceps were used to remove the brain tissue in a ventral to 
dorsal direction. Once the skull base was exposed, the auditory bullae were separated from 
the temporal bone and the cochleae exposed, taking care not to displace the implant.  
 
2.2.5 Cochlear preparations 
 
2.2.5.1 Tissue fixation 
Once isolated, fixative was gently perfused into the cochlea via an opening made by removing 
a small section of bone at the apical tip of the cochlea. The implant was retained in position 
and the cochleae were then immersed in fixative at room temperature and left on a rotator for 
2 hours. Fixative was either 4% paraformaldehyde in PBS for immunohistochemistry or 2.5% 
glutaraldehyde in 0.1M cacodylate buffer with 3mM CaCl2 for examination by electron 
microscopy. Post fixation, cochleae were decalcified in 4.13% ethylenediamine tetra-acetic 
acid (EDTA) in phosphate buffered solution (PBS) or 0.1M cacodylate buffer respectively, for 
48 hours at 4˚C. Following fixation, the implant was carefully removed unless otherwise stated.  
 
2.2.5.2 Cryosections  
Following decalcification, cochleae were rinsed in PBS and incubated in 30% sucrose in PBS 
at 4˚C overnight. They were then embedded in 1% low-temperature setting agarose gel in 
18% sucrose in PBS with sodium azide (NaN3). After pouring the gel into 35mm petri dishes, 
the cochleae were submerged and orientated and gel allowed to set at room temperature. 
ParafilmTM was used to seal the Petri dishes which were kept at 4˚C until required. Blocks of 
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agarose containing the cochleae were cut and mounted on cryostat supporting stubs with the 
aid of optimum cutting temperature (OCT) mounting medium (Tissue-Tek OCT Compound, 
Sakura, Finetek UK Ltd) before being rapidly frozen in liquid nitrogen. The mounted stubs were 
positioned within a Leica CM1900 cryostat for 30 minutes to allow the specimen to acclimatise 
to the temperature (-20˚C). Tissue was sectioned at 14µm and the sections mounted on poly-
L-lysine-coated slides (VWR, UK). Slides were kept stored at -20˚C until they were required.  
 
2.2.5.3 Toluidine blue staining 
In preparation for examination, frozen sections were stained with toluidine blue (0.005%) and 
viewed by light microscopy.  
 
2.2.5.4 Plastic embedded cochleae for light microscopy and transmission electron 
microscopy (TEM) 
Cochleae implanted with the fluorocarbon thread were plastic embedded for further evaluation. 
The decalcified cochleae with the retained implant were immersed in 1% OsO4 (osmium 
tetroxide) in 1 mM cacodylate buffer for 2 hours for further post-fixation. Dehydration was 
achieved in an ethanol series, en-bloc stained at the 70% ethanol stage using a saturated 
solution of uranyl acetate in 70% ethanol at 4˚C overnight. The dehydration process was then 
completed to 100% ethanol and the whole cochlea embedded in plastic resin. In order to 
assess the position and orientation of the implant within the cochlea, sections were cut 
approximately parallel to the modiolus at 0.5-1µm thick for light microscopy analysis and 
stained with toluidine blue. For the purposes of TEM, a series of thin sections (80nm) were 
cut. This preparation of cochleae was carried out by Mr Graham Nevill. TEM images were 
taken and collected using a Gatan camera by Professor Andy Forge. 
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2.2.5.5 Whole mounts 
Following decalcification, cochleae were dissected as per the method used by Charles 
Liberman at Eaton Peabody Laboratories (Massachusetts Eye and Ear Hospital, Boston, MA, 
USA). Cochleae were bisected through the modiolus to yield two half turns. Each half was 
then cut into half turns to provide a series of arcs which were then trimmed. The modiolar 
nerve stump and spiral ligament of each half turn was removed, above and below the basilar 
membrane, together with the remnants of any bony cochlear capsule. Both the Reissner’s and 
tectorial membranes were also removed. Whole mount sections were stored in PBS containing 
NaN3 at 4˚C until required.  
 
2.2.6 Immunofluorescence and confocal microscopy 
Prior to the application of reagents, sections on slides were marked using a PAP pen 
(ImmEdge Hydrophobic Barrier Pen, Vector Laboratories, Peterborough, UK) to ensure that 
reagents remained localized. In the case of whole mounts, 72-well plates were used to retain 
the organ of Corti segments for immunolabelling. All processing was performed at room 
temperature in humidified chambers unless otherwise detailed. Frozen sections or whole 
mount segments were permeabilised by incubation in 0.5% Triton X-100 (Sigma) for 20 
minutes (30 minutes for whole mounts) at room temperature then exposed to a blocking 
solution consisting of 10% goat serum in PBS for 2 hours at room temperature. After brief PBS 
washes the samples were incubated with the primary antibody (see Table 7a below) in 10% 
goat serum in PBS overnight at 4°C. In the case of negative controls, primary antibodies were 
omitted. After six 3 minute washes in PBS, the specimens were incubated with appropriate 
fluorescently conjugated secondary antibodies (see Table 7b below) for 2 hours at room 
temperature. Alexa Fluor® 633 phalloidin (Invitrogen, Paisley UK) was added at a dilution of 
1:500 to the secondary antibody solution. After six 3 minute washes in PBS the slides were 
cover slipped using an antifade mountant containing 4’,6- diamidino-2-phenylindole (DAPI) to 
label nuclei (Vectashield; Vector Laboratories, Peterborough, UK) and sealed with clear nail 
varnish.  
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Slides were imaged using a Zeiss LSM 510 confocal laser scanning microscope. Images were 
obtained using various objectives (20x (dry), 40x (oil), and 63x (water)) and documented as 
single, sequential or Z-series stacks (optical slice thickness of 1µm).  Settings such as the 
pinhole and power of the lasers were kept consistent to allow comparative assessments to be 
made. The fluorochromes used for immunofluorescence included DAPI (excitation/emission 
358/461nm), FITC (Fluorescein Isothiocyanate, ex/em 490/525nm), TRITC 
(Tetramethylrhodamine isothiocyanate, ex/em 544/572nm) and Alexa 633 (ex/em 632/647nm) 
and were excited by wavelengths of 405nm, 488nm, 543nm and 633nm laser lines 
respectively. 
 
Table 2.3 Primary antibodies used for immuno-labelling 
Antibody Host/Type Source Dilution Antibody 
Number 
Labelling 
Calretinin Rabbit 
polyclonal 
Thermo Scientific 
(Fisher, Loughborough, 
UK) 
1:200 11521663 Inner hair 
cells, neurons, 
SGCs 
CD45  
(leucocyte 
common 
antigen) 
Rat 
monoclonal 
Chemicon (Millipore, 
Watford, UK) 
1:200  Macrophages 
F4/80 Rat 
monoclonal 
Abcam (Cambridge, 
UK) 
1:200 ab6640 Macrophages 
Myosin VI Rabbit 
polyclonal  
Sigma-Aldrich 1:100 
1:200 
M5187 Inner and 
outer hair 
cells 
Myosin VIIa Mouse 
monoclonal 
Hybridoma Bank, 
Univeristy of Iowa 
1:200 N/A Inner and 
outer hair 
cells 
Parvalbumin Mouse 
monoclonal 
Sigma-Aldrich 1:50 
1:100 
P3088 Inner and 
outer hair 
cells 
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Table 2.4 Secondary antibodies and fluorescent-conjugated probes 
Antibody/Probe Host/Type Source Dilution Antibody 
Number 
Anti-rabbit FITC Goat Sigma-Aldrich 1:200 F6005 
Anti-rabbit TRITC Goat Sigma-Aldrich 1:200 T6778 
Anti-rat FITC Goat Sigma-Aldrich 1:200 F6258 
Anti-mouse TRITC Goat Sigma-Aldrich 1:200 T5393 
Anti-mouse Alexa Fluor 488 Goat Invitrogen 1:200 A10667 
Phalloidin Alexa Fluor 633 N/A Invitrogen 1:500 A22284 
 
 
2.2.7 Cell counts 
Cochlear sections taken from mice at each of the four time points (48 hours, 1 week, 1 month 
and 3 months) for both types of implant (fluorocarbon rod and specialised electrode array) and 
immunostained with CD45 and calretinin were analysed. CD45 positively-labelled cells at 
lower basal, upper basal and apical turns of mid-modiolar sections were counted using ImageJ 
software (http://rsbweb.nih.gov/ij/). Only cells demonstrating characteristics typical of 
leucocytes such as being pleomorphic in shape with an irregularly shaped nucleus, were 
counted. Comparisons of mean counts based on location in the cochlea and across time points 
were made. Statistical analysis of data was performed using T-Test (IBM SPSS Statistics 21.0) 
with a value of P<0.05 used to define significance. 
In the same sections, calretinin staining demonstrated SGCs within Rosenthal’s canal. 
Projections of z-stacked images were taken and the density of SGCs calculated. This was 
done by defining the area of Rosenthal’s canal in each analysed section using ImageJ 
software and counting only those cells with a visible nucleus. Comparisons were made using 
a T-Test (IBM SPSS Statistics 21.0) with a value of P<0.05 used to define significance.  
Hair cell counts were performed on whole mount segments taken from implanted mice and 
immunolabelled with myosin VIIa. The total number of IHCs and OHCs in 100µm sections 
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were counted at basal, mid-basal, mid-apical and apical regions of the cochlea. The number 
of hair cells in implanted and control cochleae were ascertained and comparisons made using 
a T-Test (IBM SPSS Statistics 21.0) with a value of P<0.05 used to define significance. 
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CHAPTER 3: DEVELOPING A MOUSE MODEL OF COCHLEAR 
IMPLANTATION 
 
3.1 Introduction 
One of the main challenges facing CI researchers investigating biological effects of 
implantation is the lack of access to human auditory tissue during life. This has therefore led 
to the development of animal models which play a key role in research and, at present, are 
the only means of assessing effects of CI at a cellular and molecular level. The development 
of an appropriate animal model requires a number of factors to be taken into consideration. 
To provide an accurate reflection of human disease, similarities in physiology and anatomy 
are important, as are the animal’s ability to correctly represent the biochemical and 
morphological characteristics of the disease in question. Other factors such as life-span, 
genetic background, availability, cost, housing, handling and reproductive capacity are also 
important (Smith and Baran 2013).  
In view of the aforementioned characteristics, the mouse is considered to be a prime model 
for the investigation of human disease and over the last 50 years has become an established 
model for auditory research. Mice share a high degree of genetic homology with humans. 
There are also anatomical and physiological similarities between the mouse and human 
auditory systems, which to date have provided important insights into human ear function and 
ontogenesis (Ahituv and Avraham 2002; Avraham 2003).  
Despite the similarities between the murine and human ear there are very few published 
studies of CI in mice. This is largely due to the technical difficulty of implantation and, until 
recently, CI technology has not been able to deliver an implant small enough. Overcoming 
these challenges to produce a viable and reproducible model of mouse CI would be hugely 
valuable and enable the many positive aspects, which are already being exploited in other 
areas of auditory research, to be utilised in CI studies.  
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3.2 Aims 
The main aim of this thesis is to develop a viable and reproducible mouse model of CI. In order 
to achieve this, the following aims were set out and will be discussed in this chapter. 
1. To develop an anaesthetic protocol to allow CI in mice. 
2. To perform sham surgery in mice to assess the viability of the surgical and anaesthetic 
approaches. 
3. To assess morbidity and mortality of the surgical and anaesthetic techniques. 
4. To find a suitable ‘dummy’ implant. 
5. To clarify correct positioning of the implant within the cochlea. 
6. To perform CI using a ‘dummy’ implant. 
7. To perform CI using the specialised electrode array.  
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3.3 Development of the surgical approach to CI in mice: Cadaveric 
dissection 
In order to become familiar with the anatomy and to ascertain the best approach to the cochlea 
for implant insertion, cadaveric dissection on C57BL/6J mice was undertaken. Two 
approaches to the mouse cochlea have been described; postauricular (Akil et al., 2012; 
Bogaerts et al., 2008; Do et al., 2004; Kawamoto et al., 2001; Praetorius et al., 2003) and 
ventral (Akil et al., 2012; Chen et al., 2006; Jero et al., 2001). Both methods were trialled 
(postauricular n=3, ventral n=3) to assess ease of access together with other important factors 
such as invasiveness, risk of damage to surrounding structures and the potential for blood loss 
and postoperative pain. Both approaches allow access to the round window and this was 
chosen as the site for CI.  
Regulations set out by the Home Office in reference to surgical procedures on protected 
animals, state that the design should allow maximum gain of information with the use of 
minimum animal numbers. The procedures themselves should also be refined to be as less 
invasive as possible (Home Office 2014). This was taken into consideration when deciding on 
the most suitable approach for CI.  
 
3.3.1 Postauricular approach 
Following removal of fur in the postauricular region using a battery operated shaver, the skin 
was exposed and a 1-1.5cm incision made. Dissection through the superficial fascial layers of 
the neck was performed to reveal the greater auricular nerve overlying the prominent 
sternocleidomastoid muscle. The nerve was either retracted or cut and the 
sternocleidomastoid muscle retracted in a superior and caudal direction. Further dissection of 
the deeper fascial layers revealed important structures such as the cartilaginous portion of the 
auditory canal and facial nerve (Figure 3.1). The facial nerve, lying in a more cranial and 
superficial position, served as a key anatomical landmark to the location of the auditory or 
tympanic bulla. A specialised small animal retractor system (Fine Science Tools, Interfocus 
Ltd, Linton, UK) was used to create a clear unobstructed view of the desired structures. Once 
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the bony bulla was identified, careful dissection of the overlying posterior belly of the digastric 
muscle was performed. Arising from the posterior half of the bony bulla, the muscle was 
carefully dissected and a small vessel cauteriser (Fine Science Tools, Interfocus Ltd, Linton, 
UK) used for haemostasis. 
 
Once exposed, entry into the bulla was required to access the round window niche. An otologic 
skeeter drill (Medtronic Ltd, Hertfordshire, UK) with a 0.5mm diamond burr was trialled in the 
first instance. Although the size of the burr was compact, vibration at the tip within the 
comparatively confined working area meant that the drill felt unstable. It was also found that 
due to the smooth surface of the bulla, there was a high risk of the burr sliding off the bony 
target and inadvertently causing damage to the surrounding structures. A 25G needle was 
then trialled. The needle was rotated at one point under direct microscopic vision until the bony 
periosteum was breached and tympanic mucosa removed with forceps to gain entry to the 
middle ear cavity. Micro forceps were then used to enlarge the hole (bullotomy) until the round 
window was visualised. The stapedial artery was noted to run immediately beneath the round 
window niche over the cochlear promontory before advancing between the crura of the stapes 
at the oval window.  
The mean time taken from starting surgery to reaching the round window niche was 7 minutes. 
Figure 3.1 illustrates key steps and anatomical landmarks of this technique. 
  
78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Postauricular approach to the round window in the mouse 
A. Fur removed in left postauricular region  
B. Postauricular incision 
C. Cartilaginous portion of the external auditory canal (EAC) and the sternocleidomastoid muscle (SCM) 
are exposed 
D. Tympanic bulla exposed partially (TB) following dissection of part of the posterior belly of digastric 
(PBD). Tympanic annular ring (AR) seen at transition between cartilaginous AC and bony TB. The facial 
nerve (FN) is a key anatomical landmark for the tympanic bulla. 
E. Cut edge of PBD is seen allowing adequate exposure of the TB. A bullotomy (B) has been performed 
(opening in TB).  
F. Bullotomy widened to expose round window (RW) niche. Stapedial artery (SA) seen running directly 
beneath RW 
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3.3.2 Ventral Approach 
Described by Jero et al. (2001), this approach offers an alternative to the postauricular method. 
It has also been performed by authors in order to access the inner ear for intracochlear drug 
delivery and to perform viral-mediated gene therapy (Akil et al., 2012; Chen et al., 2006; Jero 
et al., 2001). Following a 2cm longitudinal ventral incision extending from just above the 
mandible down to the clavicle, dissection through the superficial tissues was performed to 
expose the submandibular gland in its lateral aspect. The superior edge of the pectoralis 
muscle and the inferior edge of the masseter muscle define the lower and upper borders of 
the dissection. Careful dissection and medial retraction of the submandibular gland was then 
performed to expose the sternocleidomastoid muscle, digastric muscle and the trachea. 
Dissection at the posterolateral aspect of the sternocleidomastoid muscle to identify the 
anterior facial vein was performed and this vessel subsequently retracted laterally to expose 
the auditory canal and tympanic annular ring. With such an extensive exposure, vital structures 
contained within the carotid sheath which runs along the posterolateral aspect of the trachea, 
including the vagal nerve and common carotid artery, are visible and vulnerable to damage if 
care is not taken.  
The tympanic bulla is found beneath the inferior half of the digastric muscle and therefore, this 
muscle was carefully divided using a cauteriser. Once divided, the tympanic bulla lay exposed, 
a small opening was then made about 1.5mm from where the stapedial artery enters the bulla, 
in order to visualise the round window. Although Jero et al. (2001) recommended the use of a 
micro-drill, a needle was used for the reasons described previously. Forceps were then used 
to enlarge the opening so that better access to the round window could be gained.  
The mean time taken from starting surgery to reaching the round window niche was 40 
minutes. 
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3.3.3 Choice of approach 
The postauricular approach was associated with a less extensive dissection and therefore less 
morbidity and reduced likelihood of postoperative pain. These factors, in combination with the 
fact that it had a far shorter operative time, meant that it was selected as the technique of 
choice. It also encounters fewer vital structures unlike the ventral approach in which structures 
such as the submandibular gland, trachea and carotid sheath are widely exposed. Any 
inadvertent damage to the latter two structures would almost certainly be fatal to the animal. 
The time taken to perform surgery is an important factor which needs to be taken into 
consideration, especially in terms of minimising anaesthetic time.  
 
3.4 Anaesthesia and analgesia 
Anaesthesia is defined as ‘a state of controllable, reversible insensibility in which sensory 
perception and motor responses are both markedly depressed’ (Flecknell 1993). Selection of 
the most suitable anaesthetic agent is dependent on a number of variables. The type and 
length of surgical procedure, together with the level of expertise of the person administering 
the anaesthetic and equipment which is available all need to be taken into account. According 
to the National Centre for the Replacement, Refinement and Reduction of Animals in Research 
the following points should be considered when choosing the best anaesthetic (National 
Institute on Deafness and Other Communication Disorders 2016): 
1. Depth and duration of anaesthesia required 
2. Mode of administration – should not cause distress to the animal and be simple to 
administer. 
3. Techniques used should have minimal side-effects and allow an uncomplicated 
recovery. 
4. Minimal interference with the research at hand.  
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Other points which should be taken into consideration are as follows: the level of analgesia 
provided by the anaesthetic and whether additional agents are required to provide pain-relief, 
the ease with which the depth of anaesthesia can be assessed, whether the regimen is 
species-appropriate as well as the reliability, reproducibility, reversibility and cost of the 
anaesthetic (Flecknell 1996). 
 
3.4.1 Inhalational versus injectable anaesthesia 
Both inhalational and injectable anaesthetics can be used in rodent surgery. Inhalational 
anaesthesia involves the use of agents such as isoflurane, sevoflurane and halothane. These 
volatile gases are delivered via specialised machines which generally consist of a vaporiser, 
carrier gas source (100% oxygen in the main), flow meter and pressure valves (Flecknell 
1996). In comparison to injectable agents, inhalational anaesthesia has a more favourable 
safety profile as it is rapid acting, allows adjustment of dose according to anaesthetic depth, 
is associated with quicker recovery and has less of an impact on cardiovascular, renal and 
hepatic function (Gargiulo et al., 2012). In mice, dedicated anaesthetic chambers are used to 
induce anaesthesia and maintenance is provided via an open mask system as endotracheal 
intubation is difficult. This means waste anaesthetic gases may escape and be a potential 
hazard to the surgeon, although specialised scavenging systems can be used to reduce this 
risk. Another drawback to the open mask system is the fact that the animal cannot be manually 
ventilated should respiratory arrest occur. Additional disadvantages to the use of inhalational 
anaesthetics include their weak analgesic properties and the depressive effects on respiratory 
and myocardial function (Flecknell 1996; Gargiulo et al., 2012).  
 
Injectable anaesthetics are commonly used to induce and maintain anaesthesia in rodents 
and can be administered via intravenous, intraperitoneal, intramuscular or subcutaneous 
routes. The intravenous route produces the most rapid and predictable anaesthetic using the 
smallest dose. However, difficulties with animal restraint and access to superficial veins often 
mean that this mode of administration is not used. Advantages of the other routes include the 
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fact that they are relatively simple and can be given by a lone operator. The rate of absorption 
of drugs given by these routes can, however, vary considerably as can the anaesthetic effects.  
Frequently used drugs include ketamine, pentobarbitone and tribromoethanol. They are often 
used in combination with other drugs such as xylazine and medetomidine to provide a 
balanced anaesthetic. This ensures that the therapeutic doses are within a suitable range, 
provoking an appropriate level of anaesthesia and muscle relaxation in the absence of 
significant respiratory depression. Once administered, the duration of the anaesthetic can vary 
but the animal can be monitored and top-up doses given as required. There is also less 
equipment associated with this method and less interference when performing surgery. 
Although the doses are prescribed in relation to the weight of the animal, there can be 
significant variations in the response of individual animals, not only between species and 
strains, but also amongst animals of the same strain of mice. One of the main disadvantages 
with this form of anaesthesia is the fact that adjustment of the dose is not possible according 
to the animal’s response as they are given as a bolus at induction. With some of agents having 
a very narrow anaesthetic index this means that mortality secondary to anaesthesia can be 
high. Another problem with injectable anaesthetics especially via the intramuscular and 
intraperitoneal routes is the relatively larger doses which are required to produce the desired 
anaesthetic effect. These larger doses mean prolonged recovery times which in turn can leave 
animals vulnerable to respiratory failure and hypothermia in the postoperative period (Flecknell 
1993; Flecknell 1996).  However, the availability of reversal agents, means that these issues 
can be offset and their use is highly recommended by some (Hu et al., 1992).  
 
In order to choose the optimal type of anaesthetic for mouse CI, guidance was sought from 
the Named Veterinary Surgeon (NVS) affiliated with the Institute and other groups in the lab 
experienced in mouse anaesthesia. There appeared to be clear advantages to the use of 
injectable anaesthetic for mouse CI: the ease of administration, availability, lack of interference 
with the surgical site, no requirement for complex equipment, low cost, availability of reversal 
agents and the fact that it can be performed by a lone operator. Despite the superior safety 
profile of inhalational anaesthesia, one of the major difficulties anticipated with its use was the 
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fact that the facemask used to deliver the anaesthetic gases would overlap with the site of 
surgery. Another disadvantage to the use of the face mask was that the mouse would require 
frequent re-positioning during the procedure. Thus there were strong concerns that the mask 
may be misplaced resulting in suboptimal anaesthesia and possible distress to the animals. 
Furthermore, at the time of developing the mouse model of CI, inhalational anaesthetics were 
not available within our unit. Although provision on the main University campus could have 
been sought, the logistical problems with regards to pre- and postoperative care of the animals 
and access for performing ABRs were deemed to be significant and as a result the use of 
inhalational anaesthetic use was not considered any further. 
 
3.4.2 Choice of injectable anaesthesia  
The established laboratory regime for performing ABRs, using a combination of intraperitoneal 
ketamine and medetomidine, was adapted. This protocol is a well-tested, reliable and 
reproducible method for inducing the level of anaesthesia required to perform an ABR. It has 
been used successfully in a number of strains of mice in our lab including the C57BL/6J 
mouse. Profiles of the drugs are given below. 
 
Ketamine 
Ketamine is classed as a dissociative anaesthetic agent which is thought to induce a cataleptic 
state of sedation without awareness of the surroundings. It can be administered by a variety 
of routes and causes immobility with variable analgesic properties. It gives rise to an increase 
in blood pressure and skeletal muscle tone and can also cause significant respiratory 
depression in small rodents such as mice. The latter is dose-dependent and as such large 
amounts are required to induce surgical anaesthesia in mice, ketamine is often combined with 
other agents such as medetomidine, xylazine or diazepam. Although laryngeal and pharyngeal 
reflexes are maintained, ketamine does increase the production of salivary secretions. With 
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chronic use, it has adverse effects on hepatic enzyme function which can subsequently reduce 
its efficacy (Flecknell 1996). 
 
Medetomidine 
Medetomidine is an α-2-adrenergic agonist and a potent sedative with variable analgesic 
properties. Like other α-2-adrenergic agonists such as xylazine, medetomidine also has other 
beneficial effects such as anxiolysis and muscle relaxation. In addition, its anaesthetic-sparing 
properties, when combined with other injectable agents such as ketamine, make it a frequent 
choice in small animal anaesthesia. Unlike xylazine, the side effect profile is more favourable 
as medetomidine is much more specific α-2-adrenergic agonist. Producing complete 
immobilization and deep sedation when used alone, its use can avoid the need for general 
anaesthesia. At high doses, undesirable effects on the cardiovascular system including, 
cardiac arrhythmias, hyper- or hypotension and a reduction in cardiac output can occur as well 
as respiratory depression. The reversal agent atipamezole can, however, be used to 
completely reverse the effects of medetomidine (Flecknell 1996; Sinclair 2003). 
 
3.4.3 Analgesia 
When performing operative procedures on animals, the administration of analgesia both pre-
operatively (pre-emptive analgesia) and within the postoperative period is very important. Both 
ketamine and medetomidine have some analgesic properties, however the use of adjunctive 
analgesia is necessary to ensure adequate pain relief intra- and post-operatively. Not only 
does the presence of pain cause distress, it also slows recovery and can reduce the intake of 
food and water (Flecknell 1993).  
Buprenorphine administered intraperitoneally was chosen following veterinary advice 
(Vetergesic®, Reckitt Benckiser Healthcare (UK) Limited, 0.1mg/kg of 0.03mg/ml). It is one of 
the most common analgesics used in mice, providing pain relief for up to 6 hours. In order to 
provide pre-emptive analgesia, half of the buprenorphine was given at induction of 
  
85 
 
anaesthesia and the remainder given in the immediate postoperative period. In the first 48 
hour period, the mice were monitored closely and observations of animal behaviour in terms 
of their movement, posture, appearance, vocalizations, feeding and temperament was used 
to guide further pain relief administration (Flecknell 1996). Attenuation of the analgesic effects 
of drugs such as buprenorphine when using the reversal agent atipamezole has been a 
previous concern. However, a recent study confirmed that such a reduction in anti-nociceptive 
effects is unlikely, especially if analgesia is administered pre-emptively (Izer et al., 2014). 
Non-steroidal anti-inflammatory drugs are another type of commonly used analgesic, however, 
they were not chosen for use due to their potential to dampen any inflammatory response 
which could occur as a result of CI – an important outcome measure in terms of assessing the 
effects of implantation. 
 
3.4.4 Anaesthetic management and monitoring 
In order to monitor adequate depth of anaesthesia, absence of the pedal reflexes as well as 
the clinical observation of the rate, pattern and depth of respiration was used. In the majority 
of rodents, impending respiratory failure is indicated by a decrease in the respiratory rate to 
<40% of the pre-anaesthetic rate. Although experience is required, when a single agent or 
combination of agents is used repeatedly in the same species, developing an awareness of 
the anaesthetic depth is relatively straightforward (Flecknell 1996).  
When a mouse was deemed to be ‘light’ in terms of the depth of anaesthesia (rise in respiratory 
rate, slow return of pedal reflex), an additional dose of anaesthetic was administered for 
maintenance. Hypothermia was prevented following induction of anaesthesia using a heated 
mat and the body temperature monitored using a rectal thermometer. Postoperatively, the 
reversal drug atipamazole (Antisedan 0.002ml/g of 0.5mg/ml) was administered 
subcutaneously to counteract the effects of medetomidine and hasten recovery from the 
anaesthetic. 
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3.5 Sham surgery to assess viability of surgical and anaesthetic 
approaches 
In order to put into practice the aforementioned anaesthetic and surgical techniques, sham 
surgery was undertaken in C57BL/6J mice (n=15) aged between 2-10 months. The main 
objective was to optimise and refine the surgical approach, with minimal complications and 
survival of the animal postoperatively for up to 4 weeks. Sham surgery involved all of the 
surgical steps described in the postauricular approach in order to access the cochlea but did 
not involve implantation.  
 
3.5.1 Operative procedure 
Surgery was undertaken on the left ear in every case with the contralateral right cochlea acting 
as the non-operated control. In the first 12 mice, following bullotomy, the round window 
membrane was visualised but not breached. A small amount of muscle harvested from the 
surrounding tissues was used to carefully occlude the bullotomy without filling the middle ear 
cleft, prior to closure. In the remaining mice (n=3), a fine straight needle (5 μm radius at tip) 
was used to pierce the round window membrane in its central portion. Muscle was then used 
to seal the site at the round window to prevent perilymph leakage into the middle ear. The 
bullotomy was also occluded as in previous cases. Wound closure was performed in two layers 
using an absorbable MonocrylTM suture (Ethicon Ltd, Livingston, Scotland, UK) and Histocryl® 
tissue glue (TissueSeal LLC, Ann Arbor, MI, USA) applied to the skin edges to ensure close 
apposition.  
 
3.5.2 Evaluation of anaesthetic technique 
In all but two cases, the anaesthetic was well-tolerated. Two of the 12 animals suffered a 
respiratory arrest that could not be reversed. These animals died. The total anaesthetic time 
varied between 30 and 45 minutes and the total sleep time between 60 and 90 minutes. Depth 
of anaesthesia was assessed using a variety of markers including muscular tone, loss of the 
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righting reflex, response to noxious stimuli, loss of limb withdrawal reflex and rate and depth 
of respiration (Flecknell 1993). In cases where the level of anaesthesia was deemed too light, 
a top-up of the ketamine/medetomidine mixture was administered at half the dose. 
 
3.5.3 Evaluation of surgical technique: initial experience of 5 cases 
The outcomes for the initial 5 cases of sham surgery are shown in a Figure 3.2. The time taken 
to perform the surgical procedure varied from 20-40 minutes. In the case of 3 of the mice (mice 
2, 4 and 5), intraoperative bleeding occurred such that it resulted in death of the animal. The 
bleeding occurred at the time of dissection of the overlying muscle at the posterior-lateral 
aspect of the tympanic bulla and could not be arrested with the use of the small cauteriser or 
with manual compression. At the onset of bleeding it was difficult to isolate the relevant vessel 
and this factor in combination with the confined operating area precluded the use of hand-ties 
and/or sutures to occlude the ends of the vessel lumen for purposes of haemostasis. The 
relatively small circulating blood volume of the animal in relation to the human means that 
even the loss of 1-2mls of blood can be catastrophic.   
In the case of mouse 3, the anaesthetic and surgical procedures were straight-forward and 
completed without any complications. In the initial postoperative period the animal had a 
smooth recovery, with no evidence of any complications. Twenty-four hours post-operatively, 
the animal was found to have some swelling in the left pre-auricular region extending forwards 
over the left cheek towards the mandible. The swelling appeared unrelated to the wound and 
surgical site. On day 3 post-operatively, the cheek swelling increased in size and appeared to 
be causing discomfort to the animal; advice from the NVS was sought and it was advised that 
the animal be sacrificed. 
Following sacrifice, post-mortem examination of the area was performed to try and ascertain 
the underlying cause for the swelling. Dissection confirmed the swelling to be unrelated to the 
surgical site and wound. There was a large amount of oedema in the superficial fascial planes 
overlying the masseter muscle on the left as well as within the superficial layers of the muscle 
  
88 
 
itself. There was no evidence of haematoma or abscess formation. On reflection, the cause 
may have been due to trauma or misplacement of the subdermal electrode when performing 
ABR pre-operatively. This was taken into account and greater care observed in subsequent 
cases.  
As a result of the loss of animals when performing these initial sham operations (mainly 
secondary to intraoperative blood loss) it was decided that a return to cadaveric dissection to 
further refine the operative technique was necessary. 
 
Figure 3.2 Outcomes following initial sham surgery 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.4 Cadaveric dissection: development of technique to avoid perioperative 
haemorrhage  
Further cadaveric dissection was performed to help identify the cause of the major 
intraoperative bleeding which had led to the death of 3 of the 5 animals in the initial sham 
surgery group. Dissection down to the posterior belly of digastric was found to be straight-
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forward and did not encounter any large vessels. It was during the dissection of the posterior 
belly of digastric from the posterior half of the tympanic bulla that bleeding was consistently 
encountered. A more extensive dissection of the area revealed the source of bleeding to be 
due to trauma to the stapedial artery as it entered the bulla at posterior medial aspect (Figure 
3.3A). Following damage to the artery in this region, haemostasis was not possible due to the 
very limited access. This in combination with the small size of the artery and lack of 
visualisation once the profuse bleeding had commenced meant that the best means to deal 
with the bleeding was to prevent it in the first instance. As a result, the technique was adapted 
to ensure a much more limited dissection was performed in subsequent procedures.  
The principle of surgery was to perform CI with as minimally invasive an approach as possible 
and on reviewing the technique further, other refinements were also made as follows. 
1. Limited dissection of posterior belly of digastric – restricted to posterior-superior aspect of 
auditory bulla as this was the region for planned placement of the bullotomy. 
 
2. Rotation of the animal away from the operating surgeon to visualise and gain access to the 
round window. By performing such a simple manoeuvre, it meant that a much more limited 
bullotomy was required, thereby minimising tissue trauma and reducing the amount of muscle 
tissue required to occlude the bullotomy when closing.  
 
3. More specific and limited bullotomy (Figure 3.3B). By performing further cadaveric dissections 
it was noted that the thin and more transparent bone in the superior posterior aspect of the 
bulla was the most suitable place to gain entry to the middle ear cleft. As the bone was thin, 
less force was required to perform the bullotomy, which could be easily performed using a 25G 
needle. It was also located away from the facial nerve to avoid potential trauma and was also 
placed posterior enough to avoid any inadvertent damage to the ossicular chain.  
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Figure 3.3 Cadaveric dissection 
 
A. Extensive dissection of posterior belly of digastric muscle (PBD) from its insertion on the bony 
tympanic bulla (TB). The stapedial artery (SA) can be clearly seen beneath the dissected portion of the 
PBD entering the TB at its posterior-medial aspect and coursing beneath the round window (RW) within 
the tympanic cavity. The annular ring represents the junction between the TB and the cartilaginous part 
of the EAC.  
 
B. Image showing exposed TB after dissection of the PBD. The red dotted box shows the ideal site for 
placing the bullotomy over the thinner bone. 
 
3.5.5 Evaluation of surgical technique: further experience of 10 cases  
Sham surgery was continued once the refinements to the surgical techniques had been made 
and tested under cadaveric conditions. The overall outcomes of the sham operations, including 
the remaining 10 mice that underwent surgery, are summarised in Figure 3.4. Of these animals 
2 died. Mouse 10 died due to haemorrhage from damage to the stapedial artery within the 
bulla when performing bullotomy. Mouse 11 died of respiratory depression. The anaesthetic 
was poorly tolerated by the animal throughout the procedure as seen by the intermittently rapid 
and shallow depth of breathing. The depth of anaesthesia was regularly checked as it 
appeared that the animal may be ‘light’, however, the absence of pedal reflexes was noted 
and the decision not to give an incremental dose of anaesthetic taken. Oxygen was 
administered intraoperatively and in the immediate postoperative period together with 
atipamezole and normal saline whilst in recovery. Although the animal survived the procedure, 
it suffered a respiratory arrest and died shortly after the operation. The changes to the surgical 
technique appeared effective. The survival rate of surgery increased from 20% to 80% 
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between the initial 5 and subsequent 10 animals, with perioperative mortality due to 
haemorrhage decreasing from 60 to 10%. 
 
 
Figure 3.4 Outcomes following sham surgery 
 
 
 
 
 
 
 
In animals 13, 14 and 15 the round window was opened with a fine needle. This was performed 
without any complications. A slow ooze of perilymph was noted but there were no cases in 
which there was a profuse rush of fluid. In order to minimise perilymph loss, a small patch of 
muscle was used to close the round window perforation as soon as possible. 
Postoperatively, the eight surviving mice were kept for 4 weeks and monitored daily. The three 
mice in which the round window was opened showed no signs of vestibulopathy such as 
circling, head-bobbing, head-tilting and abnormal reaching responses. Weights were recorded 
daily for the first week and weekly thereafter (see Appendix 1). All mice maintained their pre-
operative body weights within 10%, with some gaining weight by the end of the 28 days (Table 
3.1).  
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Table 3.1 Percentage change in body weight of sham operated mice surviving to 28 days. A 
negative change indicates weight loss.  
 
 
 
 
 
 
 
 
3.6 CI in mice: the implants 
As implantable devices, cochlear implants are required to fulfil a number of essential 
requirements including biocompatibility, mechanical stability and long-term material integrity. 
The technological advances in terms of implant design have been significant since their 
introduction more than forty years ago. Initial designs drew on the experience of other 
established implantable devices such as pacemakers, to identify safety limits in terms of 
electrical stimulation, biocompatibility and electrode insulation (Zeng et al., 2008). The 
biological and chemical interaction that occurs between the implant and the surrounding tissue 
with which it comes into contact encompasses surface biocompatibility. As previously 
discussed, the introduction of a foreign material into the body will elicit an immune response, 
the extent of which is dependent on the material in question. A substrate that induces a minimal 
and stable fibrotic response and encapsulation is advantageous in this respect and a variety 
of materials have proved suitable for CI, including silicone, platinum, titanium and ceramics 
(Hassler et al., 2011; Stover and Lenarz 2009). At present, most modern cochlear implants 
consist of Teflon-coated platinum-iridium wires linking to platinum contacts encased in a 
 
% Change in body weight 
 
Day 1 Day 7 Day 28 
Mouse 6 -8.2 -9.1 -1.2 
Mouse 7 -5.6 -4.6 4.2 
Mouse 8 -4.9 -5.2 3.7 
Mouse 9 -6 0.6 3.8 
Mouse 12 -6.3 -4.7 2.7 
Mouse 13 -1.3 0 -0.7 
Mouse 14 -2.2 -4 -0.3 
Mouse 15 -1.5 0 1.2 
Mean % change in body weight -4.5 
 
-3.375 1.675 
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silicone carrier. The alloy of platinum and iridium forming the lead wires are wound in a helical 
or zig zag pattern to reduce the risk of breakage and improve flexibility (Zeng et al., 2008). 
For the purposes of this study, implantation was performed using two types of implant. One 
was a dummy implant and the other a specialised electrode array comprising of parylene 
coated platinum/iridium wire with 4 electrodes, measuring 0.21mm in diameter at the tip 
(supplied by Cochlear Ltd). Both materials are biocompatible and known to be widely used in 
medical applications. The dummy implants were used in order to optimise the technique of 
mouse CI prior to use of the bespoke arrays and allowed assessment of the general biological 
response of the mouse cochlea to implanted foreign material. They also had the advantage 
that they could be sectioned in-situ, to confirm correct placement within the scala tympani.  
 
3.6.1 Choosing a suitable dummy implant 
A variety of materials were trialled in order to find a suitable dummy implant. Candidate 
implants needed to fulfil a number of criteria including: a diameter of suitable size to pass 
through the round window, biocompatibility and flexibility in order to follow the basal turn 
without causing trauma to the delicate intracochlear structures. Studies have shown that the 
average height and width of the round window niche in mice varies between 0.3 and 0.54mm 
respectively, with an average area of 0.13mm2. With regards to the dimensions of the round 
window, the average height and width can vary between 0.19 and 0.31mm and an average 
area of 0.05mm2 (Jero et al., 2001). 
Following sacrifice, dissection to access the round window niche was performed and various 
materials trialled in order to identify a suitable dummy implant. Materials were secured at the 
round window with epoxy glue before further dissection and harvest of the cochleae. Following 
isolation, the cochleae were further dissected and examined under the light microscope. Fine 
metal threads including platinum and tungsten (diameters ranging from 0.1 – 0.5mm) were 
tested (Agar Scientific, UK). At wider diameters they were found to be too stiff and lack suitable 
flexibility to follow the curve of the basal cochlea turn (Figure 3.5A). Further dissection 
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demonstrated the wires abutting the lateral cochlea wall suggesting trauma and possible 
displacement of the wire from the scala tympani. The narrower wires were too fine and kinked 
on passage through the basal turn (Figure 3.5B). Polyimide tubing was also trialled (Product 
code 054, inner diameter 0.15mm MicroLumen, Florida, USA) both alone and in combination 
with the narrow diameter metal threads (0.1 – 0.125mm) which were passed through the lumen 
of the tubing. Polyimides are polymer thermoset plastics which are commonly used in the 
medical fields as catheters, stents and as flexible neural interface devices due to their chemical 
resistance, tensile strength, thermal stability and biocompatibility (Bellamkonda et al., 2012; 
Talbot and Hartley 2008).  When used alone, the polyimide tubing was found to lack sufficient 
stiffness to allow passage along the basal turn (Figure 3.5B). The combination of using 
polyimide tubing with the narrower metal threads was appealing, however, in practice the 
same problem occurred.  
Following consultation with one of the lead technicians within the UCL Biosciences Mechanical 
Workshop (Duncan Farquharson), a fluorocarbon thread was trialled. This is a thermoplastic 
fluoropolymer also known as polyvinylidene fluoride (PVDF). Polymers are known to have 
excellent properties for the purpose of implantation in that they are demonstrate long-term 
stability in unfavourable environments, have low material stiffness, provoke minimal tissue 
reactions and are good insulators of metallic conductors (Hassler et al., 2011). PVDF displays 
many of these strengths including flexibility, resistance to chemical corrosion and heat as well 
as biocompatibility making it a popular choice of material for a wide variety of applications 
within construction, aviation, defence and medical industries. The potential of PVDF 
monofilament as a vascular suture has been demonstrated both in-vitro and in-vivo (Laroche 
et al., 1995; Mary et al., 1998; Urban et al., 1994). More recently, it has also been used as the 
basis for surgical meshes with promising results (Klinge et al., 2002; Kohler et al., 2015). The 
fluorocarbon thread trialled had a tip diameter of 0.185mm and was found to pass easily, with 
minimal resistance and followed the contours of the basal turn of the cochlea (Figure 3.5C). It 
could also be sectioned in situ and was therefore chosen as they material of choice for the 
dummy implants. 
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Figure 3.5 Diagrammatic representation of materials trialled as ‘dummy’ implants. 
 
 
 
 
A. Platinum and tungsten threads were found to be too stiff and lacked flexibility required to follow the 
curve of the basal cochlea turn, abutting the lateral wall and therefore potentially causing trauma to 
delicate intracochlear structures. With increased pressure, the threads did flex but due to the memory of 
metal would remain kinked, causing more trauma with further advancement.  
B. Polyimide (with and without metal thread) and finer platinum and tungsten threads lacked the stiffness 
required to follow the turn of the basal cochlea coil and kinked. 
C. Fluorocarbon thread passed into basal cochlea turn with ease and minimal resistance.  
 
3.6.2 Specialised electrode array 
As stated, the specialised electrode array consisted of a parylene coated platinum/iridium wire 
with 4 electrodes, measuring 0.21mm in diameter at the tip (supplied by Cochlear Ltd, 
developed at the Bionics Institute, Melbourne, Australia) (Figure 3.6). The parylene electrode 
is an excellent model as it is essentially a much smaller version of the cochlear implants 
manufactured and used in humans, where electrodes are usually fabricated from platinum 
iridium alloy and partly encased within a silicone elastomer sheath, leaving the electrode 
contacts exposed. Parylene is a type of polymer based on paraxylene which is a medical grade 
coating also frequently used in conventional cochlear implant manufacture and other devices 
such as stents and pacemakers (Stover and Lenarz 2009; Zeng et al., 2008).  
 
 
 
 
 
 
 
 
A B C 
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Figure 3.6. Mouse cochlear electrode array (all dimensions are in mm unless stated otherwise).   
A. Electrode array consists of three platinum/iridium parylene insulated wires (Ø 25µm) 
 
 
 
 
 
B. Detail A (scale 10:1) of intracochlear part of electrode array. Includes two active platinum ring 
electrode 4 (tip, Ø 0.21) and 2 (Ø 0.25) in combination with two structural rings 3 (Ø 0.23) and 1(Ø 0.27). 
The electrode tip has two welded connections for two of the wires to increase electrode stiffness.  
 
 
 
 
3.7 Clarifying the position of the implant within the mouse cochlea 
Having established a working model of mouse CI, it was vital to ensure that the implants were 
correctly positioned within the scala tympani of the cochlea. This was established using two 
methods: CBCT and plastic embedded cochleae analysed using light microscopy. Initially 
CBCT was used to confirm placement of the electrode. Two mice implanted with electrode 
arrays, one for a period of 4 weeks and one for 12 weeks, underwent CBCT scanning following 
ABR testing and sacrifice. The images obtained of the implanted mice confirmed the presence 
of the electrode array within the cochlea (Figure 3.7 – 3.9). The array was inserted 1.5mm into 
the first part of the basal turn, with the first two electrodes being inserted fully. This finding was 
also complemented by sectioned cochleae with the fluorocarbon thread in-situ. Here, sections 
stained with toluidine blue (Figure 3.10) demonstrated the implant position to be within the 
scala tympani. Examination of the sections also showed tissue integrity was maintained 
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following implantation and there was no disruption of the basilar membrane, or inadvertent 
insertion of the implant into the scala media or scala vestibuli. Subsequently assessment of 
array position was confirmed with light microscopy following decalcification after sacrifice. 
 
Figure 3.7 Three-dimensional reconstructed CBCT images of a 3 month old mouse implanted 
for 4 weeks with electrode array.  
(A) and (B) show electrode array in position (as shown by white arrow) on left fronto-lateral and left 
lateral views respectively.  
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Figure 3.8 Axial CBCT images of a 3 month old mouse implanted for 12 weeks with electrode 
array (successive images passing from (A) ventral to (D) dorsal). Image on left is identical to the image 
on the right but has been left unlabelled.  
  
A. Green arrow – right (control/non-implanted) cochlea; small yellow arrow – left (implanted) cochlea; 
large yellow arrow – electrode array. 
B. Red arrow – right stapes; pink line – follows basal turn of right cochlea; green arrow – left stapes; 
yellow arrow – electrode array entering basal turn at round window. 
C. and D. Pink line – follows basal turn of right cochlea; yellow arrow shows electrode array within basal 
turn of cochlea. 
 
A 
B 
C 
D 
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Figure 3.9 Coronal CBCT images of a 3 month old mouse implanted for 12 weeks with electrode 
array (successive images passing from (A) posterior/caudal to (C) anterior/cranial). Image on left is 
identical to the image on the right but has been left unlabelled. 
A. Red arrow – right (control/non-implanted) cochlea; yellow arrow – electrode array entering left cochlea 
via round window; green arrow – right middle ear cleft 
B. Red arrow – bony tympanic bulla; pink dots – fluid-filled turns of right cochlea; green arrow – right 
middle ear cleft; yellow arrow – electrode within basal turn of left cochlea. 
C. Red arrow – right modiolus; yellow arrow shows electrode array within basal turn of left cochlea. 
R L R L 
A 
B 
C 
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Figure 3.10 Plastic-embedded cochlear section with the fluorocarbon thread in-situ taken from 6 
month old mouse implanted for 1 week.  
Cochlea with fluorocarbon thread implant in-situ shows evidence of fibrotic-like tissue surrounding the 
implant (Im) within the scala tympani (ST). Labels as follows: scala media (SM), scala vestibuli (SV), 
organ of Corti (OC), spiral ganglion (SG), modiolus (Mod).  (NB: bowing of Reissner’s membrane is seen 
suggestive of endolymphatic hydrops, however, this change was secondary to tissue processing rather 
than a pathological change and was also seen in controls (not shown here).  
Preparation of section by Mr Graham Nevill. 
 
3.8 Cochlear implantation in the mouse  
Having optimised the anaesthetic and surgical techniques, chosen suitable implants and 
established correct positioning and placement of the implants within the cochlea, CI in two 
groups of C57BL/6J mice was undertaken. Groups of mice aged 3 (n=18) and 6 (n=19) months 
were implanted. Figure 3.11 shows the numbers, ages and types of implants, together with 
the duration of implantation. Having optimised the procedure, survival rates improved 
dramatically. The mean ages within the 3 and 6 month groups were 101 days (p90 – p107) 
and 199 days (p176 – p221)  respectively.  
Within the implanted group of mice, the survival rates were 95% (35/37). In the case of the 
two deaths (mouse 18 and mouse 34) the first occurred as a result of anaesthetic 
complications and post-operative respiratory arrest. The second mouse survived 24 hours 
following implantation and was found dead, the cause of which was unknown. Despite this, 35 
mice were implanted successfully and underwent functional testing at the specified time points 
and were sacrificed following the desired duration of implantation (Figure 3.12). 
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Figure 3.11 Details of mice used for the development of surgical technique and cochlear 
implantation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12 Outcomes for all mice and surgical learning curve. Upper part of figure shows the 
number of mice used and details for those which did not survive. This correlates with the lower part of 
the figure shows the corresponding mean survival rate and represents the surgical learning curve. 
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3.9 Discussion 
The major anatomical and physiological similarities between the auditory systems of mice and 
humans, together with the diverse range of naturally occurring and genetically-modified mouse 
strains which mimic human deafness, have allowed significant progress in the field of hearing 
research to be made. The lack of access to human auditory tissue for histopathological 
examination during life has also meant that the use of mouse models has become vital for 
such assessment.  
In this regard, despite the wealth of information provided by existing animal models in the area 
of CI research, producing a mouse model of CI remains highly desirable. However, various 
obstacles such as the technical difficulties involved in accessing the murine cochlea for 
implantation, the small size of the cochlea, the presence of the prominent stapedial artery 
within the middle ear cleft and the requirements for a suitably-sized implant have previously 
precluded this. Overcoming these challenges to produce a model of mouse CI is deemed 
hugely valuable and would enable their auditory research potential to be unlocked in CI 
studies. 
Within this chapter, the development of a robust and reproducible method for mouse CI via 
the round window has been described. Although surgically challenging, the results 
demonstrate low rates of mortality and morbidity using the technique outlined. There are very 
few studies of mouse CI  (Irving et al., 2013; Soken et al., 2013) and at the time of developing 
this model (October 2011), there were no published studies in the literature, making this model 
novel and a clear advancement in CI research.  
 
3.9.1 Surgical approach 
The post-auricular approach used to access the mouse cochlea is less invasive compared to 
the ventral approach previously described (Jero et al., 2001). It requires a much smaller skin 
incision and more limited dissection to access the auditory bulla. The current technique allows 
important structures such as the facial nerve to be clearly identified and damage avoided. The 
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time taken to perform surgery is short thereby minimising anaesthetic administration, which in 
mice is known to be associated with difficulties related to dosing and their relatively small body 
weight. The advantages of initiating access to the mouse cochlea via the post-auricular 
approach have also been noted by other authors (Bogaerts et al., 2008; Iguchi et al., 2004; 
Irving et al., 2013; Jero et al., 2001; Soken et al., 2013). 
 
3.9.2 Stapedial artery 
The stapedial artery, a branch of the internal carotid artery, is present within the middle ear of 
adult rodents. This is in contrast to humans, where the artery usually involutes during 
embryonic development and rarely remains into the postnatal period (Govaerts et al., 1993; 
Yamamoto et al., 2003). In mice it enters the auditory bulla at its posterior-medial aspect and 
courses along the medial wall of the tympanic cavity and then superiorly to pass between the 
crura of the stapes and into the middle cranial fossa (Albiin et al., 1983; Albiin et al., 1985; 
Govaerts et al., 1993).  In the initial phase of developing this mouse model of CI, there were 3 
deaths secondary to intra-operative bleeding from trauma to the stapedial artery. This occurred 
during removal of the muscle overlying the bulla and was due to excessive dissection, 
especially at the posterior aspect of the bulla. As a result, the technique was adapted to ensure 
that a more limited approach was undertaken in this region in subsequent procedures, with no 
further complications due to bleeding.  
There is limited information available regarding the preservation of the stapedial artery in mice 
with regards to hearing outcomes. A recent analysis of cautery of the stapedial artery in 
C57BL/6J mice was undertaken (Irving et al., 2013). Cautery was performed using bipolar 
forceps (n=5) and functional testing in the form of click-evoked ABR was done pre-cautery and 
4 weeks following cautery. The results revealed mean threshold shifts in the cauterised ears 
of 21dBHL ± 9.5 (p=0.102), with some animals (numbers not stated) exhibiting threshold shifts 
of up to 40dBHL. Findings also revealed evidence of heat trauma to the cochlea at the site of 
cauterisation which they suggest may have contributed to the increased thresholds on ABR 
testing. The authors found that cautery did not affect spiral ganglion neuron densities when 
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compared to the control ear. Another study in rats where the artery was cauterised did not 
demonstrate adverse effects on hearing outcomes or on cochlear spiral ganglion density, 
however, the number of animals used (n=5) may have been too small to draw clear 
conclusions (Lu et al., 2005b). Despite the elevated hearing thresholds and potential for 
trauma, Irving et al. (2013) still recommended cauterising the stapedial artery due to the 
potential for fatal haemorrhage (Irving et al., 2013). In our experience with the technique as 
described, cautery is unnecessary if adequate care and attention is applied when performing 
implantation and is supported by others (Praetorius et al., 2001; Soken et al., 2013; Yamamoto 
et al., 2003). Aside from potential adverse effects of ceasing blood flow in the stapedial artery 
on both hearing and survival of the animal, the potential thermal effects of cautery on the 
cochlea cannot be ignored, especially when the aim is to evaluate the effects of implantation 
in a residual hearing model.  
 
3.9.3 Surgical learning curve 
The surgical learning curve is a well-recognised concept which applies when acquiring a new 
surgical skill or technique. The curve is most commonly shown graphically with performance 
plotted against experience. Performance can be based on a number of variables which can 
be broadly divided into those relating to patient outcomes including cumulative survival rates 
morbidity and mortality, or measures related to the surgical process, for example, blood loss, 
and duration of operation. An improvement in performance is indicated by the gradient of the 
curves ascent up to a point before tailing off and flattening out as the technique is refined and 
an eventual plateau is reached (Hopper et al., 2007). There was a definite surgical learning 
curve with regards to the technique of mouse CI. Figure 3.12 clearly demonstrates this, plotting 
the number of cases against cumulative mean survival. To start with there was a steady and 
more gradual ascent rather than a steep curve which correlates with the complexity of the 
procedure. As the technique was refined a plateau appeared to have been reached as there 
was just one mortality within the last 34 animals (furthermore, this death was unexplained with 
the animal found dead 24 hours following uneventful surgery).   
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3.9.4 The implants 
One of the main difficulties which has precluded use of the mouse as a model for CI in the 
past, has been the small size of the cochlea and the relative difficulties in finding an array of 
suitable dimensions. The fluorocarbon thread provided an appropriate alternative to the 
electrode array to assess the general response of the mouse cochlea to implanted material. It 
was possible to insert the fluorocarbon thread the length of the basal turn. As the tip diameter 
of the electrode array was slightly larger (0.2mm vs. 0.185mm), only partial insertion into the 
first part of the basal turn was possible before resistance was encountered. Deeper insertion 
of the electrode array may have been possible by removal of bone superiorly at the roof of the 
round window niche and may become necessary in the future should electrical stimulation of 
the implant be required. 
 
3.10 Conclusions 
In this chapter we have successfully established a viable and reproducible method for mouse 
CI. Although the mouse cochlea is small and the surgery challenging, with careful surgical 
technique, meticulous haemostasis and attentive perioperative care, mouse CI is possible. 
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CHAPTER 4: FUNCTIONAL OUTCOMES FOLLOWING 
COCHLEAR IMPLANTATION IN THE MOUSE 
 
4.1 Introduction 
Auditory brainstem response (ABR) audiometry is an objective test of brainstem function in 
response to auditory stimuli. Jewett (1970) first described the application of recording such 
auditory evoked potentials in humans generated as a result of activity in the cochlear nerve 
and brainstem (Jewett et al., 1970). Since then, the use of ABR has become the most common 
method of recording auditory evoked potentials with multiple applications including the site-
identification of retrocochlear lesions, e.g. acoustic neuromas, and for the assessment of 
auditory thresholds in ‘difficult to test’ patients and laboratory animals (Boettcher 2002). In its 
most basic terms, auditory stimuli in the form of tone pips or clicks are relayed via an acoustic 
transducer to the ear in either a freefield manner or via headphones or inserts. The evoked 
potential that is generated is measured as a waveform at surface electrodes placed at the 
scalp vertex and ear. The amplitude of response signal is averaged and plotted against time. 
Following a moderate-level stimulus, waveforms will be seen around 1-7 ms later, each being 
attributed to activity at a specific point in the auditory pathway  (Bhattacharyya and Meyers 
2015).  
ABR testing in mice is a well-established method which allows a reliable and reproducible 
appraisal of hearing function. Advantages of the technique include the fact that it is low-cost, 
minimally invasive and simple to perform (Parham et al., 2001). In both humans and mice, the 
evoked potentials that are generated at the brainstem reflect synaptic activity at specific points 
along the auditory neural pathway. In the presence of a normal response, this is typically 
represented by a series of four or five robust potential peaks, labelled I-V. Wave I represents 
an evoked potential from the auditory nerve and synapse with the cochlea itself, arising 
approximately 1 msec following stimulus initiation. Evoked potentials generated thereafter 
arise from the various auditory relay centres within the midbrain: the cochlear nuclei, 
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contralateral superior olivary complex, lateral leminsicus and contralateral inferior colliculus 
representing waves II to V respectively, with the fifth wave arising around 5 msec following the 
onset of the stimulus. In the mouse, as wave IV is the most consistent and stable component 
of the ABR recording, this is usually chosen as a marker to assess hearing thresholds 
(Boettcher 2002; Scimemi et al., 2014).  
The range of frequencies over which normal mice can hear spans from 0.5 to 120 kHz, with 
12 to 24 kHz being the most sensitive. For the purposes of testing in this study, a range around 
this optimum was used from 8 to 40 kHz, with 40 kHz representing the limit of testing on the 
equipment used. Clicks and tones were delivered at 10 dB intervals and thresholds were 
determined by visual inspection to identify the lowest sound pressure level at which clear 
waveforms were apparent (Figure 4.1). In cases where there was no ABR, at the highest 
stimulus level, a threshold of 90 dB was noted. A focus on auditory thresholds was used as a 
comparative marker to assess the effects of implantation and the presence of any hearing 
impairment rather than specific analyses of intensity-amplitude and intensity-waveform.  
Comparisons between the implanted and control ears were made across the various time 
points for both the fluorocarbon implant and electrode array groups. Combined age-specific 
comparisons were also performed as one of the major concerns regarding functional response 
was the preservation of low frequency hearing following implantation and an assessment of 
whether implantation exacerbates progressive loss at these frequencies in the two age groups 
of mice used.  
4.2 Aims 
The main aims of the work presented in this chapter are to: 
1. Assess the functional response to CI in the current mouse model 
2. Assess the effect of age on functional outcomes following CI in the mouse: 
comparison of 3 and 6 month old mice. 
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Figure 4.1 pre-operative click ABR recording from 6 month old C57BL/6J mouse. Stimuli are 
presented at decreasing 10 dB intervals. In this mouse, an auditory evoked potential  is identifiable as 
low as 30 dB.  
 
4.3 ABR outcomes following sham surgery 
Although the primary objective of the sham surgeries was to create a stable and replicable 
anaesthetic and surgical technique rather than assess the functional response, click-evoked 
ABR testing was performed preoperatively in the initial 12 mice that underwent sham surgery 
(all steps of the surgical implantation approach were performed but without opening of the 
round window). Postoperative ABR testing was performed 4 weeks following surgery where 
possible. The results are shown in Table 4.1 and Figure 4.2. As the mortality rate was initially 
high when optimising the surgical approach, data was available for only 5 of the mice. For 
these mice, results from click-evoked responses showed shifts of up to 10 dB postoperatively.  
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Table 4.1 Click ABR responses for five surviving mice from sham operations 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Pre- vs. post-operative ABR click responses in the five surviving mice. Post-operative 
increases of no more than 10dB were noted following surgery suggesting that process of accessing the 
round window does not cause significant disruption in hearing thresholds as assessed by click ABR. 
 
In the final 3 mice in which the round window membrane was breached, both click and tone 
burst testing was performed, pre-operatively and then at 48 hours and one week following 
surgery. This allowed a baseline against which the results of CI could be assessed and acted 
as a true sham. Figure 4.3 shows the mean threshold shifts in the right control ear and the left 
sham operated ear at 48 hours and 1 week post-operatively. As with the previous sham ops 
where the round window was not breached, mean threshold changes in the operated ear were 
10dB or less compared to preoperative levels. The results suggest that the operative technique 
Pre-op Post-op Pre-op Post-op
6 20 20 20 30 0 10
7 50 50 50 60 0 10
8 20 30 20 30 10 10
9 20 20 20 30 0 10
12 30 20 20 20 0 0
Mouse
Right Click (dB) Left Click (dB)
Threshold shift R ear Threshold shift L ear
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alone (in the absence of cochlear implantation) does not appear to have a significant effect on 
hearing thresholds. 
 
Figure 4.3 Mean threshold shifts for three true shams at (A) 48 hours and (B) 1 week post-operatively. 
Error bars represent standard error of the mean (±2SEM). 
(A) 
 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
4.4 ABR outcomes in fluorocarbon implant group 
The fluorocarbon group included 21 mice implanted for variable periods of time. Within the 3 
month group (n=10), the average age at implantation was 99 days (range p90 – p122) 
compared to 196 days (range p156 – p221) in the 6 month old group (n=11) (Details of 
individual mice given in Appendix 2).  
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4.4.1 Animals implanted at three months of age  
Greater threshold shifts in the implanted ear were seen compared to the non-implanted control 
ear (Figure 4.4). This was more apparent at the 48 hour, 4 week and 12 week mark following 
implantation, with 24 kHz and 32 kHz appearing to be most sensitive frequencies susceptible 
to change. At 48 hours, postoperative mean threshold shifts of around 20 dB were noted at 32 
kHz and 40 kHz following implantation when compared to preoperative thresholds. This may 
have been due changes in the middle ear cleft and inner ear immediately following surgery. At 
one week postoperatively, these shifts were not as apparent with mean threshold shifts of no 
more than 10db at any of the frequencies tested. At 4 weeks following implantation, there were 
minimal changes in thresholds across the majority of frequencies when comparing pre- and 
postoperative thresholds following implantation apart from at 32 kHz. At this frequency, a mean 
threshold shift of around 20 dB was noted in the implanted ear compared to preoperative 
levels. 
Of all of the time points assessed, the most marked increases in thresholds following 
implantation were seen at 12 weeks. In terms of the non-operated control ear, there were no 
notable alterations in hearing thresholds when comparing pre- and postoperative levels at the 
other time points tested, however, at 12 weeks, changes did become apparent, namely at 24 
kHz and 32 kHz, likely due to age-related increases in hearing thresholds. In the implanted 
ear, mean threshold shifts at 24 kHz and 32 kHz were found to be 40 dB and 15 dB 
respectively, compared to 10 dB and 15 dB in the control ears, suggesting that the larger shifts 
in the implanted ear were due to a combination of implantation effects as well as age-related 
deteriorations in hearing thresholds. 
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Figure 4.4 Comparison of thresholds recorded pre- and post-operatively in 3 month old mice 
implanted with the fluorocarbon thread for variable time periods. Numbers in each group: 48 hours 
(n=3), 1 week (n=2), 4 week (n=3) and 12 week (n=2). Error bars represent two standard error of the 
mean (±2SEM). In view of the small numbers in each group, statistical analysis was not performed.  
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4.4.2 Animals implanted at six months of age 
Animals implanted at 6 months of age showed greater threshold shifts in the implanted ear 
compared to the control ear, mainly at 1 week and 12 weeks postoperatively (Figure 4.5). At 
48 hours, comparatively smaller threshold shifts were observed in both the implanted and 
control ears as were at 4 weeks. At one week, a more marked mean threshold shift at 24 kHz 
was seen, compared to the control ear following implantation. This was also the case at 12 
weeks post-implantation where notable threshold differences were present between the 
implanted ear pre- and postoperatively, especially on testing click responses and tone bursts 
at 8 kHz and 24 kHz (mean threshold shifts of 20 dB and 35 dB respectively). However, mean 
threshold shifts were also noted in the control ear again likely due to an age-related decline in 
hearing, suggesting that the changes in the implanted ear are likely to be due to a combination 
of implantation effects and age-related changes in hearing thresholds. 
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Figure 4.5 Comparison of thresholds recorded pre- and post-operatively in 6 month old mice 
implanted with the fluorocarbon thread for variable time periods. Numbers in each group: 48 
hours (n=4), 1 week (n=3), 4 week (n=2) and 12 week (n=2). Error bars represent ±2SEM. In view of 
the small numbers in each group, statistical analysis was not performed.  . 
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4.5 ABR outcomes in electrode implant group 
The electrode array group included 14 mice implanted for variable periods of time. Within the 
3 month group (n=8), the average age at implantation was 105 days (range p91 – p147) 
compared to 206 days (range p189 – 243) in the 6 month old group (n=6).  
 
4.5.1 Animals implanted at three months of age 
The changes seen following implantation in the 3 month electrode implant group were very 
similar to those seen in the 3 month fluorocarbon group. In general, there were greater 
threshold shifts in the implanted ear compared to the non-implanted control ear were seen 
(Figure 4.6). As with the 3 month fluorocarbon group, this was more apparent at the 48 hour, 
4 week and 12 week mark following implantation. At 48 hours, only small threshold changes 
(≤10 dB) were seen in the implanted ear compared to preoperative levels. This was true for all 
frequencies tested except 32 kHz, where a more marked change was apparent in the 
implanted ear with a mean threshold shift of 27 dB. However, there was also an increase in 
the mean threshold seen in the non-implanted ear at this frequency (13 dB). At one week post-
implantation, only minor differences between pre- and post-operative thresholds were seen. 
At 4 weeks following implantation, the most notable changes in threshold were noted at 32 
kHz in both the implanted and non-implanted ears (25 dB vs. 15 dB). At 12 weeks, only one 
animal was implanted and therefore a mean threshold was not possible. Again a large shift in 
the implanted ear was seen at 32 kHz post-operatively (50 dB), however, there were also 
marked deteriorations in hearing thresholds in the control ear seen mainly at 24 kHz and 32 
kHz of 40 dB and 30 dB respectively. It is difficult and inaccurate to draw conclusions based 
on one animal, however, it is likely that the changes seen in the implanted ear were likely to 
be a combination of both age-related changes as well as the implantation process.  
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Figure 4.6 Comparison of thresholds recorded pre- and post-operatively in 3 month old mice 
implanted with the electrode array for variable time periods. Numbers in each group: 48 hours 
(n=3), 1 week (n=2), 4 week (n=2) and 12 week (n=1). Error bars represent ±2SEM. In view of the 
small numbers in each group, statistical analysis has not performed. 
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4.5.2 Animals implanted at six months of age 
Despite the smaller numbers in this six month old electrode implantation group, a similar 
pattern to those changes seen in the fluorocarbon implant group was noted, with most marked 
threshold changes seen 1 and 12 weeks following implantation (Figure 4.7). At one week, an 
increase in threshold of 20 dB at 8 kHz was seen in the implanted ear compared to the control 
ear however, minimal alterations were seen at the other frequencies tested. At 12 weeks, 
increases in thresholds in both the implanted and control ear were seen compared to pre-
operative levels. Within the control group, mean threshold shifts of between 0–15 dB (median 
10 dB) were noted and were likely due to age-related deteriorations. A similar picture was 
seen in the implanted mice (mean threshold shifts; median 12.5 dB and range 0-20 dB); likely 
to be a combination of implantation as well as age-related changes.  
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Figure 4.7 Comparison of thresholds recorded pre- and post-operatively in 6 month old mice 
implanted with the electrode array for variable time periods. Numbers in each group: 48 hours 
(n=2), 1 week (n=1), 4 week (n=1) and 12 week (n=2). In view of the small numbers in each group, 
statistical analysis was not performed. Error bars represent ±2SEM. (NB: At 4 weeks, although there 
was only one mouse implanted, ABR results were available at this time point for those mice implanted 
for up to 12 weeks and therefore a mean threshold for n=3 was performed.)  
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4.6 ABR outcomes following implantation: comparison of age-specific 
groups  
The aforementioned ABR results based on the age and type of implant used, although 
interesting, limit the conclusions which can be drawn due to the small numbers in each 
individual group. One of the major concerns regarding the functional response was to 
investigate the preservation of low frequency hearing following implantation and assess 
whether implantation exacerbates progressive loss at these frequencies in the two age groups 
of mice used. What is clear from the results so far is that there were no cases of complete 
hearing loss following implantation in either the ﬂuorocarbon thread or the electrode implant 
group. In order to examine whether ABR outcomes differed between the two age groups and 
to allow for more robust numbers in each study group, age-matched comparisons of the pre- 
and postoperative ABR data were performed. No signiﬁcant difference was found between the 
ﬂuorocarbon thread and the electrode implant group (paired T-Test, p > 0.05). Data for the two 
groups were therefore combined and have been presented as two sets according to age at 
implantation: 3 months and 6 months (Individual mouse data shown in Appendix 2).  
When comparing the pre-operative baseline mean thresholds between the two age groups, 
the 6 month old mice were found to have significantly higher thresholds than the 3 month old 
mice across all stimulus frequencies except for 8 kHz (P < 0.05) (Figure 4.8A and B). This was 
to be expected due to the age related decline in hearing which occurs in this strain. 
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Figure 4.8A and B. Comparison of preoperative mean thresholds for 3 month and 6 month old 
mice. Mean thresholds were found to be significantly higher across all stimulus frequencies in the 6 
month (6 mth) old mice compared to the 3 month (3 mth) old mice except for 8 kHz on statistical testing 
(*P < 0.05). Error bars represent standard error of the mean (±2SEM). 
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4.6.1 Comparison of mean threshold shifts: 3 month and 6 month groups 
Figure 4.8 shows the mean threshold shifts for the 3 and 6 month old groups at the various 
time points following implantation. In general, greater mean threshold shifts were observed in 
the implanted ears compared to the control ears in both of these groups but were not always 
found to be statistically significant on testing.  
In the case of animals implanted at 3 months of age, mean thresholds were found to be 
significantly greater in the implanted ear compared to the control ear at the following points 
post-implantation when compared to the control ear: at 48 hours following implantation at 32 
kHz (P=0.007); at 8 kHz (P=0.048) and 40 kHz (P=0.049) at 2 weeks following implantation 
and also at one month post implantation at 8 kHz (P=0.041), 32 kHz (P=0.006) and 40 kHz 
(P=0.048) (Figure 4.9). Although these comparative losses are statistically significant, the 
actual functional deficit is unlikely to be, as there was no shift greater than 20 dB at any point. 
Furthermore, there was no significant difference at 8 kHz at 3 months, therefore suggesting 
preservation of hearing.  
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Figure 4.9 Mean threshold shifts post-implantation in (a) 3 month old mice and (b) 6 month old 
mice (*P < 0.05). Numbers of mice at each time point: 3 month group: 48 hours n=6; 1 week n=4; 2 
weeks n=8; 4 weeks n=8; 8 weeks n=3; 12 weeks n=3. 6 month group: 48 hours n=6; 1 week n=4; 2 
weeks n=7; 4 weeks n=7; 8 weeks n=4; 12 weeks n=4. Error bars represent ±2SEM. 
 
 
Greater mean threshold shifts were seen at the higher frequencies of 24 kHz and 32 kHz in 
both the implanted and control ears at the later time points of 8 weeks and 12 months following 
implantation. This could be indicative of the naturally occurring progressive hearing loss which 
occurs with age in this strain.  
In the case of animals implanted at 6 months of age, mean thresholds were found to be 
significantly greater in the implanted ear compared to the control ear at the following points 
post implantation: at 48 hours following implantation at 24 kHz (P=0.042); on click testing at 8 
weeks and 8 kHz at 12 weeks. Again, as with the changes seen in the 3 month group, despite 
these changes being significant on statistical testing, the actual change was no more than 12.5 
6 month group 3 month group 
* 
* 
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dB which may not lead to a significant deficit in functional terms. At the highest frequency 
tested, 40 kHz, there was no difference between the implanted and control ears, in line with 
the almost complete absence of detectable hearing at this frequency pre-operatively. 
 
4.6.2 Comparison of mean threshold shifts in implanted ear only: 3 month vs. 
6 month groups 
Figure 4.10 shows a comparison between the mean threshold shifts in the implanted (left) ear 
only, for the 3 and the 6 month old mice. Since the age-related changes as well as CI have 
effects on the high frequencies, only lower frequencies have been compared. In general, 
greater mean threshold shifts were seen in the 6 month old mice compared to the 3 month old 
mice post-implantation. These changes were significant on statistical testing at 24 kHz at one 
week post-implantation (P=0.028) and at click and 8 kHz at 8 weeks following implantation 
(P=0.018). These findings suggest the presence of an age-dependent acceleration of low 
frequency hearing loss (i.e. greater threshold shifts) in the older mice following CI compared 
to the younger mice.  
There were a few exceptions where the mean threshold shifts were found to be higher in the 
3 month mice compared to the 6 month mice. These were at 24 kHz at 2 weeks following 
implantation (difference of 1.61 dB) and at 24 kHz at 8 and 12 weeks post-implantation 
(difference of 1.67 dB and 9.17 dB respectively). These changes were not found to be 
significant on statistical testing. As these changes occurred at 24 kHz, age-related changes 
may have started to have an impact on the older 6 month mice, especially at the later time 
points of 8 and 12 weeks post-implantation, resulting in higher pre-operative thresholds and 
relatively smaller changes on mean threshold shift as post-operative thresholds verged on or 
reached the limits of testing.  
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Figure 4.10 Mean threshold shifts for implanted (left) ear post-implantation in 3 and 6 month old 
mice (*P < 0.05). Error bars represent ±2SEM. 
 
 
 
 
* * 
* 
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4.7 Discussion 
 
4.7.1 Functional effects of mouse cochlear implantation 
In terms of the functional response to implantation, although greater mean threshold shifts in 
the implanted ear were seen postoperatively, equating to some loss of hearing, there were no 
cases in which implantation caused a complete hearing loss across all frequencies for any of 
the animals tested. This is reassuring since it suggests that the process of implantation itself 
does not cause profound damage at a physiological level. The changes that were noted in 
terms of mean threshold shifts post-implantation ranged from 0 dB to 37 dB in the implanted 
ear compared to -5 dB to 30 dB in the control ear. The largest mean threshold shift of 37 dB 
was seen at 24 kHz in 3 month old mice implanted for 12 weeks. Within the same group, 
however, the mean threshold shift in the control ear (non-implanted ear) was also found to be 
30 dB suggesting the likely effect of age-related changes in combination with implantation. 
Many of the ABR changes in the implanted ear were found to be statistically significant at 
certain frequencies and time points tested when compared to the control ear. However, as 
other types of auditory investigation, such as behavioural testing, were not performed in the 
current study, the actual functional deficit that the mice experienced as a result of this loss 
could not be ascertained.  
An important aspect of hearing preservation in CI surgery is maintaining low-frequency 
residual hearing. Comparison of mean threshold shifts for both the 3 and 6 month groups 
showed that hearing was preserved at the lower frequencies over the various time points 
tested. This is a crucial feature which could allow use of this mouse model to investigate 
potential changes in relation to CI and residual hearing over longer time periods. Changes in 
hearing thresholds were more pronounced in the 6 month group, suggesting an age-
dependent acceleration of low frequency hearing loss (i.e. greater threshold shifts) in the older 
mice following CI compared to the younger mice. This could be explained by the effects of 
ageing sensitising the inner ear and making it more susceptible to damage following 
implantation within this age group. The progressive hearing loss that occurs in the C57BL/6J 
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mouse with age is well known and associated with the gradual loss of hair cells together with 
other changes such as spiral ligament, stria vascularis and afferent neuronal degeneration 
(Ohlemiller 2006). Elevated hearing thresholds at the high frequencies are seen as early as 3 
months of age and correlate with the progressive loss of both OHCs and IHCs, from the basal 
to apical cochlea, in an age-related fashion  (Henry and Chole 1980; Hequembourg and 
Liberman 2001; Ison et al., 2007; Spongr et al., 1997). With regards to the lower frequencies, 
an age-related decline has also been noted in this strain, albeit, at a slower and sometimes 
more varied rate (Hequembourg and Liberman 2001; Li and Borg 1991a). Hequembourg and 
Liberman (2001) noted low-frequency losses in their study of C57BL/6J mice aged between 
1.5 to 15 months. Histological analysis showed a selective loss of OHCs within the apical 
segment of the cochlea with advancing age together with SGC loss and fibrocyte degeneration 
within the spiral ligament, postulating that these neuronal alterations could account for the low-
frequency hearing loss in part (Hequembourg and Liberman 2001).  
At the time of performing this study, due to the novel nature of the work, there were no 
published studies available assessing physiological outcomes following mouse CI. However, 
during the course of the write up, a few studies have been published. Soken et al. (2013) 
performed CI via the round window in 15 C57BL/6J mice (aged 44 – 56 days) and performed 
auditory testing in the form of click ABR and distortion product otoacoustic emissions 
(DPOAEs) preoperatively and at 2 weeks following implantation. Their findings revealed 
significantly increased mean threshold shifts on click ABR testing in the implanted ear 
compared to the control ear (27.8 dB vs 0.6 dB) with threshold shifts in the implanted ear 
ranging from -3 to 60 dB compared to -9 to 9 dB in the control ear  (Soken et al., 2013). These 
shifts seen within the implanted ear were greater than those seen in our study. Mean threshold 
shifts seen on click ABR in our 3 month old mice ranged from 1.25dB to 13.3dB in the 
implanted group compared to -3.3dB to 1.25dB in the control group over the various time 
points tested. Specifically, at 2 weeks post-implantation, the mean threshold shift in click ABR 
was 5 dB vs. 1.25 dB in the implanted ear vs. control ear respectively. In the 6 month mice, 
mean threshold shifts in click ABR ranged from 1.43 dB to 17.5 dB in the implanted ear 
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compared to -2.5 dB to 7.5 dB in the control ear. At the 2 week mark, the mean threshold shift 
was 1.43 dB in both the implanted and control ears.  
The same group also went on to publish a second study in which sixty-five C57BL/6J mice 
underwent CI with various implant materials (two types of implant grade silicone (diameter 
0.15mm) and an uncoated platinum wire (diameter 0.08mm)) (Kopelovich et al., 2015). As in 
the previous study, click-evoked ABR testing as well as DPOAEs were performed 
preoperatively and at time points between 2 and 22 weeks post-implantation. The age of the 
animals implanted was not specified. Fifty-four of the 65 mice survived to 22 weeks. Their 
results again revealed much greater increases in thresholds post-implantation compared to 
our study with mean threshold shifts as follows: silastic 1 = 49.8 dB; silastic 2 58.1 dB and 
platinum wire = 46.0d B. The majority of the shifts in threshold were seen within the first 2 
weeks post-implantation followed by a slower decline in all groups thereafter. Similar results 
were found in mice which retained their DPOAEs post-implantation.  
Despite the similarities with our study in terms of surgical technique, there may well have been 
slight differences in the approach to the round window and the insertion itself in the 
aforementioned studies. Soken et al. (2013) used a 0.127mm diameter platinum–iridium wire 
as their implant and inserted to depths of 1.5mm to 2mm  (Soken et al., 2013), whereas silastic 
coated implants and a platinum wire of 0.15mm and 0.08mm respectively were used by 
Kopelovich et al. (2015) (Kopelovich et al., 2015). The use of a non-coated platinum–iridium 
wire may have led to a greater degree of trauma at an ultrastructural level, possibly breaching 
the basilar membrane and causing damage to the organ of Corti. However, the authors did 
not perform any histological analysis to assess this in the first study. Kopelovich et al. (2015) 
found that the larger silicone implants were associated with greater loss of hearing compared 
to the platinum wire, however, interestingly, they did not find any correlation between the type 
of implant used and the degree of damage to the organ of Corti  (Kopelovich et al., 2015). 
Soken et al. (2013)  (Soken et al., 2013) found that a number of animals had a loss of DPOAEs 
postoperatively (n=6) which resulted in higher threshold shifts compared to those animals who 
maintained recordable DPOAEs postoperatively. Although effusions within the middle ear 
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were only noted otoscopically in 2 of the animals following implantation, the authors speculated 
that the presence of residual effusion could have contributed to the increased loss of hearing 
in these cases.  
Potential causes of mean threshold shifts seen following implantation in our study could be 
due to the alteration in perilymph volume, as a result of displacement of some of the fluid at 
the time of performing implantation, although this was minimised by sealing the round window 
with muscle tissue immediately after insertion had been performed. Another cause could be 
the presence of an inflammatory and fibrotic response. Further investigation continues in the 
subsequent chapter to try and correlate the functional findings and with histological findings to 
give a clearer idea of the underlying cause of hearing loss.  
 
4.7.2 Appraisal of the ABR technique used to assess hearing outcomes 
following cochlear implantation 
As a purely electrophysiological measure, ABR does not provide data in relation to the animal’s 
capacity to discriminate sounds and is not a measure auditory sensitivity rather it is more 
accurately a measure of neural coordination. The alternative is behavioural testing which 
involves conditioning procedures or which utilise reflex responses which are unconditioned 
(Heffner and Heffner 2001). From a practical perspective and for the purposes of this study, 
the use of ABR testing can be justified as our main concern was to be able to determine the 
effects of implantation on hearing thresholds rather than assess the intricacies of auditory 
sensitivity. It was important to be able to test each ear separately in a controlled environment 
allowing consistency and repeatability so that comparisons could be made. Generating such 
circumstances might not be as easy to attain when undertaking behavioural testing.  
Although the use of broadband stimuli in the form of click-evoked responses alone provides 
limited information, the use of tone burst testing has the advantage of being frequency-specific. 
Our study demonstrated clear advantages in this regard over the aforementioned studies 
(Kopelovich et al., 2015; Soken et al., 2013), as despite the technique being more time 
intensive, the data collected gives much more information regarding the physiological 
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response post-implantation. One advantage that these other studies  (Kopelovich et al., 2015; 
Soken et al., 2013) had, however, was the measurement of DPOAEs.  
Otoacoustic emissions (OAEs) are generated by vibrations of the OHCs in response to 
auditory stimulation, their transmission occurring in the form of an oscillatory wave which 
travels from the cochlea to the external auditory canal via the ossicles and tympanic 
membrane (Kemp 1978). DPOAEs use tonal stimulation, usually in the form of two stimulus 
tones applied to the cochlea, giving an assessment of cochlear function. As with other types 
of OAEs, the status of the middle ear and external canal is very important as even minimal 
conductive losses due to middle ear effusions and debris within the ear canal can affect the 
detection of DPOAEs (Kemp 2002). As such, some authors have recommended their use in 
in the evaluation of middle ear conditions, such as screening for otitis media with effusion in 
children (Yeo et al., 2002).  
Measurements of DPOAEs in C57BL/6J mice have been used to assess age-related hearing 
loss in relation to OHC function (Parham 1997). The results suggested that high to low 
frequency progression of DPOAE thresholds occurs with age and is likely to reflect the 
changes that occur in OHC function with age. In this paper, mice with clinical evidence of 
middle ear infections or large amounts of cerumen build up within the ear canal were excluded 
in an attempt to remove the possible confounding effects of middle and external ear pathology 
on DPOAE outcomes. This was also the case in the previously mentioned studies (Kopelovich 
et al., 2015; Soken et al., 2013) where otoscopy was performed to assess the presence of 
middle ear effusion or haemotympanum. Soken et al. (2013) found that 2 animals had 
otomicroscopic evidence of middle ear effusion but went on to comment that there may have 
been more animals with residual effusions present which were not detected clinically but which 
could account for the greater threshold shifts post-implantation in those who had loss of 
DPOAEs on testing (Soken et al., 2013). Kopelovich et al. (2015) found one animal had clinical 
evidence of middle ear effusion but that no other cases were detected either on otomicroscopy 
or histology. In contrast to the previous study, although a number of animals lost DPOAEs 
following implantation and had greater thresholds on ABR, analysis of those who retained 
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DPOAEs post-operatively revealed a similar pattern of hearing loss, with the majority occurring 
within the first 2 weeks post-implantation. The authors went on to suggest that loss of hearing, 
including the loss of DPOAEs, could be accounted for by the extent of implantation trauma 
rather than the presence of middle ear effusion  (Kopelovich et al., 2015).  
In our study, although DPOAEs were not undertaken, otomicroscopic examination of the 
animals’ ears was performed prior to every ABR test done. Any occluding wax was removed 
using a small wax hook. No cases of effusion were clinically apparent. As with DPOAEs, in 
order for ABR to be accurate and reliable, the middle ear and external auditory canal needs to 
be healthy and free from pathology such as effusion, haematoma or wax. It could be possible 
that some animals tested may have had residual effusions post-operatively that were not 
detected clinically, although, at the time of histological preparation and analysis, no cases of 
middle ear effusion were seen. As DPOAEs do not always provide definitive answers in terms 
of the presence or absence of middle ear effusion, a more appropriate measure could be the 
use of tympanometric testing which would allow a fast and simple measure of middle ear status 
(Zheng et al., 2007).  
Another potential disadvantage to the use of ABR in non-human subjects is the lack of 
standardisation across laboratories which exist with regards to recording parameters, 
calibration, electrode siting and stimulation (Scimemi et al., 2014). Although this is valid point, 
in our laboratory, ABR testing is performed routinely and the method and equipment are all 
rigorously tested and calibrated. The technique in terms of the set-up, sound proofing, 
electrode placement and anaesthesia are well established, consistent and reproducible. 
Further limitations to the technique include the fact that in cases where there was no ABR 
waveform at the highest stimulus level, a threshold of 90dB was used. This was due to the 
limits of testing being reached using the current equipment. As the threshold could have been 
95dB or 100dB, the analysis of threshold shifts between ears was therefore difficult to interpret. 
Attempts to justify the method of ABR testing in terms of occlusion were previously discussed. 
However, a significant limitation of the technique used in the current study was the lack of 
contralateral masking of the non-test ear to avoid the presence of crossover stimulation 
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(Megerian et al., 1996). The most definitive method to ensure that the only response being 
assessed using the ABR technique was from the implanted ear, would have been to deafen 
the control ear. Although useful in terms of gaining functional information, this approach would 
have eliminated access to control cochleae for histological analysis and was therefore not 
considered an option.  
 
4.8 Conclusion 
The results presented in this chapter show the effects of CI on functional outcomes in the mice 
tested. One of the most positive and reassuring results was the fact CI did not lead to a 
complete or profound loss in any of the mice implanted, lending evidence towards it being a 
suitable and viable model to investigate CI in relation to residual hearing. The findings also 
form a baseline against which the results of future studies involving electrical stimulation can 
be compared.  
Greater mean threshold shifts in the implanted ear were seen postoperatively, equating to 
some loss of hearing, the underlying cause of which requires further analysis. This will be 
investigated further in the following chapter where histological findings are examined for 
correlation with functional outcomes. 
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CHAPTER 5: MACROSCOPIC AND HISTOLOGIC OUTCOMES 
FOLLOWING COCHLEAR IMPLANTATION IN THE MOUSE 
 
5.1 Introduction 
Expanding candidacy for CI has become a key focus within CI research. As such, extending 
the use of cochlear implants to those with low-frequency residual hearing has become a major 
aim. The use of EAS is gaining popularity in providing some restoration of hearing through the 
use of combined electrical and acoustic stimulation to many of these patients. Despite the 
ongoing developments and improvements in EAS, patient outcomes have varied. Many 
patients have experienced an immediate or delayed loss of part or all of their residual hearing 
following implantation (Mowry et al., 2012; Santa Maria et al., 2013). The latter outcome is 
concerning, especially as maintaining residual hearing is fundamental for EAS. The underlying 
cause of this loss remains unclear and prompts questions regarding the biological effects of 
CI on cochlear structure and function. Various factors have been cited as potential reasons for 
the loss of residual hearing. These include surgical factors (choice of the electrode array, depth 
of insertion, trauma secondary to electrode insertion), the presence of an immune reaction in 
response to the implant and the combination of both electrical and acoustic stimulation on the 
remaining hair cell population (Irving et al., 2014a; Mowry et al., 2012). 
In light of the above, further investigation into the effect of CI on the cochlea is crucial now 
more than ever. To date, the majority of histopathological information regarding the effects of 
CI in humans has come from cadaveric temporal bone studies (Cervera-Paz and Linthicum, 
Jr. 2005; Fayad et al., 2009; Kawano et al., 1998; Linthicum, Jr. et al., 1991; Marsh et al., 
1992; Nadol, Jr. 1997; Nadol, Jr. et al., 2001; Somdas et al., 2007). Due to the relative 
inaccessibility of the implanted human cochlea during life, animal models are essential to 
providing an insight into the changes occurring at a cellular level following implantation. These 
have included CI in cats, guinea pigs, primates and the rat amongst others (Lu et al., 2005a; 
Pfingst et al., 1979; Shepherd et al., 1983; Spelman et al., 1980). More recently, since 
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developing the novel mouse model within this study (Mistry et al., 2014), other groups have 
also realised the benefits of implantation in the mouse (Bas et al., 2015; Irving et al., 2013; 
Kopelovich et al., 2015; Soken et al., 2013).  
A key concept of the current mouse model is to allow the effects of CI to be investigated and 
to enable the exploration of the possible underlying mechanisms which could lead to residual 
hearing loss. The work presented in this chapter is an initial analysis of the macroscopic and 
histologic findings following CI (in the absence of electrical stimulation). 
 
5.2 Aims 
The main aims of the work presented in this chapter are to: 
3. Assess effects of CI on mouse cochlea at a macroscopic level 
4. Assess effects of CI on mouse cochlea at a microscopic level, including: 
a. Assessment of the presence of inflammation and fibrosis 
b. Preservation of SGC numbers 
c. Preservation of hair cells 
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5.3 Macroscopic findings following cochlear implantation in the mouse 
Figure 5.1 shows images of postoperative dissection of the operative site following sacrifice at 
various time points. At 48 hours following implantation, the wound at the site of incision had 
started to heal and at 12 weeks was no longer visible with complete regrowth of the overlying 
fur. In animals sacrificed at 48 hours to 1 week following implantation, there was evidence of 
oedema in the tissues together with small haematomas (collections of blood) in the muscle on 
occasion, indicative of recent trauma from surgery. Minor fibrosis in the underlying muscle was 
present at 4 and 12 weeks post-implantation. Dissection of the auditory bulla revealed an 
overgrowth of tissue over the area of previous bullotomy and also showed signs suggestive of 
osteoneogenesis in some mice implanted for 4 and 12 weeks (Figure 5.2A). In all cases, the 
implants maintained their position through the round window (Figure 5.2B).  
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Figure 5.1 Images of postoperative dissection of operative site following sacrifice at various time 
points post-CI. 
A - C: Postauricular wounds (indicated by black arrow), even as early as 48 hours to 1 week post-
implantation, have healed well. P indicates mouse pinna. 
D - F: Superficial dissection following opening of the post-auricular wound at 48 hours (d) reveals oedema 
in the superficial tissues and muscles. At 4 and 12 weeks this is less pronounced. 
G - I: Dissection down towards the bulla (TB) reveals the facial nerve (FN), cartilaginous portion of the 
auditory canal (AC) and sternocleidomastoid muscle (SCM). Again at the earlier time points oedema in 
the tissue is more evident.  
J - L: Further dissection over the bulla reveals a thin layer of tissue over the previous bullotomy site 
(indicated by black arrow) overlying the implant. Posterior belly of digastric muscle is noted. At later time 
points partial closure/complete closure of the bullotomy had taken place with new bone formation 
(osteoneogenesis) (see Figure 5.2). 
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Figure 5.2 Postoperative responses in the auditory bulla. A) Auditory bulla of 3 month old mouse at 
4 weeks post-implantation with fluorocarbon thread (indicated by the white arrow). New tissue suggestive 
of osteoneogenesis is evident at site of previous bullotomy (grey dashed line). B) Electrode array in place 
at round window (RW, outline marked). The stapedial artery (SA) is seen inferior to the RW and passing 
through the crura of the stapes (S). 
 
5.4 Microscopic findings following cochlear implantation  
5.4.1 Toluidine blue staining of cochlear cryosections and light microscopy 
 
5.4.1.1 Sham mice 
Figure 5.3 shows cochlear cryosections stained with toluidine blue taken from 3 month old 
mice that underwent sham surgery. In these cases, in the sham (left) operated ear, the round 
window was opened using a fine needle but no implant was inserted. The round window was 
subsequently sealed using a small amount of muscle tissue to prevent perilymph leak. In the 
section taken both at 48 hours and 1 week following the sham operation, small amounts of 
cellular debris can be seen within the scala tympani of the far lower basal turns (Figure 5.3B 
and C). However, subsequent sections (D and E) do not reveal such changes suggesting that 
this debris is confined only to the lower basal turns. The cellular debris may represent 
intrascalar blood or remnants from the muscle tissue used to seal the opening or could be an 
inflammatory reaction in response to the trauma of opening the round window membrane. The 
control sections do not demonstrate such changes within the scala tympani. 
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Figure 5.3 Cochlear cryosections taken from 3 month old mice that underwent sham surgery and 
were sacrificed at 48 hours and 1 week postoperatively. Sham surgery involved opening of the round 
window but no implantation. The round window was subsequently sealed with a small amount of muscle 
tissue. Sections have been stained with toluidine blue.  
48 hours: Sections labelled A and B taken from right control, unoperated right ear and left sham operated 
ear respectively. There is evidence of cellular debris (black arrows) in the scala tympani (ST) of the left 
ear (B) compared to the control ear (A). 
1 week: Sections C – E are taken from left operated ear, sections F and G are from the unoperated 
(right) ear. Similar to 48 hours, in the left lower basal turn (C) there is some evidence of cellular debris 
(black arrows) within the ST, however, on subsequent sections this is not as apparent (D and E) and 
appears to be limited to the far basal turn. In the control sections (F and G) the ST appears clear. 
Image H included to indicate areas of cochlea from which sections were taken. Areas of cochlea 
defined as lower basal (LB), mid basal (MB), mid-apical (MA) and apical (A). Sections shown A – H 
taken from far lower basal turn (taken and adapted from Lee et al. 2006.
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5.4.1.2 Implanted mice 
An example of cochlear sections where implantation was performed is shown in Figure 5.4. 
These cochlear cryosections are taken from 3 month old and 6 month old mice implanted for 
48 hours (Figure 5.4A and B) and 4 weeks (Figure 5.4C and D) respectively, with an electrode 
array. The implant was carefully removed following fixation, prior to sectioning and staining 
with toluidine blue. Sections from the left (implanted) cochlea (Figure 5.4A and B) from the 
mouse implanted for 48 hours revealed evidence of cellular tissue within the scala tympani. At 
higher magnification, this was found to be highly suggestive of erythrocytes. The presence of 
intrascalar blood is likely to be as a result of surgery on opening the round window membrane 
and following insertion of the implant. These findings were also seen in other animals at the 
earliest time point of 48 hours but less so at later time points, most likely due to absorption of 
intrascalar blood. 
In sections taken from the mouse implanted for 4 weeks, evidence of cellular debris is again 
seen within the scala tympani of the implanted ear (Figure 5.4 D) but not in the unoperated 
(control) ear (Figure 5.4C). These findings were noted in sections taken from other implanted 
mice (with either the fluorocarbon implant or the electrode array) at all time points over which 
implantation occurred. The response appeared to be limited to the basal turn. 
 
 
 
5.4.2 Light microscopy of plastic-embedded cochlear sections 
Plastic-embedded cochlear sections were examined with the fluorocarbon thread in-situ and 
revealed encapsulation of the implant with fibrotic-like tissue within the scala tympani (Figure 
5.5). The tissue appeared to have features of a dense fibrocollagenous capsule with scattered 
fibroblast-type cells and immune-type cells including macrophages. Other important structures 
including the organ of Corti, spiral ganglion cells and stria vascularis (Figure 5.5b) were also 
intact and not damaged as a result of CI. Both implant groups (fluorocarbon thread and 
electrode array) exhibited similar fibrotic-like tissue. This encapsulation was present as early 
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as 1 week post implantation, and persisted for all time points examined (up to 12 weeks), but 
remained confined to the basal turn of the cochlea. 
 
 
 
 
Figure 5.4 Cochlear cryosections stained with toluidine blue from mice implanted with electrode 
array. 
 
A and B Cochlear cryosections taken from a 3 month old mouse implanted with an electrode array for 
48 hours. Sections from the implanted (left) ear are shown depicting the presence of cellular debris within 
the scala tympani (A), which at higher magnification (B) suggests the presence of erythrocytes 
 
C and D: Cochlear cryosections taken from a 6 month old mouse implanted with an electrode array for 
4 weeks. The sections are taken from comparable regions of the basal turn of the control and implanted 
ears respectively. (C) Section from right (control) cochlea shows absence of excess tissue in scala 
tympani. (D) Section from left (implanted) cochlea with evidence of reactive tissue within scala tympani. 
Loss of hair cells is notable at this age and corresponds to the high frequency loss seen in this strain.  
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Figure 5.5 Plastic-embedded cochlear sections with the fluorocarbon thread in-situ taken from 6 
month old mouse implanted for 1 week. (A) Cochlea with fluorocarbon thread implant in-situ shows 
evidence of fibrotic-like tissue surrounding the implant (Im) within the scala tympani (ST). Sections (C) 
and (D) show this fibrotic-like tissue at higher magnification. Scala media (SM), scala vestibuli (SV), 
organ of Corti (OC), spiral ganglion (SG), modiolus (Mod) are clearly seen. (B) Organ of Corti at higher 
magnification. Outer hair cells (OHC), inner hair cells (IHC), tectorial membrane (TM), tunnel of Corti 
(TC), Deiters’ cells (DC) and Hensen’s cells (HC) are labelled. 
(NB: bowing of Reissner’s membrane is seen in section A, suggestive of endolymphatic hydrops, 
however, this change was secondary to tissue processing rather than a pathological change and was 
also seen in controls (not shown here). 
Sections prepared by Mr Graham Nevill. 
 
5.4.3 Transmission electron microscopy (TEM)  
Plastic embedded fluorocarbon-implanted cochleae were also analysed by TEM for further 
evaluation (Figure 5.6). The preparation and TEM scanning was undertaken by Mr Graham 
Nevill and Professor Andrew Forge respectively. Analysis of sections revealed further detail 
regarding the encapsulating tissue present around the electrode confirming the presence of 
fibroblast-type cells together with collagen fibrils and inflammatory cells. Sections also showed 
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evidence of organised tissue of epithelial origin suggesting the possibility of epithelial cells 
growing along the implant following round window insertion.  
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Figure 5.6 Plastic-embedded cochlear sections with the fluorocarbon thread in-situ taken from 6 month old mouse implanted for 1 week analysed by TEM.  
A. Low magnification image shows 
implant (Im) encapsulated by 
tissue (T). Hexagons represent 
grid bars to aid identification of 
location. Red square shows area 
which has been magnified in 
subsequent panels (Scale bar = 
50µm).  
B. Higher power image shows 
encapsulating tissue (T) in further 
detail around the implant (Im) 
(Scale bar = 10µm). 
C. Numerous mitochondria (1) 
associated with mesothelial cell (2) 
(Scale bar = 2µm). 
D. Laminated appearance of 
encapsulating tissue (Scale bar = 
10µm). 
E. Epithelial cells are present within 
the tissue (1) and may have 
originated from the round window 
membrane at the time of 
implantation (Scale bar = 2µm). 
F. Rough endoplasmic reticulum 
(RER) (1) is noted together with 
numerous collagen fibrils (2) 
(Scale bar = 0.5µm) 
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5.5 Analysis of inflammatory response to cochlear implantation in the 
mouse 
To assess the inflammatory response of the tissue to implantation, the technique of 
immunofluorescence was used. Two antibodies, CD45 and F480, were trialled in the initial 
phase to decide which would be the most appropriate and also to optimise conditions for their 
use in the detection of inflammatory-type cells. CD45 or common leucocyte antigen as it is 
otherwise known, is a tyrosine phosphatase integral membrane protein expressed on the cell 
surface of all haematopoietic cells with the exception of platelets and mature erythrocytes 
(Charbonneau et al., 1988). It is through its role in the regulation of protein-tyrosine kinases, 
which are key to signal transduction, and through the mediation of cell-to-cell interactions, that 
CD45 acts to promote B and T cell activation. CD45 is also involved in the migration of immune 
cells and plays a crucial role in integrin-mediated adhesion (Trowbridge and Thomas 1994).  
In the murine cochlea, studies have utilised these qualities of CD45 to investigate the presence 
of an inflammatory response to insults including acoustic trauma. Hirose et al. (2005) 
performed immunohistochemistry for CD45 to study the effects of acoustic trauma on the 
cochleae of CBA/CaJ mice. Results revealed many CD45 positively-labelled cells, mainly 
within the spiral limbus and ligament of the cochlea following noise injury. Through further 
experiments the authors found that the majority of cells present were of monocyte/macrophage 
lineage with a few lymphocytes and natural killer  cells present. It was suggested that the 
primary aim of these inflammatory cells was to aid in the reestablishment of the endocochlear 
potential through the clearance of debris and repair of the reticular lamina, which was ruptured 
with noise exposures of 116 dB or greater, rather than to promote repair of sensory epithelia 
damaged as a result of acoustic trauma (Hirose et al., 2005). Similarly, other studies have also 
used CD45 to investigate the cochlea’s immune response and the role of inflammatory cells 
following acoustic injury (Miyao et al., 2008; Tan et al., 2008).  
F4/80 is a monoclonal antibody which was first described as a marker for mouse monocytes 
and macrophages (Austyn and Gordon 1981). It forms part of the epidermal growth factor-
seven transmembrane (EGF-TM7) family which represent a group of heptahelical 
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transmembrane receptors principally expressed by cells of the immune system. EGF-module-
containing mucin-like hormone receptor (EMR) 1 (EMR1) is the human equivalent and has 
been found to show high levels of expression on monocyte and macrophage lines on reverse 
transcriptase polymerase chain reaction (RT-PCR) and is thought to share 68% homology with 
its mouse counterpart (Taylor et al., 2005). Expression during development and through adult 
life in a variety of infectious and inflammatory disease models, means that F4/80 has lent itself 
widely as a mouse macrophage antigen marker (Gordon et al., 2011). In the mouse auditory 
system, F4/80 has been used in a similar manner to CD45 to detect immune cell recruitment 
following acoustic trauma within the cochlea  (Tornabene et al., 2006) and to characterise and 
investigate the inflammatory response of perivascular-resident macrophage-like melanocytes 
in the vestibular system  (Zhang et al., 2013).  
 
5.5.1 Optimisation of antibodies  
For the purposes of the current study, the aim was to investigate the presence of inflammatory 
cells within cochlear sections taken from mice implanted with both the fluorocarbon implant 
and the electrode array. Both CD45 and F4/80 antibodies were trialled at concentrations of 
1:100 and 1:200 in conjunction with other antibodies. Following optimisation, CD45 at 1:100 
concentrations gave the best results and was used together with calretinin (1:100) to stain 
sections for CD45 and spiral ganglion cell counts respectively (Figure 5.7). 
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Figure 5.7A. Immunofluorescence using CD45 and MyoVIIa antibodies – control sections taken from 3 month old mouse for optimisation of antibodies 
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Figure 5.7B. Immunofluorescence using F4/80 and MyoVI antibodies – control sections taken from 3 mo nth old mouse for optimisation of antibodies 
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Figure 5.7C. Immunofluorescence using MyoVIIa and calretinin antibodies – control sections taken from 3 month old mouse for optimisation of antibodies 
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5.5.2 Analysis of inflammatory response 
Counts of CD45-positively labelled cells were performed on sections taken from cochleae of 
mice implanted with both the fluorocarbon thread as well as the electrode array. Multiple 
sections from the implanted and control ears of 14 mice were analysed using 
immunofluorescence, the group having an average age of 186 days. Numbers in each group 
were as follows, fluorocarbon implants: 48 hours (n=3), 1,4,12 weeks (n=2); electrode array 
48 hours (n=2), 1,4,12 weeks (n=1).  
When comparing CD45-postively labelled cells from implanted and control cochleae, a clear 
difference was noted, with significantly greater numbers of positively-labelled cells within the 
implanted cochleae compared to the control cochleae at the majority of time points and 
regardless of the type of implant used (T-Test, P<0.05) (Table 5.1). Figure 5.8 shows the mean 
number of CD45-positively labelled cells for combined implants across the different time points 
for all three cochlear regions. When analysing the various cochlear turns of the implanted ear, 
significantly greater numbers of CD45-positively labelled cells were noted in the lower basal 
region compared to upper basal and apical regions (T-Test, P<0.05). As the implant is 
physically located in the lower basal turn of the cochlea, these results suggest a more 
pronounced inflammatory response confined to this region in response to implantation. The 
inflammatory response can also be seen to peak between 1 and 4 weeks in all three cochlear 
regions before decreasing to lower levels at 12 weeks. These findings are particularly 
important with regards to the potential location of delivery and timing of therapeutic agents to 
reduce inflammation. 
Figures 5.9 to 5.12 show sections demonstrating the presence of CD45-positively labelled 
cells in control and implanted ears at various times post-implantation. At all four time points 
tested, for both implantation with fluorocarbon thread or electrode array,  more CD45-positively 
labelled cells were noted in similar regions of the cochlea, namely, the basilar membrane, 
scala tympani, spiral ligament and within the region of the osseous spiral lamina. As well as 
the presence of CD45-positively labelled cells in sections from implanted cochleae, the 
presence of cellular debris and possible fibrosis was noted within the scala tympani. At 48 
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hours, the presence of cellular material within the scala tympani may have been due to the 
presence of residual blood secondary to haemorrhage at the time of surgery and as a result 
of sealing the round window with muscle tissue. This was also seen on toluidine blue staining 
of sections taken from implanted mice at this time point (Figure 5.4 A and B). At later time 
points of 1, 4, and 12 weeks this staining within the scala tympani is likely to be due to the 
presence of fibrotic tissue forming as demonstrated previously (Figure 5.5 and 5.6). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Comparison of the mean number of CD45-positively labelled cells for combined 
implants across the different time points for all three cochlear regions.  
Significantly greater numbers of cells are present in the lower basal turn of the implanted ear compared 
to the other regions (P<0.05). This is also the case when the lower basal implanted ear is compared to 
the control ear (P<0.05). The inflammatory response can be seen to peak at between one and four 
weeks in all three cochlear regions before decreasing to lower levels at 12 weeks. (Numbers in each 
group: 48 hours, n=5; 1,4,12 weeks, n=3. Error bars represent ±2SEM.
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Table 5.1 Mean numbers of CD45-postiviely labelled cells from implanted (left) and control (right) cochleae. Comparisons made based on the presence of CD45-
positively labelled cells seen in each of the three cochlear regions: lower basal, upper basal and apical. T-test performed to compare implanted and control ears at each time 
point within each region (±2SEM shown in brackets next to mean in table). Numbers in each group: fluorocarbon implants n=3 48 hours, n=2 for 1,4,12 weeks; electrode array 
n=2 for 48 hours, n=1 for 1,4,12 week.
Implant type Duration of implantation Control Implanted P-value Control Implanted P-value Control Implanted P-value
48 hours 19 (1.59) 37 (7) <0.001 12 (2) 18 (2) 0.001 11 (2) 15 (2) 0.004
1 week 14 (3) 35 (4) <0.001 10 (2) 25 (2) <0.001 10 (2) 23 (3) <0.001
4 weeks 13 (3) 37 (11) <0.001 12 (1) 18 (2) <0.001 13 (2) 18 (3) 0.006
12 weeks 11 (2) 18 (4) 0.003 11 (2) 17 (3) 0.002 11 (2) 10 (3) 0.698
Implant type Duration of implantation Control Implanted P-value Control Implanted P-value Control Implanted P-value
48 hours 9 (1) 16 (3) 0.004 5 (1) 11 (2) <0.001 6 (2) 10 (2) 0.02
1 week 24 (5) 41 (15) 0.028 8 (4) 14 (7) 0.168 8 (2) 14 (2) 0.001
4 weeks 25 (7) 51 (9) 0.001 7 (2) 24 (3) <0.001 10 (2) 15 (4) 0.08
12 weeks 14 (5) 26 (4) 0.003 12 (4) 17 (5) 0.083 14 (4) 20 (3) 0.019
Implant type Duration of implantation Control Implanted P-value Control Implanted P-value Control Implanted P-value
48 hours 16 (2) 30 (6) <0.001 8 (1) 15 (12) <0.001 10 (2) 14 (2) 0.001
1 week 19 (4) 38 (6) <0.001 9 (2) 22 (3) <0.001 11 (2) 20 (3) <0.001
4 weeks 17 (4) 42 (9) <0.001 10 (1) 21 (2) <0.001 12 (1) 16 (3) 0.009
12 weeks 12 (2) 22 (3) <0.001 11 (2) 17 (3) <0.001 12 (2) 14 (3) 0.186
Upper basalLower basal 
Mean CD45 counts
Lower basal Upper basal Apical
Mean CD45 counts
Apical
Fluorocarbon implant
Electrode array
Combined implants
Mean CD45 counts
Lower basal Upper basal Apical
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Figure 5.9 Immunofluorescence of cochlear cryosections (basal turn) taken from mice 
implanted for 48 hours.  
(A) Control (right) and (B) implanted (left) ear of mouse implanted with a fluorocarbon thread for 48 hours. 
CD45 staining reveals increased numbers of CD45-positively labelled cells in the implanted ear (white 
arrows) compared to the control ear, particularly in the regions of the basilar membrane (BM), scala 
tympani (ST), spiral lamina (SLa) and spiral limbus (SLi). There is also evidence of cellular debris within 
the ST (red arrow).  
(C) and (D) Immunolabelling of cochlear cryosection from mouse implanted for 48 hours with electrode 
array. Increased numbers of CD45-positively labelled cells confirmed by their characteristic appearance 
at higher magnification (D). 
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Figure 5.10 Immunofluorescence of cochlear cryosections (basal turn) taken from mouse 
implanted for 1 week with electrode array. 
Sections reveal increased numbers of CD45-positively labelled cells in the (B) implanted ear (white 
arrows) compared to the (A) control ear particularly in the regions of the spiral lamina (SLa) and spiral 
limbus (SLi). There is also evidence of cellular debris within the scala tympani (ST) which may represent 
the presence of fibrosis (red arrow).  
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Figure 5.11 Immunofluorescence of cochlear cryosections (basal turn) taken from mouse 
implanted for 4 weeks with fluorocarbon thread. 
Sections reveal increased numbers of CD45-positively labelled cells in the implanted ear (B) (white 
arrows) compared to the control ear (A) particularly in the region of the basilar membrane (BM) and scala 
tympani (ST). There is also evidence of cellular debris within the scala tympani (ST) (red arrow). 
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Figure 5.12 Immunofluorescence of cochlear cryosections (basal turn) taken from mouse 
implanted for 12 weeks with electrode array. 
The presence of CD45-positively labelled cells in the implanted ear (B) compared to the control ear (A) 
is not so pronounced at this stage. In the implanted ear, evidence of deposition of possible fibrosis at the 
periphery of the ST is present (tissue surrounded by red-dashed line). 
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5.6 Quantitative analysis of spiral ganglion cells following cochlear 
implantation in the mouse 
As electrical stimulation of spiral ganglion neurons by the electrode array is the main basis of 
hearing restoration in CI, preserving and maintaining the health of these cells and their 
connections is vital (Bas et al., 2015; Nadol, Jr. et al., 1989). In order to perform a quantitative 
analysis of SGCs following CI in the mouse, immunofluorescence was used.  Anti-calretinin, 
based on the intracellular calcium-binding protein calretinin, was used as the primary antibody. 
As a member of the calmodulin family, calretinin plays a key role in calcium homeostasis and 
is a vital in component of many of the regulatory pathways requiring calcium within the central 
nervous system. It is also expressed by some groups of peripheral neurons and found within 
the olfactory bulb and auditory pathways (Arai et al., 1991; Dechesne et al., 1991; Rogers 
1987). 
In order to perform a quantitative analysis following CI in the mouse, counts of SGCs within 
the area of Rosenthal’s canal were performed and expressed as a density. As numbers were 
small within each individual implant group, a combined analysis of all implants, fluorocarbon 
thread and electrode array, was performed in the 6 month old group.  
The mean SGC densities for the implanted and control ears at each cochlear region and at 
the various time points following implantation are shown in Table 5.2 and Figure 5.13. 
Comparisons of implanted and control ears did not reveal statistically significant differences in 
SGC density for any of the cochlear regions at any time points tested (T-Test, P>0.05). 
Changes in SGC density measured across the various time points for each cochlear region 
were assessed (Jonckheere–Terpstra test for repeated measures). In the lower basal region 
(Figure 5.14A) overall SGC density did not decline significantly in the control ear (P=0.801) 
and showed only a slight decline in the left ear by 12 weeks (P=0.327). When plotted as the 
difference between the two ears (Figure 5.14B), however, a downward slope is seen 
suggesting the progressive loss of SGCs in the implanted ear with time. In the case of the 
upper basal and apical regions, the converse was seen with a slight increase in SGC densities 
over time in both the implanted and control ears (P>0.05) (Figure 5.14C and E). This is also 
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case when the mean difference between the ears is plotted over time, where greater SGC 
densities are seen in the implanted ear (Figure 5.14D and F). These latter results did not prove 
significant on statistical testing. 
Examples of images obtained following labelling for calretinin in spiral ganglion cell bodies of 
cochlear cryosections are shown in Figure 5.15. 
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  Mean SGC density (number/mm2)  
  Right lower basal  Left lower basal Right upper basal Left upper basal  Right  Apical Left Apical 
48 hours 
1843 (204) 1718 (154) 1637 (136) 1569 (124) 1533 (98) 1554 (148) 
0.339 0.465 0.816 
       
  Mean SGC density (number/mm2)  
  Right lower basal  Left lower basal Right upper basal Left upper basal  Right  Apical Left Apical 
1 week 
1530 (190) 1497 (212) 1529 (93) 1528 (194) 1884 (240) 1635 (141) 
0.817 0.997 0.132 
       
  Mean SGC density (number/mm2)  
  Right lower basal  Left lower basal Right upper basal Left upper basal  Right  Apical Left Apical 
4 weeks 
1736 156) 1687 (121) 1574 (116) 1480 (241) 1937 (199) 2170 (226) 
0.638 0.459 0.128 
       
  Mean SGC density (number/mm2)  
  Right lower basal  Left lower basal Right upper basal Left upper basal  Right  Apical Left Apical 
12 weeks 
1721 (320) 1529 (193) 1789 (193) 1908 (177) 1735 (314) 1927 (203) 
0.294 0.370 0.298 
 
Table 5.2 Mean SGC densities (±2SEM) are shown for the combined group of implants undertaken in the 6 month old mice (n=3 mice at each time point except 48 hours 
where n=4). T-Test was performed to assess for the presence of significant differences between the implanted and control ears. P values are shown in the table. There were no 
significant differences between SGC densities at the various regions at the four different time points (P>0.05).
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Figure 5.13 Mean SGC densities for the three cochlear regions are shown over the various implantation time points tested. SGC densities were similar across the three 
regions and there were no significant differences noted when comparing implanted and control ears on statistical testing. Error bars represent two SEM (n=3 mice at each time 
point except 48 hours where n=4). 
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Figure 5.14 A - F Mean SGC densities and difference in mean SGC densities between implanted and control ear are shown over the various implantation time points 
tested. Graphs A, C, and E show the implanted (left) ear compared to the control (right) ear over the various time points. Graphs B, D and F show the difference between the 
implanted and control ears over the various time points. Trend lines have also been shown. 
 
 
 
 
 
 
 
 
 
 
 
  
161 
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Figure 5.15 Immunofluorescence labelling for calretinin in spiral ganglion cell bodies of cochlear cryosections (lower basal turn) at various time points following 
implantation in 6 month old mice. The images suggest a reduction in SGC numbers over time in both the control and implanted ears. However, the overall SGC density was 
not found to decline significantly in either the control ear or the implanted ear over time (P>0.05). 
 
 
 
 
 
 
 
 
 
 
48 hours 
1 week 
4 weeks 
12 weeks 
Implanted ear Control ear 
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5.7 Quantitative analysis of hair cells following cochlear implantation in 
the mouse 
A quantitative analysis of hair cells following CI in the mouse was performed using whole 
mounts of the organ of Corti taken from 3 month old mice. As numbers of mice in each group 
were small, a combined analysis of all implants, fluorocarbon thread and electrode array, was 
again performed. The mean age of the mice included in this analysis was 99.25 days. Mean 
hair cell counts for each of the cochlear regions analysed over the various time points are 
shown in table 5.3 and represented graphically in Figure 5.16.  
 
a) Mean inner hair cells/100µm 
 Implanted (Left) Ear Control (Right) Ear 
 Basal Mid-basal Mid-apical Apical Basal Mid-basal Mid-apical Apical 
48 hours   11 11 12   10 12 12 
1 week   11 11 12   11 12 13 
4 weeks 11 11 12 12 16 12 13 11 
12 weeks   12 11 13   11 11 11 
         
         
b) Mean outer hair cells/100µm 
 Implanted (Left) Ear Control (Right) Ear 
 Basal Mid-basal Mid-apical Apical Basal Mid-basal Mid-apical Apical 
48 hours   35 38 37   22 36 38 
1 week   39 38 38   35 38 37 
4 weeks 18 37 37 44 41 35 38 38 
12 weeks   39 39 35   35 36 36 
 
(c) Inner hair cells Outer hair cells 
 Basal Mid-basal Mid-apical Apical Basal Mid-basal Mid-apical Apical 
48 hours - 0.459 0.520 0.700 - 0.535 0.229 0.483 
1 week - 0.163 0.094 0.346 - 0.423 0.772 0.605 
4 weeks 0.034 0.440 0.072 0.381 0.022 0.144 0.810 0.499 
12 weeks - 0.784 0.922 0.584 - 0.199 0.166 0.724 
 
Table 5.3 Mean inner and outer hair cell counts for the four cochlear regions (a) inner hair cells 
and (b) outer hair cells - basal, mid-basal, mid-apical and apical areas assessed at each time point for 
implanted and control ears. (c) P-values are shown following statistical testing to compare implanted and 
control ears (Paired T-test, significance level: P<0.05). N=3 mice at each time point.  
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Comparisons of mean hair cell counts between the implanted and control ears did not show 
significant differences across the various cochlear regions over the four time points tested. 
There were, however, two exceptions to this, at 4 weeks where a significantly lower mean 
number of inner and outer hair cells were found in the basal region of the implanted ear 
compared to the control ear (P=0.03 and 0.02 respectively) (Figure 5.16 and 5.17). 
Unfortunately, reproducibility of this finding within the basal cochlea at the various other time 
points (48 hours, 1 week and 12 weeks) was not possible due to architectural damage to the 
whole mount sections, sustained during dissection and processing, which prevented counts 
from being performed accurately. Examples of whole mount segments are shown in Figure 
5.17. 
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Figure 5.16 Mean hair cell counts post-implantation (*P < 0.05) n=3 mice at each time point. Error bars represent two standard error of the mean (±2SEM).  
   
 
 
 
 
 
 
 
 
 
* 
* 
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Figure 5.17 Organ of Corti whole mount segments taken from 3 month old mice. Immunoabelling of hair cells has been performed using Myosin VIIa (Myo VIIa). DAPI 
labelled nuclei. Example sections are shown for implanted and control ears at each time point (A - D). Comparisons of mean hair cell counts between the implanted and control 
ears did not show significant differences across the various cochlear regions over the four time points tested (A, B, D). However, an exception to this was at 4 weeks  where a 
significantly lower mean number of inner and outer hair cells were found in the basal region of the implanted ear compared to the control ear (P<0.05). This is demonstrated in 
the sections below (C). 
 
(A) Comparison of mid-apical turn sections taken from mouse implanted for 48 hours. Upper sections (i) taken from right (control) ear, lower sections (ii) from left (implanted) ear. 
 
 
 
IHC 
OHC 
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(B) Comparison of mid-basal turn sections taken from mouse implanted for 1 week. Upper sections (i) taken from right (control) ear, lower sections (ii) from left (implanted) ear. 
 
 
 
 
IHC 
OHC 
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(C) Comparison of basal turn sections taken from mouse implanted for 4 weeks. Upper sections (i) taken from right (control) ear, lower sections (ii) from left (implanted) ear. A 
greater loss of inner and outer hair cells are observed in the implanted ear (ii) compared to the control ear (i). 
 
 
 
 
 
IHC 
OHC 
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(D) Comparison of mid-apical turn sections taken from mouse implanted for 12 weeks. Upper sections (i) taken from right (control) ear, lower sections (ii) from left (implanted) 
ear. 
 
 
 
 
IHC 
OHC 
5.8 Discussion 
 
5.8.1 Cochlear inflammation and fibrosis following cochlear implantation in 
the mouse 
The main aim of the current chapter was to investigate the effect of CI in the mouse at a cellular 
level. The concept of cochlear damage following CI is well-recognised and can occur 
immediately at the site of insertion, along the electrodes trajectory and as a result of disruption 
to cochlear fluids. A more delayed response is thought to arise following activation of the host’s 
response to CI and due to the loss of function of the delicate intracochlear structures (Li et al., 
2007). As with other biomedically-active implantable devices, cochlear implants represent the 
presence of a foreign body within the cochlea which has the potential to provoke an acute 
inflammatory reaction. Progression then occurs to the chronic phase if the presence of the 
electrode is sustained, with the ultimate formation of a fibrous capsule around the implant (Bas 
et al., 2012a; Bas et al., 2012b; Bas et al., 2015; Richard et al., 2012). Such a response was 
confirmed within the current mouse model of CI. The initial inflammatory reaction was noted 
within 48 hours of implantation as demonstrated by the presence of significantly greater 
numbers of positively labelled CD45 cells within the scala tympani of implanted cochleae 
compared to the controls. This response predominated within the lower basal region of the 
implanted cochleae and was sustained up to 12 weeks following implantation. As further work 
to establish the type of leucocytes present within sections from implanted cochleae was not 
performed, it cannot be confirmed as to whether the inflammatory cellular infiltrate seen on 
CD45 labelling at 48 hours differed from the inflammatory infiltrate found at 12 weeks.  
Following cochlear implantation, any associated trauma, for example to the lateral cochlear 
wall, is met with an immediate inflammatory response to repair the damaged site. Following 
injury localised capillary permeability and vasodilatation is induced due to the release of 
vasoactive amines such as histamine from mast cells. Leucocytes are recruited which migrate 
and adhere to sites of tissue damage. A variety of inflammatory mediators play a part in the 
tissue response, including chemokines, neuropeptides, proteolytic enzymes and cytokines. 
The persisting presence of the cochlear implant also promotes a foreign body reaction in the 
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form of chronic inflammation characterised by mononuclear cells such as macrophages, 
together with evidence of fibrosis and angiogenesis. The complex cascade of events which 
occur include the interplay between pro-inflammatory cytokines such as TNF-α and interleukin 
(IL) 1-β, chemokines and growth factors such as TGF–β1. At high levels, this latter precursor 
for fibrosis leads to the scar tissue encapsulating the implant (Bas et al., 2012a; Bas et al., 
2012b; Bas et al., 2015). The events are summarised in Figure 5.18. 
 
 
Figure 5.18 Sequence of events leading to inflammation and fibrosis within the cochlea following 
CI. An acute inflammatory reaction is initiated following trauma secondary to electrode insertion into the 
cochlea. The release of vasoactive amines such as histamine causes vasodilatation and promotes the 
migration and activation of leucocytes such as monocytes which mature into macrophages. 
Macrophages and fibrocytes release chemokines, which encourage inflammatory cell recruitment and 
release of cytokines and reactive oxygen species (ROS), and growth factors which promote wound 
healing and formation of a fibrous scar around the electrode (adapted from Bas et al. 2012). 
 
The presence of fibrous tissue within the cochlea and surrounding the electrode array is an 
accepted consequence of CI (Friedland and Runge-Samuelson 2009). The current mouse 
model of CI was no exception to this as fibrotic-like tissue was found within the lower basal 
turn and encapsulating the implant as early as 1 week following CI. This tissue persisted in 
mice implanted for 12 weeks but remained confined to the lower basal turn in the vicinity of 
the implant. This finding correlates with data from recent mouse studies (Irving et al., 2014b; 
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Kopelovich et al., 2015) as well as human temporal bone studies (Cervera-Paz and Linthicum, 
Jr. 2005; Fayad et al., 2009; Li et al., 2007; Linthicum, Jr. et al., 1991; Marsh et al., 1992; 
Nadol, Jr. 1997; Nadol, Jr. et al., 2001; Somdas et al., 2007). Li et al. found a strong correlation 
between the volume of new tissue (fibrosis and neo-osteogenesis) within the cochlea with 
damage to the lateral cochlear wall sustained during insertion, emphasising the importance of 
soft surgical techniques to minimise trauma (Li et al., 2007). In the latter study, cochleostomy 
was performed to allow implant insertion. It was within the vicinity of the cochleostomy and 
extending into the lower basal turn that the greatest volume of fibrous and new bone tissue 
was found. These findings are not limited to the cochleostomy approach, however, as others 
have noted similar findings with round window insertions (Irving et al., 2013; Kopelovich et al., 
2015; Ribari et al., 2000). This concurs with the findings of the current study where fibrotic-like 
tissue was evident within the basal turn following a round window approach.  
In clinical practice, fibrous encapsulation of the implant is thought to significantly reduce 
electrical signal transmission between the device and target neurones, thus reducing the utility 
of the device by increasing power consumption, and increasing the spread of the electrical 
field generated by electrode stimulation (Clark et al., 1995b; Fayad et al., 2009). Fibrosis 
results in a reduction in the efficacy of signal coding, increases the implant size, reduces 
battery life and in many patients necessitates replacement of the device. In terms of 
performance, Kawano et al. (1998) studied various psychophysical percepts thought to play 
an important role in speech recognition and correlated them with histological findings in 
temporal bones of CI recipients. Results revealed reductions in dynamic range and increases 
in auditory thresholds for individual electrodes with greater amounts of fibrous tissue and new 
bone formation (Kawano et al., 1998). With regards to residual hearing, Choi and Oghalai 
(2005) developed a passive cochlea model and used computer simulation to predict the effects 
of fibrosis on residual hearing. Their findings suggested that fibrous tissue formation at the 
basal cochlea could alter basilar membrane velocity at the apex, thereby having a detrimental 
effect on residual hearing and impairing performance post-CI (Choi and Oghalai 2005). A 
recent study of human temporal bone pathology was performed from a patient previously 
implanted with a hybrid electrode who suffered delayed hearing loss post-CI. Histopathological 
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analysis revealed new bone formation and loose fibrous tissue filling the scala tympani of the 
basal cochlea turn. The authors suggested that the presence of such tissue could have 
contributed to the hearing loss observed due to reduced compliance at the round window and 
increased damping in the scala tympani (Quesnel et al., 2016). Conversely, Li et al. did not 
find a significant correlation between word recognition scores post-implantation and the total 
volume of new tissue deposition in the cochlea (Li et al., 2007). This was also seen in a guinea 
pig model of residual hearing where post-surgical hearing loss was not correlated with the 
area of fibrosis within the cochlea (Tanaka et al., 2014). Similarly, Kopelovich et al. (2015) did 
not find significant correlations between a greater degree of hearing loss and the presence of 
fibrotic tissue within the scala tympani in a mouse model of CI (Kopelovich et al., 2015)  
 
5.8.2 Effect of cochlear implantation on spiral ganglion cells 
With respect to hearing preservation CI surgery, successful outcomes are dependent not only 
on the maintenance of residual hair cells, but also on the viability of SGCs and their neurons. 
Two main factors require discussion in relation to the current mouse model: the effect of ageing 
on SGC populations as well as the potential effects of implantation. 
 
5.8.2.1 Age and spiral ganglion cells 
Age-related loss of hair cells and SGCs is well documented in the C57BL/6J  mouse (Henry 
and Chole 1980; Li and Borg 1991b; Mikaelian 1979). As previously discussed, high-frequency 
hearing losses in these mice can occur from around 3 months of age, progressing to include 
lower frequencies and produce a severe to profound loss by 12 to 18 months (Hequembourg 
and Liberman 2001). At a histological level, this correlates with a loss of OHCs initially followed 
by loss of IHCs and SGCs (Mikaelian 1979). The survival of SGCs and their neurons is 
dependent upon pre- and post-synaptic trophic support from hair cells and central axons 
respectively. In the mouse, loss of the former leads to SGC death in a retrograde manner, 
starting distally at the dendritic processes and extending proximally to involve the cell body 
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(Hequembourg and Liberman 2001; Roehm and Hansen 2005; White et al., 2000). This is 
similar to the findings in human studies (Felder et al., 1997; Nadol, Jr. 1990; Otte et al., 1978; 
Suzuka and Schuknecht 1988). Primary degeneration can also occur in the absence of hair 
cell and central axonal loss within the apical cochlea, where neuronal losses can occur despite 
a steady increase in IHC numbers from midcochlear to apical regions (Hequembourg and 
Liberman 2001). Such losses have also been found to correlate with degenerative changes in 
pillar cells and Reissner’s membrane, suggesting the interplay of various mechanisms 
including loss of trophic support and ion dysregulation (Ohlemiller and Gagnon 2004). The 
idea of primary SGC degeneration has also been shown in other mammals also where the 
involvement of independent cellular mechanisms such as the presence of reactive oxygen 
species have been proposed (Perez and Bao 2011).  
In the present study, inclusion of a non-implanted control ear allowed an assessment of 
potential age-related change in SGC density over time. As six month old mice were used, an 
element of age-related change was already apparent from the outset, with evidence of missing 
SGCs and a reduction in volume of some of the cell bodies within Rosenthal’s canal (Figure 
5.10). Interestingly, however, median SGC density was not found to change significantly with 
time in this group (Table 5.2). It would have been reasonable to expect SGC numbers to 
decline, especially 12 weeks following initial implantation, however, this was not observed. 
This may have been due to the fact that the numbers of animals within each group were too 
small to demonstrate such a change. As SGC death occurs in a retrograde manner, 
degeneration of the peripheral dendritic processes may already have been present despite 
retention of the cell body.  
 
5.8.2.2 Effect of cochlear implantation on spiral ganglion cells 
As well as direct mechanical injury, the fact that CI leads to provocation of a robust 
inflammatory process can be damaging to SGCs as well as residual hair cells. Bas et al. found 
evidence of leucocyte recruitment and release of pro-inflammatory cytokines within the area 
of the spiral ganglia in the early stages following CI. The subsequent reparative phase also 
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showed persisting neuro-inflammation of the spiral ganglion neurons, both of which could have 
detrimental effects on the viability of SGCs (Bas et al., 2015). Kawano et al. found a negative 
correlation between SGC survival and the level of new bone and fibrous tissue (Kawano et al., 
1998). In contrast to this, Li et al. (2007) found no correlation between the total number of 
SGCs and new tissue formation (Li et al., 2007).  
In the current study, no significant reduction in SGC density was noted as a result of 
implantation. A decline in SGC density was seen in the lower basal turn of implanted cochleae 
compared to controls but this was not significant on statistical testing. This is supported by 
Kopelvich et al. (2015) who also found no significant difference in SGC body density or 
peripheral axon density when comparing implanted and non-implanted controls in a murine 
model of CI. The latter study similarly represented CI in the absence of any acoustic or 
electrical inputs (Kopelovich et al., 2015). In other animal models of CI, similar findings were 
noted, as spiral ganglion neuron density was not found to differ significantly between implanted 
and non-implanted cochleae (Addams-Williams et al., 2011; Kang et al., 2010; Lu et al., 2005a; 
Tanaka et al., 2014). Human temporal bone studies have also shown that implantation does 
not impact negatively upon the numbers of SGCs (Fayad et al., 2009; Linthicum, Jr. et al., 
1991; Marsh et al., 1992; Nadol, Jr. 1997; Nadol, Jr. et al., 2001; Quesnel et al., 2016). The 
role of electrical stimulation on SGC numbers, as well as the relationship between SGC 
numbers and outcomes following CI, remain contentious issues and are discussed further in 
the following chapter.  
 
5.8.3 Effect of cochlear implantation on hair cells 
The survival of residual hair cells is important for a positive outcome following hearing 
preservation CI surgery and emphasises the importance of performing an atraumatic implant 
insertion to prevent or minimise damage and loss of these cells (Bas et al., 2012a; Coco et al., 
2007; Mowry et al., 2012). There are a variety of potential traumatic stimuli which can promote 
loss of hair cells including direct trauma from the electrode array, vibrational and acoustic 
trauma secondary to use of a drill during surgery, the presence of intrascalar blood and bone 
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dust, trauma to the stria vascularis and spiral ligament, disruption of the basilar membrane 
leading to loss of the endocochlear potential, foreign body response to the electrode array and 
bacterial infection (Bas et al., 2012a). All of the aforementioned insults have the ability to 
initiate oxidative stress and an inflammatory response leading to the release of cytokines, 
enzymes and growth factors which lead to apoptosis of hair cells (Bas et al., 2012a; Bas et al., 
2012b; Bas et al., 2015). 
In the current study, three month old C57BL/6J  mice were used to analyse the potential effects 
of implantation on hair cell counts. At this age, high frequency SNHL was already present as 
reflected by the greater mean thresholds seen at the higher frequencies of 32 kHz and 40 kHz 
on preoperative ABR testing (Figure 4.7a and b). As low frequency hearing was maintained in 
these mice, it functioned well as a residual hearing model. Comparisons of mean hair cell 
counts between the implanted and control ears did not show significant differences across the 
mid-basal, mid-apical and apical regions over the four time points tested. However, at 4 weeks 
a significantly lower mean number of inner and outer hair cells were found in the basal region 
of the implanted ear compared to the control ear. The latter result may have occurred as a 
result of implantation trauma due to the inflammatory and fibrotic changes which predominated 
within this region of the cochlea. These findings also correlate with functional outcomes as 
ABR testing revealed mean thresholds to be significantly greater in the implanted ear 
compared to the control ear at this time point at the higher frequencies of 32 kHz and 40 kHz, 
corresponding to changes in the basal turn. Apical hair cell counts did not appear to be affected 
by implantation in the cohort of mice analysed. In terms of functional outcomes, this was also 
reflected by the fact that low-frequency hearing was preserved (Figure 4.8).  
Other studies have also examined the effect of implantation on hair cells. Bas et al. (2012) 
used novel organ of Corti explants from rats to demonstrate the detrimental effects of 
implantation on hair cells, specifically identifying the role of the activated caspase-3 pathway 
leading to apoptosis (Bas et al., 2012b). Hair cell loss following implantation trauma has also 
been seen in vivo in other animal models (Eshraghi et al., 2005; Vivero et al., 2008). 
Conversely, Kopelvich et al. (2015) did not find a significant difference in terms of organ of 
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Corti damage (including loss of hair cells) between control and implanted cochleae of mice 
(Kopelovich et al., 2015). This was also the case in the guinea pig, where hair cell loss 
following implantation was not observed (Kang et al., 2010; Tanaka et al., 2014). Human 
temporal bone studies have also shown preservation of inner and outer hair cells apical to the 
electrode array suggesting that factors other than hair cell loss may be contributing to the loss 
of residual hearing seen in some patients (Linthicum, Jr. et al., 1991; Quesnel et al., 2016).  
 
5.8.4 Limitations and further work 
There are a number of limitations related to the work performed in this chapter which requires 
discussion. One of the main drawbacks was related to the sample sizes used in the analysis 
of inflammation, SGC counts and hair cell counts. Although the findings were interesting and 
in line with those of other studies, as numbers were small, the data needs to be interpreted 
with this in mind. It would also have been useful to include both age groups of mice (3 month 
and 6 month old) in the analysis of SGC and hair cell counts as this would have enabled the 
presence of any age-related changes to also be discussed.  
As mentioned, further analysis of the inflammatory response to identify the various subtypes 
of leucocytes present would have been beneficial in establishing the phase of the response 
over the various durations of implantation. Use of cell-specific antibodies would therefore be 
valuable in future studies. Confirmation and quantification of fibrous tissue developing in the 
mouse cochlea post-CI would have also be useful and allow correlation with functional 
outcomes. 
When analysis of the plastic embedded fluorocarbon-implanted cochleae was undertaken by 
TEM, as well as presenting the fibrotic-like tissue in more detail, sections also showed 
evidence of tissue of epithelial origin. This suggested the possibility of epithelial remnants from 
the round window being pushed into the scala tympani on insertion of the implant or possibly 
migrating along the implant. Although the fibrotic reaction most likely results from the surgical 
trauma, initiation of inflammation and subsequent reparative response, there may also be 
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other factors at play such as the remnants from the round window membrane and the muscle 
tissue used in sealing the incision. The current mouse model could be used to investigate this 
area further, for example, through the use of fluorescently labelled cell-trackers to ascertain 
the origin of cells contributing to the scar tissue present post-CI.  
 
5.9 Conclusion 
With increasing interest in widening candidacy for CI to patients with low frequency residual 
hearing, knowledge of the potential effects of implantation, including the role of inflammation 
and fibrosis, on residual hearing is of paramount importance to avoid loss of remaining hair 
cells and neurons. In the current study, preservation of hair cells and spiral ganglion cells 
following CI in the mouse, correlates with functional findings and reinforces the suitability of 
the mouse as a model for the investigation of residual hearing in CI. As electrical stimulation 
was not used in the current model, the findings represent a baseline against which future 
studies incorporating electrical stimulation can be compared. This is important not only in 
terms of investigating hearing loss but also as a means to evaluate potential therapeutic 
interventions to preserve it and improve patient outcomes following CI.  
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CHAPTER 6: GENERAL DISCUSSION 
 
Since their introduction cochlear implants have revolutionised the treatment of profound 
hearing loss and have now provided hearing rehabilitation to more than 300,000 individuals 
worldwide (National Institute on Deafness and Other Communication Disorders 2016). 
Alongside technological innovations, device improvements and the relaxation of eligibility 
criteria, candidacy for CI has also changed, with more and more individuals gaining benefit 
from implantation (Irving et al., 2014a). One of the main areas of change has been the 
extension of cochlear implants to patients with residual hearing loss through the use of 
combined electrical and acoustic stimulation. Despite many patients being implanted in this 
group, mixed outcomes have raised concerns regarding their potential benefits, as some 
patients have lost all or part of their residual hearing. The underlying cause of this loss has not 
been fully elucidated (Mowry et al., 2012; Santa Maria et al., 2013). With this in mind, 
deciphering the effects of CI on cochlear structure and function has become paramount, 
especially if these implants are to be offered more widely. 
Animal models have formed a key aspect of CI research mainly due to the fact that CI in the 
human cochlea cannot be studied during life. Mice are an important model for auditory 
research, partly due to the wide range of naturally-occurring and genetically-modified strains 
which mimic human deafness, as well the their similarities to humans in terms of anatomy and 
physiology. As such, being able to harness these and many of the other advantageous 
features of mice as a model for CI research is highly sought after. 
 
6.1 Development of a mouse model of CI 
This thesis describes a body of research whose primary aim was to develop a mouse model 
of CI. Chapter 3 describes the successful development of this model. There was evidence of 
a clear learning curve with an initial high rate of mortality. As a result of refining the surgical 
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technique, however, mortality fell and survival rates reached 95%. The main driver for 
improved mortality was an increased understanding of murine anatomy together with the initial 
decision to use a post auricular approach to access the middle ear. Benefits of this approach 
included a less extensive dissection than is associated with the ventral approach, with reduced 
potential for morbidity and mortality. However, the principle modification to surgical technique 
was the avoidance of iatrogenic injury to the stapedial artery. This vessel arises from the 
internal carotid artery and runs within the deeper aspect of the posterior belly of digastric 
muscle to enter the bulla at its posterior-medial aspect. It is necessary to partly divide this 
muscle to obtain access to the auditory bulla. Careful and minimal dissection in this area 
resulted in a reduced incidence of injury to the stapedial artery and when combined with a 
more limited bullotomy meant that a targeted approach to the round window could be used. 
These are the key steps in the evolution of this postauricular approach to CI in the mouse. 
At the time of developing this model (October 2011), there were no published studies of CI in 
the mouse, making this model novel and a clear advancement in CI research. Since 
developing this model, however, there have been a few studies of mouse CI published (Bas 
et al., 2015; Irving et al., 2013; Kopelovich et al., 2015; Soken et al., 2013). Although all of 
these studies also utilised a postauricular approach in order to access the mouse cochlea, 
other aspects of the surgical procedure and investigation varied. As part of their study Irving 
et al. (2013) assessed the effects of acute and chronic implantation in young C57BL/6J (aged 
8-10 weeks) who had been deafened using neomycin. The group advocated cauterisation of 
the stapedial artery as part of their approach to access the round window. This was despite 
the recognised potential for thermal injury to the cochlea and also after they had demonstrated 
the fact that cautery of the artery can lead to elevated hearing thresholds on ABR. They 
suggested that the risk of fatal haemorrhage from the artery outweighed these consequences 
(Irving et al., 2013). In the present study there were no cases of mortality due to haemorrhage 
from the stapedial artery following implantation. It is an unnecessary step which is not required 
if adequate care is taken and is supported by others (Bas et al., 2015; Kopelovich et al., 2015; 
Soken et al., 2013).  
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Both Irving et al. (2013) and Soken et al. (2013) accessed the tympanic bulla using a drill with 
a diamond burr (Irving et al., 2013; Soken et al., 2013). Although this method was trialled 
initially, it was found that the potential for collateral damage was high and that the bony wall 
was thin enough to be breached with a hypodermic needle and could be increased in size with 
ease using micro-forceps. This also allowed a more targeted bullotomy to be performed. 
Soken et al. (2013) and Kopelovich et al. (2015) performed closure of the tympanic bulla using 
muscle tissue as in the current study (Kopelovich et al., 2015; Soken et al., 2013). However, 
a polycarboxylate cement (Irving et al., 2013) and tissue glue (Bas et al., 2015) were used by 
others. 
Survival rates in the current study (95%) were favourable or similar compared to other studies 
that have reported overall survival rates of 83% (Kopelovich et al., 2015; Soken et al., 2013). 
The study by Irving et al did not report overall survival so it is unclear from this group what the 
procedural mortality was (Irving et al., 2013).  
A successful surgical technique needs to be reproducible in the hands of other researchers, 
ideally regardless of whether they have a clinical or surgical background. Within our research 
group the method as described has been used by a post-doctoral research fellow with training 
in basic science. She experienced a learning curve with high early mortality as in the current 
study but towards the latter part of the experiments survival exceeded 90%. We are not aware 
that the technique has been adopted by other research groups yet and thus remains to be 
externally validated. 
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6.2 Functional and histological outcomes following CI in the mouse 
 
6.2.1 Strain of mouse 
The choice of C57BL/6J mice allowed investigation into the functional and histological 
consequences following CI in a naturally occurring partial or residual hearing model. As a 
validated model for age-related hearing loss, this strain offers the advantage of not requiring 
the exogenous application of ototoxic agents or noise exposure to induce hearing loss (Soken 
et al., 2013). This strain was also used successfully by others as a model for CI (Kopelovich 
et al., 2015; Soken et al., 2013).  
An alternative strain to assess the baseline effects of cochlear implantation would have been 
the CBA mouse. This strain, which carries an ahl-resistant allele, also develops an age-
dependent high frequency SNHL as a result of the loss of basal IHCs, but does so more 
gradually and at an older age (22-25 months) (Park et al., 2010). The genetically determined 
effects of ageing on the C57BL/6J mouse cochlea can be rapid and profound from as young 
as 3 months and therefore, defining the effects of implantation alone on cochlear pathology 
may have been more straight-forward in the CBA strain.  
6.2.2 Functional outcomes following CI in the mouse 
An important observation of this work is that the very process of CI (in the absence of electrical 
stimulation) is associated with some deterioration in hearing as assessed by ABR testing. 
However, the mean threshold shift in the implanted ear was no greater than 20 dB and 12.5 
dB in the 3 month and 6 month old mice respectively. As behavioural testing in the mice post-
implantation was not performed to assess the impact of this level of hearing loss in one ear, it 
can only be postulated that such a deficit would not be significantly detrimental in functional 
terms. Increased mean threshold shifts in the implanted ear compared to the control ear were 
also seen in other mouse studies and were found to be of greater magnitude compared to the 
current study (Kopelovich et al., 2015; Soken et al., 2013). This may reflect variations in 
surgical technique and differences in the types of electrode used. 
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Importantly, no animal demonstrated complete hearing loss postoperatively and up to 12 
weeks following CI in the current study. Furthermore, results revealed that hearing in the low 
frequencies was maintained in both the 3 and 6 month old age groups over the four time points 
tested. This is an essential feature which could allow use of this mouse model to investigate 
potential effects of CI on residual hearing over longer time periods. The benefit of using the 3 
and 6 month old groups of mice also meant that the effect of age on functional outcomes could 
be assessed, an important factor in the C57BL/6J strain. Results revealed greater mean 
threshold shifts in the older mice suggesting an age-dependent acceleration of low frequency 
hearing loss following CI. This finding could be attributed to the age-related sensitisation of 
the cochlea causing increased susceptibility to implantation-induced damage. 
 
6.2.3 Histological outcomes following CI in the mouse 
Histological sections of plastic-mounted implanted cochleae, in conjunction with CBCT of 
implanted mice, demonstrated that the implants were sited correctly within the scala tympani. 
This data validates the mouse model of CI as it is clearly essential that any surgical technique 
delivers the implant to the correct anatomical location.  
The loss of hearing in the implanted ear following CI may in part relate to the observed 
presence of inflammatory cells and fibrotic-like tissue encapsulating the implant confirmed on 
immunofluorescence, light microscopy and TEM. These findings are in line with other studies 
where normal hearing (James et al., 2008; O'Leary et al., 2013) and residual or partial hearing 
models have been used to investigate the effects of CI (Choi and Oghalai 2005; Irving et al., 
2014b; Kopelovich et al., 2015; Quesnel et al., 2016). The mechanism by which these factors 
give rise to or are associated with the existence of residual hearing loss remains to be clarified. 
Several theories regarding the effect of implantation-induced inflammation, fibrosis and 
osteoneogenesis have been proposed (Bas et al., 2012a; Bas et al., 2012b; Bas et al., 2015; 
Eshraghi et al., 2006; Li et al., 2007). 
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Other authors have also assessed the cochlea’s response to implantation and its potential to 
promote loss of residual hearing. Reiss et al. (2015) investigated hearing loss following CI and 
EAS in a residual hearing guinea pig model. Elevated thresholds were found to be associated 
with stria vascularis capillary changes and reduced presynaptic ribbon and postsynaptic 
receptor counts. The authors speculated that the cause of residual hearing loss may be linked 
to lateral wall blood flow changes rather loss of hair cells following surgical trauma. They also 
proposed that delayed loss of hearing could be as a result of stimulation excitotoxicity or 
inflammation inducing loss of hair cell ribbons and post-synaptic receptors (Reiss et al., 2015).  
Comparisons of insertion technique, comparing round window insertion with cochleostomy 
and their potential influence on residual hearing have also been performed. A recent 
systematic review did not find one technique to be superior over the other in terms of the 
degree of hearing preservation (Havenith et al., 2013). Hod et al. (2016) investigated the round 
window approach and cochleostomy in normal hearing rats and also found both techniques to 
have a similar risk of hearing loss. The majority of hearing loss was experienced at the stage 
of opening the membranous labyrinth, regardless of the approach and was reflected as a 
sensorineural  hearing loss due to alterations in inner ear mechanics (Hod et al., 2016). 
Conversely, Rowe et al. (2016) studied delayed low frequency hearing loss in a guinea pig 
model, comparing round window with cochleostomy insertion. Delayed low frequency hearing 
loss was noted with round window insertions but not with cochleostomy. The authors 
speculated that this loss was unrelated to injury within the scala tympani or the extent of tissue 
reaction post-implantation, but rather related to the muscle graft used to seal the round window 
post-insertion. They suggested that this could be due to round window fibrosis causing 
changes in cochlear mechanics (Rowe et al., 2016). This latter point may also be applicable 
to the current model as a potential contribution to the elevated hearing thresholds noted.  
Despite the numerous studies, it is still difficult to determine which of the various pathological 
responses are directly responsible for, or associated with, the loss of residual hearing following 
CI. Implantation may also act to accelerate the underlying cause of hearing loss rather than 
be a direct cause of it (Irving et al., 2014a). In this regard, the current mouse model will help 
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investigate this area further in an attempt to clarify factors which could be potentially modified 
to produce better outcomes for patients.   
 
 
6.3 Limitations of study 
There are several limitations with regards to the work described in the current study. The 
number of animals used was in line with Home Office regulations which state that the study 
design should allow maximum gain of information with the use of minimum animal numbers, 
for this reason there was judicious use of animals for experiments. Thus, the perioperative 
death of animals early in the study period reduced the subsequent availability of tissue for 
histological analysis. However, since the main aim of the study was to develop a working 
model of CI in mice, this observation was related to the development of the surgical and 
anaesthetic aspects.   
Due to limitations of time related to the two year research program, there were a finite number 
of experiments that could be performed. With more time, it would have been more informative 
to verify the histological findings noted with regards to inflammation, SGC and hair cell counts 
in both age groups of mice rather than just one group as was performed. Comparing findings 
between the 3 and 6 month age groups would have helped validate the findings and allow for 
any age-related changes to be analysed. 
Although both click and tone burst ABR testing were performed, the addition of tympanometry 
or DPOAEs would have added further information with regards to assessing the potential effect 
of middle ear effusions on functional outcomes following CI. The use of automated threshold 
detection when performing ABR testing would also remove the potential for the observer effect 
on results, as ABRs were analysed unblinded by the author.  
With regards to the histological analysis, aside from the main limitation of having small 
numbers of mice in each group when performing analyses, several further avenues warrant 
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investigation to build upon the current findings. These include the use of cell-specific markers 
to identify inflammatory cells, quantification of fibrotic-like tissue and correlation with functional 
outcomes and use of cell-trackers to identify the origin of cells within the tissue encapsulating 
the electrode.  Investigation of the effect of electrical stimulation in this mouse model on all of 
the above would also be extremely valuable (see below).  
6.4 Experimental work performed 
The vast majority of the experimental work was performed by the author unless otherwise 
stated. Work performed included the following: all animal work including cadaveric dissection, 
development of surgical techniques, administration of anaesthesia and other drugs, surgery 
to perform CI, recovery of animals and ABR testing. Laboratory work included sacrifice of 
animals, harvest of cochleae and cochlear preparation for histological analysis (tissue fixation, 
cryosectioning, toluidine blue staining of cryosections and whole mount preparation). Light 
microscopy of toluidine blue stained cryosections, immunofluorescence preparation and 
image acquisition using the confocal microscope was also performed by the author.  
Preparation of plastic-embedded cochleae for light microscopy and TEM was performed by 
Mr Graham Nevill. TEM images were acquired by Professor Andrew Forge. 
 
6.5 Future directions of study using the mouse model of CI 
6.5.1 Use of other mouse strains to investigate the effects of CI 
Although not formally assessed in the current study, this surgical model of CI could be used in 
other strains of mice, including the various naturally occurring and genetically modified strains 
which mimic various types of human deafness. These mice have contributed extensively to 
the identification of causative genes underlying human hereditary deafness as well as 
providing insight into disease-susceptibility genes, for example, in presbyacusis (Ahituv and 
Avraham 2000). As such, these models could also form an important role in CI research. In 
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the case of hereditary hearing loss, including those cases secondary to mutations in Cx26, the 
most common cause of non-syndromic hereditary hearing loss, cochlear implants form a major 
treatment option for hearing rehabilitation. Outcomes in these patients can vary and this is an 
area which still requires investigation (Varga et al., 2014; Vivero et al., 2010). A variety of 
reasons have been cited including age at implantation, social environment, inner ear 
malformations, duration of deafness and the presence of additional disabilities (Black et al., 
2011; Varga et al., 2014). Some authors have suggested, however, that the underlying 
aetiology is one of the most important factors predicting outcomes in terms of auditory 
performance (Varga et al., 2014; Vivero et al., 2010). In this regard, the use of mouse models 
of hearing loss will allow the objective assessment of the effects of CI and further analyse how 
implantation can be optimised and translated to improve patient outcomes.  
 
6.5.2 Use of mouse model of CI to assess the effect of electrical stimulation 
The current study has assessed the effects of CI in the mouse in the absence of electrical 
stimulation. The next logical step would be to investigate the effect of electrical stimulation on 
both functional and histological outcomes in this model to allow a more realistic perspective to 
be gained, analogous to the setting experienced by CI patients. In essence the present work 
forms a baseline investigation against which future studies involving electrical stimulation can 
be compared.  
From the few mouse CI studies that have been published to date, only one has involved the 
use of electrical stimulation. Irving et al. (2013) used an electrode array with a fully implantable 
stimulator to investigate the effects of acute and chronic electrical stimulation in young 
C57BL/6J mice deafened using neomycin. The team were able to successfully record 
electrically-evoked auditory brainstem responses (EABR) and magnetically-induced, 
electrically-evoked auditory brainstem responses (mEABR) in the mice following acute and 
chronic implantation respectively. Chronic stimulation over a 1 month period revealed stable 
mEABRs and no evidence of altered spiral ganglion neuron density when compared to the 
unstimulated controls, although these findings need to be interpreted in the context of the small 
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numbers of animals used (n=3) (Irving et al., 2013). As SGCs are the target for stimulation in 
CI, their survival is critical to producing a positive outcome following implantation. That said, 
however, several human temporal bone studies have shown a lack of correlation between 
numbers of SGCs and CI performance (Fayad and Linthicum, Jr. 2006; Irving et al., 2013; 
Khan et al., 2005; Nadol, Jr. et al., 2001). The effect of electrical stimulation on SGCs has 
remained a contentious issue in cochlear implant research. Some studies have suggested that 
SGC density can be increased with electrical stimulation (Hartshorn et al., 1991; Leake et al., 
1991; Leake et al., 1999; Mitchell et al., 1997). Conversely, as per the findings from the 
aforementioned mouse study (Irving et al., 2013), many others have reported that chronic 
electrical stimulation has no effect on spiral ganglion neuron survival (Araki et al., 1998; Araki 
et al., 2000; Chen et al., 2010; Coco et al., 2007; Landry et al., 2011; Shepherd et al., 1994; 
Shepherd et al., 2005; Wise et al., 2011).  
With regards to the effect of electrical stimulation on the survival of hair cells and maintenance 
of residual hearing, Coco et al. (2007) found that chronic stimulation did not affect residual hair 
cell function apical to the electrode array in a partial hearing feline model (Coco et al., 2007). 
These findings correlate with other studies in normal hearing animals which have 
demonstrated hair cell survival apical to the electrode array following atraumatic CI (Shepherd 
et al., 1983; Xu et al., 1997). Within their partial hearing model, the authors also noted evidence 
of fibrous tissue in the basal turn of implanted cochleae but did not find a significant difference 
in the extent of fibrous tissue between stimulated and non-stimulated cochleae (Coco et al., 
2007). This was also the case in the mouse model where comparable amounts of fibrous 
tissue and new bone filled the scala tympani of both stimulated and unstimulated animals 
following CI (Irving et al., 2013). 
Aside from the effects of chronic electrical stimulation alone on the cochlea following CI, one 
of the main areas of interest in relation to EAS is the interaction between electrical and acoustic 
stimuli. Ensuring optimal interactions between the two in spatial and temporal terms means 
that patients will be able to gain maximal benefit. There is the risk, however, that the quality of 
the incoming signal can deteriorate due to one stimulus masking the other (Irving et al., 2014a). 
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Use of the current mouse model will therefore prove invaluable in terms of investigating and 
further refining EAS strategies. It will also play a vital part in assessing the effects of electrical 
stimulation on residual hearing and allow a detailed histological assessment to be made.   
 
6.5.3 Potential role of mouse model of CI in therapeutics 
The role of therapeutics in CI is an expanding field. In the case of EAS, the development of 
agents to preserve residual hair cells and SGC function is gaining momentum alongside 
refinements in surgical technique and device advances. Localised drug delivery is the modality 
of choice in most cases as it allows targeted administration without the associated adverse 
outcomes that may arise from systemic delivery. Methods include infusion to the cochlear 
fluids at the time of implant insertion, drug-eluting electrode arrays, cell-based therapies and 
specific carriers which allow diffusion of agents across the round window membrane (Irving et 
al., 2014a).  
A variety of therapeutic agents have been used to date including neurotrophic factors (BDNF 
and NT-3) to provide trophic support to SGCs (Altschuler et al., 1999; Kanzaki et al., 2002; 
Nakaizumi et al., 2004; Shepherd et al., 2005; Staecker et al., 1998). Corticosteroids (Bird et 
al., 2007; Bird et al., 2011; Chang et al., 2009; Eshraghi et al., 2007; James et al., 2008; Vivero 
et al., 2008) and anti-oxidants (Yamasoba et al. 1998; Eastwood et al. 2010; Kawamoto et al. 
2004) have been used to ameliorate the adverse effects of inflammation and fibrosis and 
antiapoptotic agents to prevent hair cell degeneration (Eshraghi et al., 2006; Matsui et al., 
2002). In addition, neurotrophins have demonstrated huge potential in the role of 
neuritogenesis (Altschuler et al., 1999; Miller et al., 2007; Staecker et al., 1996; Wise et al., 
2005) and with the continual development of gene therapy, the application of these factors to 
the inner ear over the longer term is looking more promising (Atkinson et al., 2012; Shibata et 
al., 2010; Wise et al., 2011; Yagi et al., 2000). 
In order for these therapeutic interventions to be translated to patients to improve CI outcomes, 
further work to determine the most suitable agent or combination of agents, delivery method, 
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duration and doses of treatment is required (Irving et al., 2014a). Animal models are essential 
for this type of investigation and the present mouse model of CI represents an excellent 
candidate for such purposes.  
 
6.6 Conclusion 
The work presented in this thesis describes the successful development of a viable and 
reproducible model of mouse CI. This model has many advantages over previously described 
animal models used in CI research. It provides numerous possibilities for exploring the 
interface between the biological and technological aspects of CI, as well as playing a vital 
potential role in the development of therapeutic interventions. Ultimately, it is hoped that the 
result of such investigations will one day translate to improved outcomes for patients 
undergoing CI.  
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APPENDIX 1 Weight chart for sham operated mice 
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Sham operated mice - weight chart 
Mouse Time point Weight Mouse Time point Weight 
 
6 
Pre-operative 48.5  
9 
Pre-operative 31.3 
Day 1 post-op 44.5 Day 1 post-op 29.4 
Day 2 post-op 44 Day 2 post-op 30.1 
Day 3 post-op 43.2 Day 3 post-op 30.6 
Day 4 post-op 44.7 Day 4 post-op 31.4 
Day 5 post-op 44.6 Day 5 post-op 31.7 
Day 6 post-op 44.5 Day 6 post-op 31.9 
Day 7 post-op 44.1 Day 7 post-op 31.5 
Day 14 post-op 45.6 Day 14 post-op 33.3 
Day 21 post-op 45.9 Day 21 post-op 32.8 
Day 28 post-op 47.9 Day 28 post-op 32.5 
 
7 
Pre-operative 40.9  
12 
Pre-operative 36.4 
Day 1 post-op 38.6 Day 1 post-op 34.1 
Day 2 post-op 37.8 Day 2 post-op 34.5 
Day 3 post-op 38.1 Day 3 post-op 34.5 
Day 4 post-op 39.2 Day 4 post-op 35.9 
Day 5 post-op 39 Day 5 post-op 33.9 
Day 6 post-op 39 Day 6 post-op 35.3 
Day 7 post-op 39 Day 7 post-op 34.7 
Day 14 post-op 42.3 Day 14 post-op 35.1 
Day 21 post-op 43.4 Day 21 post-op 35.5 
Day 28 post-op 42.6 Day 28 post-op 37.4 
 
8 
Pre-operative 40.5  
13 
Pre-operative 42.3 
Day 1 post-op 38.5 Day 1 post-op 41 
Day 2 post-op 38.5 Day 2 post-op 40.4 
Day 3 post-op 38.1 Day 3 post-op 40.6 
Day 4 post-op 38.7 Day 4 post-op 41.4 
Day 5 post-op 38.4 Day 5 post-op 40.3 
Day 6 post-op 38.3 Day 6 post-op 40.7 
Day 7 post-op 38.4 Day 7 post-op 42.3 
Day 14 post-op 40.6 Day 14 post-op 42.5 
Day 21 post-op 42 Day 21 post-op 42.1 
Day 28 post-op 42 Day 28 post-op 42 
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Mouse Time point Weight 
 
14 
Pre-operative 37.9 
Day 1 post-op 35.7 
Day 2 post-op 35 
Day 3 post-op 34.1 
Day 4 post-op 34.3 
Day 5 post-op 36.5 
Day 6 post-op 36.4 
Day 7 post-op 36.4 
Day 14 post-op 36.8 
Day 21 post-op 38 
Day 28 post-op 37.8 
 
15 
Pre-operative 37.3 
Day 1 post-op 37.9 
Day 2 post-op 35.4 
Day 3 post-op 35.6 
Day 4 post-op 36.4 
Day 5 post-op 35.3 
Day 6 post-op 35.7 
Day 7 post-op 37.3 
Day 14 post-op 37.5 
Day 21 post-op 37.1 
Day 28 post-op 36.9 
 
 
  
mouse 
6 
mouse 
7 
mouse 
8 
mouse 
9 
mouse 
12 
mouse 
13 
mouse 
14 
mouse 
15 
Pre-op 
wt 48.5 40.9 40.5 31.3 36.4 42.3 37.9 37.3 
Wt day 1 44.5 38.6 38.5 29.4 34.1 41 35.7 37.9 
wt 
change 4 2.3 2 1.9 2.3 1.3 2.2 -0.55 
% 
change 8.2 5.6 4.9 6.1 6.3 3.1 5.8 -1.5 
 
  
mouse 
6 
mouse 
7 
mouse 
8 
mouse 
9 
mouse 
12 
mouse 
13 
mouse 
14 
mouse 
15 
Pre-op 
wt 48.5 40.9 40.5 31.3 36.4 42.3 37.9 37.3 
Wt day 7 44.1 39 38.4 31.5 34.7 42.3 36.4 37.3 
wt 
change 4.4 1.9 2.1 -0.2 1.7 0 1.5 0 
% change 9.1 4.6 5.2 -0.6 4.7 0 4.0 0 
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mouse 
6 
mouse 
7 
mouse 
8 
mouse 
9 
mouse 
12 
mouse 
13 
mouse 
14 
mouse 
15 
Pre-op wt 48.5 40.9 40.5 31.3 36.4 42.3 37.9 37.3 
Wt day 
28 47.9 42.6 42 32.5 37.4 42 37.8 36.9 
wt 
change 0.6 -1.7 -1.5 -1.2 -1 0.3 0.1 0.45 
% change 1.2 -4.2 -3.7 -3.8 -2.7 0.7 0.2 1.2 
  
Wt = weight  
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APPENDIX 2 Mouse details 
Details of mice implanted in study 
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Details of all mice implanted mice in (a) 3 month and (b) 6 month age group 
 
 
Number  Gender Age (Days) Group Implant time Implant type 
1 M 97 3 month 48 hours Fluorocarbon 
2 M 97 3 month 48 hours Fluorocarbon 
3 M 122 3 month 48 hours Fluorocarbon 
4 M 98 3 month 48 hours Electrode array 
5 M 98 3 month 48 hours Electrode array 
6 M 99 3 month 48 hours Electrode array 
7 M 96 3 month 1 week Fluorocarbon 
8 M 92 3 month 1 week Fluorocarbon 
9 F 147 3 month 1 week Electrode array 
10 M 92 3 month 1 week Electrode array 
11 M 90 3 month 4 weeks Fluorocarbon 
12 M 96 3 month 4 weeks Fluorocarbon 
13 M 93 3 month 4 weeks Fluorocarbon 
14 M 109 3 month 4 weeks Electrode array 
15 M 109 3 month 4 weeks Electrode array 
16 M 97 3 month 12 weeks Fluorocarbon 
17 M 107 3 month 12 weeks Fluorocarbon 
18 M 91 3 month 12 weeks Electrode array 
 
Gender Age (Days) Group Implant time Implant type 
1 F 189 6 month 48 hours Electrode array 
2 F 194 6 month 48 hours Electrode array 
3 F 201 6 month 48 hours Fluorocarbon 
4 F 184 6 month 48 hours Fluorocarbon 
5 F 184 6 month 48 hours Fluorocarbon 
6 M 199 6 month 48 hours Fluorocarbon 
7 M 212 6 month 1 week Electrode array 
8 M 213 6 month 1 week Fluorocarbon 
9 F 194 6 month 1 week Fluorocarbon 
10 F 194 6 month 1 week Fluorocarbon 
11 M 243 6 month 4 weeks Electrode array 
12 M 207 6 month 4 weeks Fluorocarbon 
13 M 221 6 month 4 weeks Fluorocarbon 
14 M 198 6 month 12 weeks Electrode array 
15 M 199 6 month 12 weeks Electrode array 
16 F 156 6 month 12 weeks Fluorocarbon 
17 M 199 6 month 12 weeks Fluorocarbon 
 
(a) 
(b) 
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